<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1 20151215//EN"  "JATS-archivearticle1.dtd"><article article-type="research-article" dtd-version="1.1" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn pub-type="epub" publication-format="electronic">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">59464</article-id><article-id pub-id-type="doi">10.7554/eLife.59464</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Research Advance</subject></subj-group><subj-group subj-group-type="heading"><subject>Developmental Biology</subject></subj-group><subj-group subj-group-type="heading"><subject>Neuroscience</subject></subj-group></article-categories><title-group><article-title>Establishment and maintenance of motor neuron identity via temporal modularity in terminal selector function</article-title></title-group><contrib-group><contrib contrib-type="author" id="author-149048"><name><surname>Li</surname><given-names>Yinan</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="con1"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-190389"><name><surname>Osuma</surname><given-names>Anthony</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="other" rid="fund1"/><xref ref-type="fn" rid="con2"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-190390"><name><surname>Correa</surname><given-names>Edgar</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="other" rid="fund2"/><xref ref-type="fn" rid="con3"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-190391"><name><surname>Okebalama</surname><given-names>Munachiso A</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con4"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-149049"><name><surname>Dao</surname><given-names>Pauline</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con5"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-190392"><name><surname>Gaylord</surname><given-names>Olivia</given-names></name><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="fn" rid="con6"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-149050"><name><surname>Aburas</surname><given-names>Jihad</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con7"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-149051"><name><surname>Islam</surname><given-names>Priota</given-names></name><xref ref-type="aff" rid="aff5">5</xref><xref ref-type="aff" rid="aff6">6</xref><xref ref-type="fn" rid="con8"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-149054"><name><surname>Brown</surname><given-names>André EX</given-names></name><xref ref-type="aff" rid="aff5">5</xref><xref ref-type="aff" rid="aff6">6</xref><xref ref-type="other" rid="fund6"/><xref ref-type="fn" rid="con9"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-81091"><name><surname>Kratsios</surname><given-names>Paschalis</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-1363-9271</contrib-id><email>pkratsios@uchicago.edu</email><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="aff" rid="aff7">7</xref><xref ref-type="other" rid="fund3"/><xref ref-type="other" rid="fund4"/><xref ref-type="other" rid="fund5"/><xref ref-type="fn" rid="con10"/><xref ref-type="fn" rid="conf1"/></contrib><aff id="aff1"><label>1</label><institution>Department of Neurobiology, University of Chicago</institution><addr-line><named-content content-type="city">Chicago</named-content></addr-line><country>United States</country></aff><aff id="aff2"><label>2</label><institution>Committee on Neurobiology, University of Chicago</institution><addr-line><named-content content-type="city">Chicago</named-content></addr-line><country>United States</country></aff><aff id="aff3"><label>3</label><institution>Cell and Molecular Biology Program, University of Chicago</institution><addr-line><named-content content-type="city">Chicago</named-content></addr-line><country>United States</country></aff><aff id="aff4"><label>4</label><institution>Committee on Development, Regeneration and Stem Cell Biology, University of Chicago</institution><addr-line><named-content content-type="city">Chicago</named-content></addr-line><country>United States</country></aff><aff id="aff5"><label>5</label><institution>MRC London Institute of Medical Sciences</institution><addr-line><named-content content-type="city">London</named-content></addr-line><country>United Kingdom</country></aff><aff id="aff6"><label>6</label><institution>Institute of Clinical Sciences, Imperial College London</institution><addr-line><named-content content-type="city">London</named-content></addr-line><country>United Kingdom</country></aff><aff id="aff7"><label>7</label><institution>The Grossman Institute for Neuroscience, Quantitative Biology, and Human Behavior, University of Chicago</institution><addr-line><named-content content-type="city">Chicago</named-content></addr-line><country>United States</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor"><name><surname>Desplan</surname><given-names>Claude</given-names></name><role>Reviewing Editor</role><aff><institution>New York University</institution><country>United States</country></aff></contrib><contrib contrib-type="senior_editor"><name><surname>Bronner</surname><given-names>Marianne E</given-names></name><role>Senior Editor</role><aff><institution>California Institute of Technology</institution><country>United States</country></aff></contrib></contrib-group><pub-date date-type="publication" publication-format="electronic"><day>01</day><month>10</month><year>2020</year></pub-date><pub-date pub-type="collection"><year>2020</year></pub-date><volume>9</volume><elocation-id>e59464</elocation-id><history><date date-type="received" iso-8601-date="2020-06-01"><day>01</day><month>06</month><year>2020</year></date><date date-type="accepted" iso-8601-date="2020-09-20"><day>20</day><month>09</month><year>2020</year></date></history><permissions><copyright-statement>© 2020, Li et al</copyright-statement><copyright-year>2020</copyright-year><copyright-holder>Li et al</copyright-holder><ali:free_to_read/><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><ali:license_ref>http://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-59464-v1.pdf"/><related-article ext-link-type="doi" id="ra1" related-article-type="article-reference" xlink:href="10.7554/eLife.50065"/><abstract><p>Terminal selectors are transcription factors (TFs) that establish during development and maintain throughout life post-mitotic neuronal identity. We previously showed that UNC-3/Ebf, the terminal selector of <italic>C. elegans</italic> cholinergic motor neurons (MNs), acts indirectly to prevent alternative neuronal identities (Feng et al., 2020). Here, we globally identify the direct targets of UNC-3. Unexpectedly, we find that the suite of UNC-3 targets in MNs is modified across different life stages, revealing ‘temporal modularity’ in terminal selector function. In all larval and adult stages examined, UNC-3 is required for continuous expression of various protein classes (e.g. receptors, transporters) critical for MN function. However, only in late larvae and adults, UNC-3 is required to maintain expression of MN-specific TFs. Minimal disruption of UNC-3’s temporal modularity via genome engineering affects locomotion. Another <italic>C. elegans</italic> terminal selector (UNC-30/Pitx) also exhibits temporal modularity, supporting the potential generality of this mechanism for the control of neuronal identity.</p></abstract><kwd-group kwd-group-type="author-keywords"><kwd>transcription factors</kwd><kwd>neuronal identity</kwd><kwd>motor neurons</kwd><kwd>UNC-3/Ebf</kwd><kwd>UNC-30/Pitx</kwd></kwd-group><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd><italic>C. elegans</italic></kwd></kwd-group><funding-group><award-group id="fund1"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000057</institution-id><institution>National Institute of General Medical Sciences</institution></institution-wrap></funding-source><award-id>Graduate student fellowship (2R25GM109439-06)</award-id><principal-award-recipient><name><surname>Osuma</surname><given-names>Anthony</given-names></name></principal-award-recipient></award-group><award-group id="fund2"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000057</institution-id><institution>National Institute of General Medical Sciences</institution></institution-wrap></funding-source><award-id>Graduate student fellowship (T32 GM007183)</award-id><principal-award-recipient><name><surname>Correa</surname><given-names>Edgar</given-names></name></principal-award-recipient></award-group><award-group id="fund3"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100001391</institution-id><institution>Whitehall Foundation</institution></institution-wrap></funding-source><award-id>New Faculty Award (2017-12-50)</award-id><principal-award-recipient><name><surname>Kratsios</surname><given-names>Paschalis</given-names></name></principal-award-recipient></award-group><award-group id="fund4"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000065</institution-id><institution>National Institute of Neurological Disorders and Stroke</institution></institution-wrap></funding-source><award-id>R00NS084988</award-id><principal-award-recipient><name><surname>Kratsios</surname><given-names>Paschalis</given-names></name></principal-award-recipient></award-group><award-group id="fund5"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000065</institution-id><institution>National Institute of Neurological Disorders and Stroke</institution></institution-wrap></funding-source><award-id>R21NS108505</award-id><principal-award-recipient><name><surname>Kratsios</surname><given-names>Paschalis</given-names></name></principal-award-recipient></award-group><award-group id="fund6"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100000265</institution-id><institution>Medical Research Council</institution></institution-wrap></funding-source><award-id>MC-A658-5TY30</award-id><principal-award-recipient><name><surname>Brown</surname><given-names>André EX</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.</funding-statement></funding-group><custom-meta-group><custom-meta specific-use="meta-only"><meta-name>Author impact statement</meta-name><meta-value>The terminal selector-type transcription factor UNC-3/Ebf partially modifies the suite of its target genes at different life stages to establish and maintain the identity of <italic>C. elegans</italic> motor neurons.</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="s1" sec-type="intro"><title>Introduction</title><p>Nervous system development is a multi-step process that culminates in the generation of distinct neuron types necessary for animal behavior. Seminal studies in many model systems have begun to elucidate the molecular mechanisms that control the early steps of neuronal development, such as specification of neural progenitors and generation of post-mitotic neurons (<xref ref-type="bibr" rid="bib8">Catela and Kratsios, 2019</xref>; <xref ref-type="bibr" rid="bib14">Doe, 2017</xref>; <xref ref-type="bibr" rid="bib22">Greig et al., 2013</xref>; <xref ref-type="bibr" rid="bib35">Jessell, 2000</xref>; <xref ref-type="bibr" rid="bib50">Lodato and Arlotta, 2015</xref>; <xref ref-type="bibr" rid="bib61">Perry et al., 2017</xref>). However, our understanding of the final steps of neuronal development is very rudimentary. Once neurons become post-mitotic, how do they acquire their unique functional features, such as neurotransmitter synthesis, electrical activity and signaling properties? And, perhaps more importantly, how do neurons maintain such features throughout post-embryonic life?</p><p>Terminal selectors represent one class of transcription factors (TFs) with continuous expression – from development through adulthood – in specific neuron types (<xref ref-type="bibr" rid="bib26">Hobert, 2008</xref>; <xref ref-type="bibr" rid="bib27">Hobert, 2011</xref>; <xref ref-type="bibr" rid="bib29">Hobert, 2016b</xref>; <xref ref-type="bibr" rid="bib21">García-Bellido, 1975</xref>). A defining feature of terminal selectors is the ability to activate the expression of effector genes, whose protein products determine the terminally differentiated state, and thereby function, of a given neuron type. Such effector genes, herein referred to as ‘terminal identity genes’, are expressed continuously in specific neuron types and endow them with distinct functional and phenotypic properties. Examples include neurotransmitter (NT) biosynthesis components, NT receptors, ion channels, neuropeptides, and adhesion molecules (<xref ref-type="bibr" rid="bib26">Hobert, 2008</xref>; <xref ref-type="bibr" rid="bib27">Hobert, 2011</xref>; <xref ref-type="bibr" rid="bib29">Hobert, 2016b</xref>). Numerous studies support the idea that terminal selectors establish during development and maintain throughout life neuronal identity (and function) by activating expression of terminal identity genes (<xref ref-type="bibr" rid="bib13">Deneris and Hobert, 2014</xref>; <xref ref-type="bibr" rid="bib26">Hobert, 2008</xref>; <xref ref-type="bibr" rid="bib29">Hobert, 2016b</xref>; <xref ref-type="bibr" rid="bib30">Hobert and Kratsios, 2019</xref>). Multiple cases of terminal selectors have been described thus far in worms, flies, chordates and mice (<xref ref-type="bibr" rid="bib13">Deneris and Hobert, 2014</xref>; <xref ref-type="bibr" rid="bib30">Hobert and Kratsios, 2019</xref>; <xref ref-type="bibr" rid="bib43">Konstantinides et al., 2018</xref>), suggesting high conservation of this type of regulators. Importantly, human mutations in terminal selectors and their effector target genes have been linked to either developmental or degenerative conditions of the nervous system (<xref ref-type="bibr" rid="bib13">Deneris and Hobert, 2014</xref>).</p><p>However, the molecular mechanisms through which terminal selectors establish and maintain neuronal identity are poorly understood, in part due to two major challenges. First, the majority of studies follow a candidate approach focused on a select subset of terminal identity genes (<xref ref-type="bibr" rid="bib20">Flames and Hobert, 2009</xref>; <xref ref-type="bibr" rid="bib28">Hobert, 2016a</xref>; <xref ref-type="bibr" rid="bib51">Lopes et al., 2012</xref>). Hence, the extent of terminal identity features and breadth of biological processes controlled by terminal selectors remain largely unknown. Addressing this knowledge gap requires unbiased methods for the identification of terminal selector target genes, but such approaches have only been applied to a limited number of terminal selectors to date (<xref ref-type="bibr" rid="bib11">Corbo et al., 2010</xref>; <xref ref-type="bibr" rid="bib31">Housset et al., 2013</xref>; <xref ref-type="bibr" rid="bib39">Kadkhodaei et al., 2013</xref>; <xref ref-type="bibr" rid="bib84">Wyler et al., 2016</xref>; <xref ref-type="bibr" rid="bib88">Yu et al., 2017</xref>). Second, the continuous expression of terminal selectors represents an additional challenge because it is not known whether their function - in a particular neuron type - remains the same, or changes at different life stages. This is partly due to the difficulty of tracking individual neurons in the complex vertebrate nervous system throughout embryonic and post-natal life. Hence, longitudinal studies in simple model organisms are needed to determine whether terminal selectors control an identical suite of target genes across different stages (e.g., embryo, adult), or whether the suite of targets can change over time. Addressing these two challenges may extend our knowledge of how terminal selectors control neuronal identity, as well as advance our understanding of how cellular identity is established and maintained.</p><p>This study focuses on UNC-3, the sole <italic>C. elegans</italic> ortholog of the Collier/Olf/Ebf (COE) family of TFs (<xref ref-type="bibr" rid="bib15">Dubois and Vincent, 2001</xref>). UNC-3 acts as a terminal selector in cholinergic motor neurons (MNs) of the <italic>C. elegans</italic> ventral nerve cord (<xref ref-type="bibr" rid="bib44">Kratsios et al., 2011</xref>). Importantly, mutations in EBF3, a human ortholog of UNC-3, cause a neurodevelopmental syndrome characterized by motor developmental delay (<xref ref-type="bibr" rid="bib3">Blackburn et al., 2017</xref>; <xref ref-type="bibr" rid="bib9">Chao et al., 2017</xref>; <xref ref-type="bibr" rid="bib23">Harms et al., 2017</xref>; <xref ref-type="bibr" rid="bib74">Sleven et al., 2017</xref>). A previous study proposed that UNC-3 controls cholinergic MN identity in <italic>C. elegans</italic> by activating directly the expression of various terminal identity genes (e.g., acetylcholine biosynthesis components, ion channels, NT receptors, neuropeptides), which were identified via a candidate approach (<xref ref-type="bibr" rid="bib44">Kratsios et al., 2011</xref>). More recently, it was demonstrated that UNC-3 can also act indirectly to prevent the adoption of alternative neuronal identities (<xref ref-type="bibr" rid="bib19">Feng et al., 2020</xref>). Lastly, animals lacking <italic>unc-3</italic> gene activity display severe locomotion defects (<xref ref-type="bibr" rid="bib5">Brenner, 1974</xref>; <xref ref-type="bibr" rid="bib19">Feng et al., 2020</xref>), suggesting UNC-3 may broadly control gene expression in cholinergic MNs. However, an unbiased identification of UNC-3 targets, as well as a longitudinal analysis of <italic>unc-3</italic> mutants are currently lacking.</p><p>Here, we employ chromatin immunoprecipitation followed by DNA sequencing (ChIP-Seq) and report the identification of ~3500 protein-coding genes as putative direct targets of UNC-3. Protein class ontology analysis suggests that UNC-3, besides terminal identity genes, also controls additional biological processes, such as neuronal metabolism and downstream gene regulatory networks comprised of numerous TFs and nucleic acid-binding proteins. These findings help obtain a comprehensive understanding of terminal selector function.</p><p>Through a longitudinal analysis of <italic>unc-3</italic> mutants at embryonic, larval and adult stages, we identified two groups of target genes with distinct temporal requirements for UNC-3 in cholinergic MNs. One group encodes multiple classes of proteins (e.g., receptors, secreted molecules, TFs) that require UNC-3 for both embryonic initiation and post-embryonic maintenance of their expression. Contrasting this stable mode of regulation over time, a second group of targets consists exclusively of TFs (<italic>cfi-1/Arid3a, bnc-1/BNC1-2, mab-9/Tbx20, ceh-44/CUX1-2, nhr-40/nuclear hormone receptor</italic>) that do not require UNC-3 for initiation, but depend on UNC-3 activity for maintenance. Hence, the suite of UNC-3 targets in cholinergic MNs is modified across different life stages, a phenomenon we term ‘temporal modularity’ in terminal selector function. To provide mechanistic insights, we focused on the second group of targets and identified a molecular mechanism for their <italic>unc-3</italic>-independent initiation that relies on Hox proteins. Importantly, preventing UNC-3’s ability to selectively maintain expression of a single TF (<italic>cfi-1/Arid3a</italic>) from the second target group led to locomotion defects, indicating minimal disruption of temporal modularity affects animal behavior. Lastly, we provide evidence for temporal modularity in the function of UNC-30/PITX, the terminal selector of GABAergic MN identity in <italic>C. elegans</italic> (<xref ref-type="bibr" rid="bib16">Eastman et al., 1999</xref>; <xref ref-type="bibr" rid="bib36">Jin et al., 1994</xref>). Because terminal selectors have been identified in both invertebrate and vertebrate nervous systems (<xref ref-type="bibr" rid="bib13">Deneris and Hobert, 2014</xref>; <xref ref-type="bibr" rid="bib30">Hobert and Kratsios, 2019</xref>), we hypothesize that temporal modularity in their function may be a general mechanism for the establishment and maintenance of neuronal identity.</p></sec><sec id="s2" sec-type="results"><title>Results</title><sec id="s2-1"><title>Identifying the global targets of UNC-3 via ChIP-Seq</title><p>To identify in an unbiased manner putative UNC-3 target genes, we employed chromatin immunoprecipitation followed by DNA sequencing (ChIP-Seq). We used a reporter strain with in-frame GFP sequences inserted immediately upstream of the stop codon of the endogenous <italic>unc-3</italic> gene (<xref ref-type="fig" rid="fig1">Figure 1A</xref>). Expression of UNC-3::GFP fusion protein was observed in the nucleus of 53 cholinergic MNs (SAB subtype = 3 neurons, DA = 9, DB = 7, VA = 12, VB = 11, AS = 11) and 19 other neurons known to express <italic>unc-3</italic> (<xref ref-type="fig" rid="fig1">Figure 1A</xref>), indicating that this reporter faithfully recapitulates the endogenous <italic>unc-3</italic> expression pattern (<xref ref-type="bibr" rid="bib60">Pereira et al., 2015</xref>; <xref ref-type="bibr" rid="bib66">Prasad et al., 1998</xref>). Insertion of GFP does not detectably alter the function of UNC-3 since expression of known UNC-3 targets (<italic>cho-1/ChT, unc-17/VAChT, ace-2/AChE</italic>) is unaffected in <italic>unc-3::gfp</italic> animals (<xref ref-type="fig" rid="fig1">Figure 1B</xref>). Unlike <italic>unc-3</italic> null mutants, <italic>unc-3::gfp</italic> animals do not display locomotion defects. We therefore performed ChIP-Seq on <italic>unc-3::gfp</italic> animals at larval stage 2 (L2) because all <italic>unc-3</italic> expressing neurons have been generated by this stage.</p><fig-group><fig id="fig1" position="float"><label>Figure 1.</label><caption><title>Mapping UNC-3 binding genome-wide with ChIP-Seq.</title><p>(<bold>A</bold>) Diagram illustrating the endogenous reporter allele of UNC-3. GFP is inserted immediately upstream of <italic>unc-3</italic>’s stop codon. Below, a representative image at L2 stage showing expression of UNC-3::GFP fusion protein in cholinergic MN nuclei. Region highlighted in dashed box is enlarged. Scale bar, 20 μm. (<bold>B</bold>) Quantification of terminal identity gene markers that report expression of known UNC-3 targets (<italic>cho-1/ChT, unc-17/VAChT, ace-2/AChE</italic>) in WT and <italic>ot839 [unc-3::gfp]</italic> animals at the L4 stage (N = 15). N. S.: not significant. (<bold>C</bold>) Heatmap of UNC-3 ChIP-Seq signal around 1.0 kb of the center of the binding peak. (<bold>D</bold>) Summary plot of UNC-3 ChIP-Seq signal with a 95% confidence interval (gray area) around 3.0 kb of the TSS. The average signal peak is detected at ~200 bp upstream of the TSS. (<bold>E</bold>) de novo motif discovery analysis of 6,892 UNC-3 binding peaks identifies a 12 bp-long UNC-3 binding motif. (<bold>F</bold>) Pie chart summarizes genomic distribution of UNC-3 ChIP-Seq signal.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-59464-fig1-v1.tif"/></fig><fig id="fig1s1" position="float" specific-use="child-fig"><label>Figure 1—figure supplement 1.</label><caption><title>UNC-3 ChIP-Seq results yield genome-wide enrichment of UNC-3.</title><p>(<bold>A</bold>) Fingerprint plot indicating localized, strong enrichment of UNC-3 in the genome. Specifically, when counting the reads contained in 93% of all genomic bins (data point 0.93, 0.5 on UNC-3 ChIP curve), only 50% of the maximum number of reads are reached, which indicates 7% of the genome contains half of total sequencing reads from the ChIP sample. (<bold>B</bold>) Snapshots of UNC-3 ChIP-Seq and input (negative control) signals at the <italic>cis</italic>-regulatory regions of known UNC-3 targets (<italic>del-1, acc-4, twk-13, dbl-1, unc-77, twk-40</italic>).</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-59464-fig1-figsupp1-v1.tif"/></fig></fig-group><p>Our ChIP-Seq dataset revealed strong enrichment of UNC-3 binding in the genome by identifying a total of 6892 unique binding peaks (q-value cutoff: 0.05) (<xref ref-type="fig" rid="fig1">Figure 1C</xref> and <xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1</xref>). The majority of UNC-3 binding peaks (91.95%) are predominantly located between 0 and 3 kb upstream of a transcription start site, whereas only a small fraction is found in introns (2.05%) or downstream of a gene (0.99%), suggesting UNC-3 chiefly acts at promoters and enhancers to regulate gene expression (<xref ref-type="fig" rid="fig1">Figure 1D and F</xref>). Through de novo motif discovery analysis (see Materials and methods), we identified a 12 bp pseudo-palindromic sequence overrepresented in the UNC-3 binding peaks (<xref ref-type="fig" rid="fig1">Figure 1E</xref>), which highly resembles the binding site of UNC-3 vertebrate orthologs (<xref ref-type="bibr" rid="bib78">Treiber et al., 2010a</xref>; <xref ref-type="bibr" rid="bib79">Treiber et al., 2010b</xref>; <xref ref-type="bibr" rid="bib82">Wang and Reed, 1993</xref>; <xref ref-type="bibr" rid="bib81">Wang et al., 1997</xref>). To test the quality of our ChIP-Seq results, we sought to determine whether UNC-3 binding peaks are present in the <italic>cis</italic>-regulatory region of all previously described UNC-3 targets in cholinergic MNs, because these neurons constitute the majority of <italic>unc-3</italic>-expressing cells (53 out of 72 cells). Previous studies identified 10 terminal identity genes as putative direct UNC-3 targets and 43 terminal identity genes whose expression is affected by genetic removal of <italic>unc-3</italic> (<xref ref-type="bibr" rid="bib45">Kratsios et al., 2015</xref>; <xref ref-type="bibr" rid="bib44">Kratsios et al., 2011</xref>). In the current study, we found UNC-3 binding peaks in 9 out of 10 (90%) direct UNC-3 targets and 38 of the 43 (88.37%) downstream targets of UNC-3, indicating high quality in the ChIP-Seq results (<xref ref-type="fig" rid="fig2">Figure 2A</xref> and <xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1</xref>, <xref ref-type="supplementary-material" rid="supp1">Supplementary file 1</xref>). Moreover, ChIP-Seq for UNC-3 appears highly sensitive, as it identified peaks in <italic>unc-3</italic>-dependent genes expressed in a limited number of neurons (e.g., <italic>glr-4/GluR</italic> is expressed in 4 out of 72 <italic>unc-3+</italic> neurons) (<xref ref-type="fig" rid="fig2">Figure 2A</xref>). In conclusion, our ChIP-Seq experiment generated a comprehensive map of UNC-3 binding in the <italic>C. elegans</italic> genome and provided biochemical evidence to the hypothesis that UNC-3 binds to the <italic>cis</italic>-regulatory region of multiple terminal identity genes, consolidating UNC-3’s function as a terminal selector of cholinergic MN identity.</p><fig id="fig2" position="float"><label>Figure 2.</label><caption><title>Global analyses of UNC-3 ChIP-Seq data.</title><p>(<bold>A</bold>) Snapshots of UNC-3 ChIP-Seq and input (negative control) signals at the <italic>cis</italic>-regulatory regions of known UNC-3 targets (<italic>cho-1/ChT, unc-17/VAChT, acr-2/AChR, glr-</italic>4<italic>/GluR</italic>). (<bold>B</bold>) Graph summarizing protein class ontology analysis of putative target genes of UNC-3 identified by ChIP-Seq. Out of the 3502 protein-coding UNC-3 targets, 1425 encode for proteins with known protein class terms and these were the ones considered by PANTHER. This analysis classifies UNC-3 targets into three broad categories: terminal identity genes, gene expression regulators, and enzymes. (<bold>C</bold>) Pie chart breaking down TF families that show UNC-3 binding.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-59464-fig2-v1.tif"/></fig><p>Our bioinformatic analysis of the UNC-3 binding peaks revealed 3502 protein-coding genes as putative UNC-3 targets (see Materials and methods). To classify these new targets, we performed gene ontology (GO) analysis focused on protein classes using PANTHER (<xref ref-type="bibr" rid="bib55">Mi et al., 2013</xref>). This analysis revealed three broad categories (<xref ref-type="fig" rid="fig2">Figure 2B</xref>, <xref ref-type="supplementary-material" rid="supp2">Supplementary file 2</xref>). First, there is a preponderance (42.18% of the total number of UNC-3 targets classified by PANTHER) of terminal identity genes (e.g., 114 transporter proteins, 111 receptors and trans-membrane proteins, 37 signaling molecules, 11 cell adhesion molecules), suggesting that UNC-3 broadly affects multiple features of neuronal terminal identity. The second overrepresented category (24.07% of UNC-3 targets) contains a large number of proteins involved in the control of gene expression, such as 239 nucleic acid-binding proteins (16.77%) and 104 TFs (7.3%), highlighting the possibility of an extensive network of gene regulatory factors downstream of UNC-3. The third category (24.14%) consists of genes coding for various types of enzymes (e.g., hydrolases, ligases, oxidoreductases), suggesting a new role for UNC-3 in neuronal metabolic pathways. Together, this analysis unravels the breadth of biological processes potentially under the direct control of UNC-3.</p><p>The ChIP-Seq experiment was performed on endogenously tagged UNC-3, which is expressed in 53 cholinergic MNs of the nerve cord and 19 other neurons located in the <italic>C. elegans</italic> head and tail (<xref ref-type="bibr" rid="bib60">Pereira et al., 2015</xref>). Since MNs are the majority (53 cells) of <italic>unc-3</italic>-expressing cells (72 in total), a significant portion of the UNC-3-bound genes may be expressed in MNs. To test this, we used available single-cell RNA-Seq data (CeNGEN project: <ext-link ext-link-type="uri" xlink:href="http://www.cengen.org">www.cengen.org</ext-link>) that identified 576 transcripts specifically enriched in cholinergic MNs (<xref ref-type="bibr" rid="bib77">Taylor et al., 2019</xref>). We found that 52.95% of these MN-expressed genes are bound by UNC-3 and fall in the aforementioned gene categories (<xref ref-type="supplementary-material" rid="supp3">Supplementary file 3</xref>), thereby constituting putative UNC-3 targets in cholinergic MNs.</p></sec><sec id="s2-2"><title><italic>Cis</italic>-regulatory analysis reveals novel TFs as direct UNC-3 targets in MNs</title><p>Our ChIP-Seq results provide an opportunity to reveal new roles for UNC-3, beyond the direct control of terminal identity genes. To this end, we focused on the 104 TFs identified by ChIP-Seq as putative UNC-3 targets (<xref ref-type="fig" rid="fig2">Figure 2B–C</xref>). To functionally test whether the UNC-3 bound DNA elements upstream of these TF-encoding genes carry information critical for gene expression, we carried out a <italic>cis</italic>-regulatory analysis. We isolated and fused to RFP elements located upstream of 16 randomly selected TFs of different families (e.g., homeobox, nuclear hormone receptors, Zn finger) (<xref ref-type="fig" rid="fig2">Figure 2C</xref>, <xref ref-type="table" rid="table1">Table 1</xref>). We generated transgenic reporter animals and found that 10 of these TF reporters were sufficient to drive RFP expression in ventral cord MNs (<xref ref-type="table" rid="table1">Table 1</xref>). Next, we identified 9 TFs (<italic>nhr-1, nhr-40, mab-9, ztf-26, ceh-44, zfh-2, cfi-1, bnc-1, nhr-19</italic>) with expression in cholinergic MNs. Some of those are also expressed in the <italic>unc-3</italic>-negative GABAergic MNs of the nerve cord (<xref ref-type="table" rid="table1">Table 1</xref>). Interestingly, one reporter (<italic>nhr-49</italic>) is exclusively expressed in GABAergic MNs. Expression of five TFs (<italic>nhr-1, nhr-19, nhr-49, zfh-2, ztf-26</italic>) in ventral cord MNs has not been previously described. The remaining 5 TFs (<italic>cfi-1/Arid3a</italic>, <italic>bnc-1/Bnc1/2</italic>, <italic>mab-9/Tbx20</italic>, <italic>nhr-40</italic>, <italic>ceh-44/Cux1)</italic> are known to be expressed in subsets of <italic>unc-3</italic>-positive MNs (<xref ref-type="bibr" rid="bib41">Kerk et al., 2017</xref>; <xref ref-type="bibr" rid="bib65">Pocock et al., 2008</xref>; <xref ref-type="bibr" rid="bib6">Brozová et al., 2006</xref>), but our analysis revealed <italic>cis</italic>-regulatory elements sufficient for their MN expression. Next, we tested for <italic>unc-3</italic> dependency at the L4 stage, and found that 8 of the 9 TF reporters (<italic>nhr-1, nhr-40, zfh-2, ztf-26, ceh-44, cfi-1, bnc-1, mab-9)</italic> with expression in cholinergic MNs are positively regulated by <italic>unc-3</italic>; their expression significantly decreased in <italic>unc-3</italic> mutants (<xref ref-type="table" rid="table1">Table 1</xref>, <xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1</xref>). On the other hand, <italic>nhr-49</italic>, which is normally expressed in GABAergic MNs, is negatively regulated by <italic>unc-3</italic>; ectopic expression was observed in cholinergic MNs of <italic>unc-3</italic> mutants (<xref ref-type="table" rid="table1">Table 1</xref>, <xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1</xref>). Together, this <italic>cis</italic>-regulatory analysis revealed novel TFs as direct UNC-3 targets in cholinergic MNs. Besides its known role as an activator of terminal identity genes (<xref ref-type="bibr" rid="bib45">Kratsios et al., 2015</xref>; <xref ref-type="bibr" rid="bib44">Kratsios et al., 2011</xref>), these findings suggest UNC-3 can also act directly to either activate or repress expression of multiple TF-encoding genes. Alternatively, UNC-3 binding could facilitate recruitment of other factors that function either as activators or repressors. Altogether, these data uncover an extensive gene regulatory network downstream of UNC-3.</p><table-wrap id="table1" position="float"><label>Table 1.</label><caption><title>Summary of <italic>cis</italic>-regulatory analysis to identify novel transcription factors controlled by UNC-3.</title><p>Transgenic reporter (RFP) animals for each TF were generated and examined for neuronal expression. GFP markers for cholinergic and GABAergic MNs were used to define TF reporter expression. TF reporters expressed in MNs were further tested for UNC-3 dependency. Eighteen reporters were generated that correspond to 16 TFs (Two reporters were generated for <italic>nhr-1</italic> and <italic>nhr-40</italic> because two distinct UNC-3 ChIP-Seq peaks were found in the <italic>cis</italic>-regulatory region of these genes). Not applicable (N/A).</p></caption><table frame="hsides" rules="groups"><thead><tr><th>Number of reporters</th><th>Gene</th><th>TF family</th><th><italic>DNA</italic> region included relative to ATG</th><th><italic>unc-3</italic> dependence</th><th>RFP expression</th><th>Expression in cholinergic MNs</th><th>Expression in GABAergic MNs</th><th># of lines</th></tr></thead><tbody><tr><td>1</td><td><italic>nhr-1</italic> <break/>(second peak)</td><td>Nuclear hormone receptor</td><td>−838 bp to +1,535 bp</td><td>Positively regulated</td><td>VNC, Head and Tail Neurons</td><td>YES</td><td>YES</td><td>2</td></tr><tr><td>2</td><td><italic>nhr-40</italic> <break/>(second peak)</td><td>Nuclear hormone receptor</td><td>+4,356 bp to +5,525 bp</td><td>Positively regulated</td><td>VNC, Head and Tail Neurons</td><td>YES</td><td>YES</td><td>2</td></tr><tr><td>3</td><td><italic>mab-9</italic></td><td>T-box</td><td>−5,561 bp to −3,773 bp</td><td>Positively regulated</td><td>VNC, Head and Tail Neurons</td><td>YES</td><td>YES</td><td>2</td></tr><tr><td>4</td><td><italic>ztf-26</italic></td><td>Zinc finger</td><td>+910 bp to 3,394 bp</td><td>Positively regulated</td><td>VNC and Head Neurons</td><td>YES</td><td>NO</td><td>2</td></tr><tr><td>5</td><td><italic>ceh-44</italic></td><td><italic>C. elegans</italic> homeobox</td><td>+1,605 bp to 3,111 bp</td><td>Positively regulated</td><td>VNC, Head and Tail Neurons</td><td>YES</td><td>Not determined</td><td>2</td></tr><tr><td>6</td><td><italic>zfh-2</italic></td><td>Zinc finger</td><td>+12,048 bp to +13,549 bp</td><td>Positively regulated</td><td>VNC, Head and Tail Neurons</td><td>YES</td><td>NO</td><td>2</td></tr><tr><td>7</td><td><italic>cfi-1</italic></td><td>AT-rich interaction domain</td><td>−13,824 bp to −11,329 bp</td><td>Positively regulated</td><td>VNC, Head and Tail Neurons</td><td>YES</td><td>YES</td><td>2</td></tr><tr><td>8</td><td><italic>bnc-1</italic></td><td>Zinc finger</td><td>−1,800 bp to −1 bp</td><td>Positively regulated</td><td>VNC and Tail Neurons</td><td>YES</td><td>NO</td><td>2</td></tr><tr><td>9</td><td><italic>nhr-19</italic></td><td>Nuclear hormone receptor</td><td>+1,261 bp to +2,294 bp</td><td>NO</td><td>VNC, Head and Tail Neurons</td><td>YES</td><td>YES</td><td>2</td></tr><tr><td>10</td><td><italic>nhr-40</italic> <break/>(first peak)</td><td>Nuclear hormone receptor</td><td>+919 bp to +1,839 bp</td><td>NO</td><td>VNC, Head and Tail Neurons</td><td>YES</td><td>YES</td><td>2</td></tr><tr><td>11</td><td><italic>nhr-49</italic></td><td>Nuclear hormone receptor</td><td>−750 bp to 75 bp</td><td>Negatively regulated</td><td>VNC, Head and Tail Neurons</td><td>NO</td><td>YES</td><td>2</td></tr><tr><td>12</td><td><italic>nhr-1</italic> <break/>(first peak)</td><td>Nuclear hormone receptor</td><td>−7,452 bp to −5,871 bp</td><td>Not determined</td><td>Head and Tail Neurons</td><td>N/A</td><td>N/A</td><td>2</td></tr><tr><td>13</td><td><italic>ccch-3</italic></td><td>Zinc finger</td><td>−385 bp to −1 bp</td><td>Not determined</td><td>Head Neurons</td><td>N/A</td><td>N/A</td><td>2</td></tr><tr><td>14</td><td><italic>ztf-17</italic></td><td>Zinc finger</td><td>−1,031 bp to +3 bp</td><td>Not determined</td><td>Head Neurons, Muscles, and Intestine</td><td>N/A</td><td>N/A</td><td>2</td></tr><tr><td>15</td><td><italic>nhr-47</italic></td><td>Nuclear hormone receptor</td><td>−675 bp to +171 bp</td><td>N/A</td><td>No RFP expression</td><td>N/A</td><td>N/A</td><td>2</td></tr><tr><td>16</td><td><italic>unc-55</italic></td><td>Nuclear receptor</td><td>−2,105 bp to −1,327 bp</td><td>N/A</td><td>No RFP expression</td><td>N/A</td><td>N/A</td><td>2</td></tr><tr><td>17</td><td><italic>ztf-13</italic></td><td>Zinc finger</td><td>−1,392 bp to −1 bp</td><td>N/A</td><td>No RFP expression</td><td>N/A</td><td>N/A</td><td>2</td></tr><tr><td>18</td><td><italic>ztf-14</italic></td><td>Zinc finger</td><td>−2,087 bp to −531 bp</td><td>N/A</td><td>No RFP expression</td><td>N/A</td><td>N/A</td><td>2</td></tr></tbody></table></table-wrap></sec><sec id="s2-3"><title>Temporal modularity of UNC-3 function in cholinergic MNs</title><p>Terminal selectors are continuously expressed, from development through adulthood, in specific neuron types. However, it remains unclear whether – in the same neuron type – a terminal selector controls an identical suite of targets across different life stages, or the suite of targets can change over time. The case of UNC-3 offers an opportunity to address this issue because its direct targets (terminal identity genes and newly identified TFs [<xref ref-type="table" rid="table1">Table 1</xref>]) are continuously expressed in cholinergic MNs. However, <italic>unc-3</italic> dependency of terminal identity genes was mostly tested at a single developmental stage, the last larval stage (L4) (<xref ref-type="bibr" rid="bib44">Kratsios et al., 2011</xref>). We therefore performed a longitudinal analysis to determine whether target gene dependency on <italic>unc-3</italic> remains stable or changes at different life stages.</p><p>First, we tested four terminal identity genes (<italic>acr-2/AChR</italic>, <italic>unc-129/TGFbeta</italic>, <italic>glr-4/GluR</italic>, <italic>unc-17/VAChT</italic>) at larval (L2, L4) and adult (day 1) stages and found that their MN expression, at every stage, critically depends on UNC-3 (<xref ref-type="fig" rid="fig3">Figure 3A</xref>). Because this analysis relied on animals lacking <italic>unc-3</italic> gene activity since early development (a null allele was used), whether UNC-3 is continuously required to maintain expression of these genes remained unclear. We therefore employed the auxin-inducible degradation (AID) system to deplete the endogenous UNC-3 protein in cholinergic MNs at late larval and young adult stages (<xref ref-type="bibr" rid="bib89">Zhang et al., 2015</xref>). Compared to controls, we found a significant decrease in the number of adult MNs expressing <italic>acr-2/AChR</italic>, <italic>glr-4/GluR</italic>, and <italic>unc-17/</italic>VAChT in animals treated with auxin (<xref ref-type="fig" rid="fig3s2">Figure 3—figure supplement 2</xref>). These findings indicate UNC-3 is required to initiate and maintain the expression of terminal identity genes, consolidating its role as a terminal selector of cholinergic MN fate.</p><fig-group><fig id="fig3" position="float"><label>Figure 3.</label><caption><title>Terminal identity genes and transcription factors display distinct temporal requirements for UNC-3.</title><p>(<bold>A</bold>) Top: snapshots of UNC-3 ChIP-Seq and input (negative control) signals at the <italic>cis</italic>-regulatory regions of four cholinergic terminal identity genes (<italic>acr-2/AChR, unc-129/TFGb, glr-4/GluR,</italic> and <italic>unc-17/VAChT</italic>). The length of DNA elements included in each reporter is shown. Bottom: quantification of terminal identity gene reporters in WT and <italic>unc-3 (n3435)</italic> animals at three different developmental stages – L2, L4, and day 1 adults (N ⩾ 12). UNC-3 is required for both initiation and maintenance of all four terminal identity genes. ***p&lt;0.001. (<bold>B</bold>) Top: snapshots of UNC-3 ChIP-Seq and input (negative control) signals at the <italic>cis</italic>-regulatory regions of 5 transcription factors (<italic>cfi-1/Arid3a, bnc-1/Bnc1, nhr-40, mab-9/Tbx20, and ceh-44/Cux1</italic>). The length of DNA elements included in each reporter is shown. Middle: representative images of WT L4 animals showing expression of the transgenic reporters in MNs. Scale bar, 20 μm. Bottom: quantification of transcription factor reporters in WT and <italic>unc-3 (n3435)</italic> animals at three different developmental stages – L2, L4, and young adults (day 1 or day 3) (N ⩾ 12). UNC-3 is required for maintenance, but not initiation of the 5 TFs. N.S.: not significant, *p&lt;0.05, ***p&lt;0.001. (<bold>C</bold>) Schematic summarizing the phenomenon of temporal modularity in UNC-3 function. The first module consists of terminal identity genes and TFs (<xref ref-type="fig" rid="fig3s2">Figure 3—figure supplement 2</xref>), which require UNC-3 for both initiation and maintenance of gene expression. The second module consists exclusively of TFs that require UNC-3 only for maintenance.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-59464-fig3-v1.tif"/></fig><fig id="fig3s1" position="float" specific-use="child-fig"><label>Figure 3—figure supplement 1.</label><caption><title>UNC-3 directly controls the expression of several TF reporters in MNs.</title><p>(<bold>A–C</bold>) Top: snapshots of UNC-3 ChIP-Seq and input (negative control) signal at the <italic>cis</italic>-regulatory regions of 5 TF-encoding genes (<italic>nhr-1, ztf-26, zfh-2, nhr-49, nhr-19</italic>). Transgenic RFP reporters contain the <italic>cis</italic>-regulatory regions bound by UNC-3, as well as flanking sequences. Middle: representative images of WT L4 animals showing expression of the transgenic reporters in nerve cord MNs. Scale bar, 20 μm. Bottom: quantification of TF reporters in WT and <italic>unc-3 (n3435)</italic> animals at three different developmental stages – L2, L4, and day 3 adult. <italic>nhr-1, ztf-26,</italic> and <italic>zfh-2</italic> are activated by UNC-3 (<bold>A</bold>), while <italic>nhr-49</italic> is repressed by UNC-3 (<bold>B</bold>) and <italic>nhr-19</italic> does not appear to be controlled by UNC-3 (<bold>C</bold>). N ⩾ 15. N.S.: not significant, *p&lt;0.05, **p&lt;0.01, ***p&lt;0.001. (<bold>D</bold>) Three TF reporters (<italic>ccch-3, ztf-17, nhr-1</italic>) are not expressed in nerve cord MNs, but show expression in head neurons. Top: snapshots of UNC-3 ChIP-Seq and input (negative control) signals at the <italic>cis</italic>-regulatory regions of <italic>ccch-3, ztf-17,</italic> and <italic>nhr-1</italic>. Transgenic RFP reporters contain the <italic>cis-</italic>regulatory regions bound by UNC-3. Bottom: representative images of WT L4 animals showing expression of the transgenic reporters in some unidentified neurons of the head. It is known that UNC-3 is expressed in some head neurons.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-59464-fig3-figsupp1-v1.tif"/></fig><fig id="fig3s2" position="float" specific-use="child-fig"><label>Figure 3—figure supplement 2.</label><caption><title>UNC-3 is required to maintain the expression of <italic>glr-4/GluR, unc-17/VAChT,</italic> and <italic>acr-2/AChR</italic> in cholinergic motor neurons.</title><p>(<bold>A</bold>) Diagram illustrating the design of UNC-3 knock-down experiments. Auxin (or EtOH, as control) was applied to L3 worms carrying <italic>unc-3::mNG::AID</italic> and a pan-neuronal tir-1 allele (with reporters of target genes to be tested). Examination of reporter expression was performed following 3 days of continuous auxin/EtOH administration. (<bold>B</bold>) Diagram illustrating the worm body with highlights of the locations of the SAB neurons (in the anterior) and the MNs along the VNC. Two boxed regions focus on the SAB neurons and the MNs in the posterior half of the worm body, which are shown in the representative images in the next panels. C-D: Demonstration of UNC-3 knock-down efficiency. Left: representative images showing expression of <italic>unc-3::mNG::AID</italic> after 3 days of auxin or EtOH administration in the SAB neurons (<bold>C</bold>) or MNs in the posterior VNC (<bold>D</bold>); Right: Quantification of the number of SAB neurons (<bold>C</bold>) or MNs in the posterior VNC (<bold>D</bold>) showing expression of <italic>unc-3::mNG::AID</italic> following auxin/EtOH treatment. To get a preliminary idea of the efficiency, nine worms from the auxin group and 10 worms from the EtOH group were checked one day after starting the treatment. To demonstrate the knock-down is persistent, five worms from each group were checked 3 days after starting the treatment. ***p&lt;0.001. E-G: <italic>glr-4/GluR, unc-17/VAChT, and acr-2/AChR</italic> require UNC-3 for both initiation and maintenance of their expression. Left: representative images showing the expression of <italic>glr-4::RFP</italic> (<bold>E</bold>), <italic>unc-17::GFP</italic> (<bold>F</bold>), and <italic>acr-2::GFP</italic> (<bold>G</bold>) following 3 days or auxin/EtOH treatment. Downregulation of these reporters is apparent in terms of both the number of cells showing positive expression and the fluorescent intensity of the positive cells; Right: quantification of the number of SAB neurons expressing <italic>glr-4::RFP</italic> (<bold>E</bold>), and the number of MNs in the posterior VNC expressing <italic>unc-17::GFP</italic> (<bold>F</bold>) and <italic>acr-2::GFP</italic> from worms shown on the left (N = 15). ***p&lt;0.001.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-59464-fig3-figsupp2-v1.tif"/></fig></fig-group><p>However, a different picture emerged after testing the 8 TF reporters that are positively regulated by UNC-3 (<xref ref-type="table" rid="table1">Table 1</xref>). Similar to terminal identity genes, the expression of 3 TFs (<italic>zfh-2/Zfhx3, ztf-26, nhr-1</italic>) critically depends on UNC-3 at every stage (L2, L4, adult) (<xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1</xref>), suggesting UNC-3 controls initiation and maintenance of their expression. In striking contrast, the early expression (L2 stage) of five TFs (<italic>cfi-1, bnc-1, mab-9, nhr-40, ceh-44</italic>) does not require UNC-3 (<xref ref-type="fig" rid="fig3">Figure 3B</xref>). However, maintenance of their expression during late larval and/or adult stages does depend on UNC-3 (<xref ref-type="fig" rid="fig3">Figure 3B</xref>). Hence, this longitudinal analysis revealed two groups of targets with distinct requirements for UNC-3 at different life stages. One group consists of terminal identity genes (<italic>acr-2/AChR</italic>, <italic>unc-129/TGFbeta</italic>, <italic>glr-4/GluR</italic>, <italic>unc-17/VAChT</italic>) and TFs (<italic>zfh-2/Zfhx3, ztf-26, nhr-1</italic>) that require UNC-3 for both initiation and maintenance of expression (‘initiation and maintenance’ module, <xref ref-type="fig" rid="fig3">Figure 3A,C</xref>). The second group consists exclusively of TFs (<italic>cfi-1/Arid3a, bnc-1/Bnc1, mab-9/Tbx20, ceh-44/Cux1, nhr-40</italic>) that depend on UNC-3 for maintenance, but not initiation (‘maintenance-only’ module, <xref ref-type="fig" rid="fig3">Figure 3B–C</xref>).</p><p>Collectively, these findings suggest that, in cholinergic MNs, the suite of UNC-3 target genes can partially change at different life stages. In all larval and adult stages examined, UNC-3 is required for the continuous expression of one set of genes (‘initiation and maintenance’ module). However, only in late larvae and adults, UNC-3 is required to maintain expression of another set of genes (‘maintenance-only’ module). To describe this phenomenon, we use the term ‘temporal modularity in UNC-3 function’ given that the function of a TF in a specific cell type and at a particular life stage is determined by the suite of targets it controls in that cell type and at that stage (<xref ref-type="fig" rid="fig3">Figure 3C</xref>). In the following sections, we hone in on a single target (<italic>cfi-1/Arid3a)</italic> from the ‘maintenance-only’ module, aiming to dissect the molecular mechanisms underlying the temporal modularity of UNC-3 function in cholinergic MNs.</p></sec><sec id="s2-4"><title>A distal enhancer is necessary for initiation and maintenance of <italic>cfi-1/Arid3a</italic> expression in MNs</title><p>Our <italic>cis</italic>-regulatory analysis suggests that maintenance, but not initiation, of <italic>cfi-1</italic> expression depends on UNC-3 (<xref ref-type="fig" rid="fig3">Figure 3B</xref>). We therefore hypothesized that the sole UNC-3 binding peak on the <italic>cfi-1</italic> locus (located ~12 kb upstream) demarcates an enhancer element selectively required for maintenance (<xref ref-type="fig" rid="fig3">Figures 3B</xref> and <xref ref-type="fig" rid="fig4">4A</xref>). If this were to be the case, then it would be logical to assume that a separate <italic>cis</italic>-regulatory element would control <italic>cfi-1</italic> initiation in MNs. To test this assumption, we conducted an unbiased <italic>cis</italic>-regulatory analysis <italic>in vivo</italic> by generating a series of 12 transgenic reporter (GFP or RFP) animals, with each reporter carrying small and contiguous DNA fragments spanning a ~15 kb region (<xref ref-type="fig" rid="fig4">Figure 4A</xref>). Surprisingly, this analysis did not reveal a separate initiation element. Instead, it showed that the same 2.5 kb distal element (reporter #7) that drives RFP expression in subsets of <italic>unc-3</italic>-expressing cholinergic MNs (DA, DB, VA, VB subtypes) at larval and adult stages (<xref ref-type="fig" rid="fig3">Figure 3B</xref>), is also sufficient for embryonic (3-fold stage) MN expression (<xref ref-type="fig" rid="fig4">Figure 4A–C</xref>). In addition, this 2.5 kb element also showed expression at all these stages in <italic>unc-3</italic>-negative neurons of the nerve cord, namely the GABAergic (DD, VD subtypes) MNs (<xref ref-type="fig" rid="fig4">Figure 4A,C</xref>), which will be discussed later in Results. We conclude that this enhancer element is sufficient for initiation and maintenance of <italic>cfi-1</italic> reporter expression in nerve cord MNs.</p><fig-group><fig id="fig4" position="float"><label>Figure 4.</label><caption><title>UNC-3 acts through a distal enhancer to maintain <italic>cfi-1</italic> expression in cholinergic motor neurons.</title><p>(<bold>A</bold>) Top: Snapshots of UNC-3 ChIP-Seq and input (negative control) signals at the <italic>cis</italic>-regulatory region of <italic>cfi-1</italic>. The gray bar highlights an UNC-3 binding peak located ~12 kb upstream of the TSS of <italic>cfi-1</italic> (−11,391 bp to −12,146 bp). Bottom: schematic showing the strategy of constructing <italic>cfi-1</italic> reporters. Twelve transcriptional fusion reporters ([−1 bp to −8,170 bp], #2 [993 bp to 3,764 bp], #3 [547 bp to −1,173 bp], #4 [-1,164 bp to −2,875 bp], #5 [−2,865 bp to −6,141 bp], #6 [-8,162 bp to −11,346 bp], #7 [−11,329 bp to −13,824 bp], #8 [−11,329 bp to −11,881 bp], #9 [−11,851 bp to −12,234 bp], #10 [−12,223 bp to −12,722 bp], #11 [−12,705 bp to −13,284 bp], and #12 [-13,263 bp to −13,824 bp]) carry <italic>cis</italic>-regulatory regions fused to fluorescent reporters (GFP or RFP). The endogenous reporter alleles (<italic>mNG::AID::cfi-1</italic> and <italic>mNG::AID::cfi-1 <sup>Δenhancer (769 bp)</sup></italic>) have an in-frame fluorescent protein mNeonGreen (mNG) insertion immediately after the ATG of <italic>cfi-1</italic>. The enhancer KO allele <italic>mNG::AID::cfi-1 <sup>Δenhancer (769 bp)</sup></italic> carries a 769 bp deletion (−11,329 bp to −12,097 bp). Table on the right summarizes the expression pattern of each reporter allele at L4 stage. N ⩾ 12. +: reporter expressed, –: reporter not expressed, +/–: reporter partially expressed in the respective neurons. Number of independent transgenic lines tested for each reporter is shown on the right. (<bold>B</bold>) Representative images showing the expression of reporter #7, reporter #8, <italic>mNG::AID::cfi-1</italic>, and <italic>mNG::AID::cfi-1 <sup>Δenhancer (769 bp)</sup></italic> at specific life stages. Areas highlighted in dashed boxes are enlarged and presented on the right side of each picture. The onset of <italic>cfi-1</italic> expression occurs at the 3-fold embryonic stage. mNG+ MNs are annotated with arrowheads. Scale bars, 5 μm (3-fold embryos); 20 μm (larvae and adults). (<bold>C</bold>) Schematic summarizing the expression pattern of <italic>cfi-1</italic> and <italic>unc-3</italic> in nerve cord MNs. (<bold>D</bold>) Quantification of the number of cholinergic MNs expressing endogenous <italic>cfi-1</italic> (<italic>mNG::AID::cfi-1)</italic> in WT and animals carrying the enhancer deletion (<italic>mNG::AID::cfi-1 <sup>Δenhancer (769 bp)</sup></italic>). Deletion of the enhancer element located ~12 kb upstream of the TSS of <italic>cfi-1</italic> completely abolishes <italic>cfi-1</italic> expression in MNs at all tested stages. A red fluorescent marker (<italic>ttr-39::mCherry</italic>) for GABAergic MNs was used to exclude these neurons from the quantification. Cholinergic MNs expressing <italic>cfi-1</italic> were positive for mNG and negative for mCherry. (<bold>E</bold>) Bioinformatic analysis predicted 8 UNC-3 binding sites (COE motifs, shown as pink boxes) in the <italic>cfi-1</italic> enhancer region, which displays UNC-3 binding (−11,391 bp to −12,146 bp). Using CRISPR/Cas9, these eight motifs were mutated by substituting duplets or triplets of nucleotides as shown below, thereby generating the strain <italic>cfi-1 (syb1856 [mNG::AID::cfi-1<sup>8 COE motifs mut</sup></italic>]). (<bold>F</bold>) Quantification of the number of cholinergic MNs expressing the endogenous <italic>cfi-1</italic> reporter (<italic>mNG::AID::cfi-1)</italic> in WT and <italic>unc-3 (n3435)</italic> animals, as well as in animals with mutated COE motifs (<italic>mNG::AID::cfi-1<sup>8 COE motifs mut</sup></italic>) at L2, L4, and day 1 adult stages (N ⩾ 12). N.S.: not significant, ***p&lt;0.001.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-59464-fig4-v1.tif"/></fig><fig id="fig4s1" position="float" specific-use="child-fig"><label>Figure 4—figure supplement 1.</label><caption><title>CFI-1 does not auto-regulate its expression in motor neurons.</title><p>(<bold>A</bold>) Snapshots of UNC-3 ChIP-Seq signal at the <italic>cfi-1</italic> locus in WT and <italic>cfi-1 (ot786)</italic> animals. UNC-3 binds to the <italic>cfi-1</italic> enhancer normally in <italic>cfi-1 (ot786)</italic> mutants. (<bold>B</bold>) Quantification of the number of MNs expressing the transcriptional fusion reporter #7 (<italic>cfi-1<sup>2.5kb</sup>::RFP</italic>) in WT worms and <italic>cfi-1 (ot786)</italic> mutants (N = 14). No significant difference was detected between WT and <italic>cfi-1 (ot786)</italic>, suggesting that the expression of reporter #7 (<italic>cfi-1<sup>2.5kb</sup>::RFP</italic>) is not altered upon genetic removal of <italic>cfi-1</italic>. N.S.: not significant.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-59464-fig4-figsupp1-v1.tif"/></fig></fig-group><p>To test the necessity of this element, we first generated via CRISPR/Cas9 an endogenous mNeonGreen (mNG) reporter allele for <italic>cfi-1,</italic> which also carries an auxin-inducible degron (AID) tag (<italic>mNG::AID::cfi-1</italic>), enabling inducible depletion of CFI-1 (depletion experiments are described later in Results). Animals carrying the <italic>mNG::AID::cfi-1</italic> allele do not show any developmental phenotypes, suggesting that the mNG::AID tag does not detectably alter <italic>cfi-1</italic> activity. This reporter showed expression in subsets of <italic>unc-3</italic>-expressing MNs (DA, DB, VA, VB subtypes), GABAergic nerve cord MNs (DD, VD subtypes), tail and head neurons, as well as head muscle (<xref ref-type="fig" rid="fig4">Figure 4A–C</xref>), a pattern consistent with previous studies describing <italic>cfi-1</italic> expression (<xref ref-type="bibr" rid="bib72">Shaham and Bargmann, 2002</xref>; <xref ref-type="bibr" rid="bib41">Kerk et al., 2017</xref>). We determined the onset of the endogenous <italic>cfi-1</italic> reporter (<italic>mNG::AID::cfi-1)</italic> in MNs to be at the 3-fold embryonic stage, coinciding with the onset of transgenic reporters (#7 and #8) containing the distal enhancer (<xref ref-type="fig" rid="fig4">Figure 4B</xref>). Next, we employed CRISPR/Cas9 genome editing and deleted 769 bp that constitute the core of the UNC-3 binding peak (located ~12 kb upstream) in the context of the endogenous <italic>cfi-1</italic> reporter (<italic>mNG::AID::cfi-1<sup>Δ enhancer (769 bp)</sup>)</italic>. We found that <italic>mNG::AID::cfi-1</italic> expression is selectively eliminated in cholinergic (DA, DB, VA, VB) and GABAergic (DD, VD) nerve cord MNs at all life stages examined (3-fold embryo, L4, Day 1 adult) (<xref ref-type="fig" rid="fig4">Figure 4A–B</xref>, quantification of cholinergic MNs shown in <xref ref-type="fig" rid="fig4">Figure 4D</xref>).</p><p>We conclude that a distal 2.5 kb enhancer (located ~12 kb upstream of <italic>cfi-1</italic>) is sufficient for <italic>cfi-1</italic> expression in nerve cord MNs. Genome editing suggests that a 769 bp sequence within this 2.5 kb enhancer is required for both initiation and maintenance of <italic>cfi-1</italic> in nerve cord MNs (<xref ref-type="fig" rid="fig4">Figure 4D</xref>). In the ensuing sections, we test the hypothesis that this enhancer integrates UNC-3 input for <italic>cfi-1</italic> maintenance in cholinergic MNs, as well as UNC-3-independent input for <italic>cfi-1</italic> initiation in these neurons.</p></sec><sec id="s2-5"><title>UNC-3 maintains <italic>cfi-1</italic> expression in cholinergic MNs via direct activation of the distal enhancer</title><p>The binding of UNC-3 to the distal enhancer strongly suggests UNC-3 acts directly to maintain <italic>cfi-1</italic> expression in cholinergic MNs (<xref ref-type="fig" rid="fig4">Figure 4A</xref>). However, the UNC-3 peak is spread across several hundred base pairs due to the inherently low ChIP-Seq resolution. Hence, the precise DNA sequences recognized by UNC-3 remained unknown. Through bioinformatic analysis (see Materials and methods), we identified eight putative UNC-3 binding sites (COE motifs) within the 769 bp distal enhancer (<xref ref-type="fig" rid="fig4">Figure 4E</xref>). Using CRISPR/Cas9 technology, we simultaneously mutated all eight motifs in the context of the endogenous <italic>cfi-1</italic> reporter allele (<italic>mNG::AID::cfi-1<sup>8 COE motifs mut</sup></italic>) by substituting nucleotides known to be critical for DNA binding of UNC-3 orthologs (<xref ref-type="bibr" rid="bib78">Treiber et al., 2010a</xref>; <xref ref-type="bibr" rid="bib80">Wang et al., 1993</xref>; <xref ref-type="fig" rid="fig4">Figure 4E</xref>). During the L2 stage, expression of <italic>mNG</italic> in MNs is not affected in <italic>mNG::AID::cfi-1 <sup>8 COE motifs mut</sup></italic> animals, indicating early <italic>cfi-1</italic> expression occurs normally (<xref ref-type="fig" rid="fig4">Figure 4F</xref>). Intriguingly, <italic>mNG</italic> expression is significantly down-regulated in cholinergic MNs at later larval (L4) and adult (day 1) stages, resembling the phenotype of <italic>unc-3</italic> null mutants (<xref ref-type="fig" rid="fig4">Figure 4F</xref>). We conclude that UNC-3 binds to the distal enhancer and directly acts through one or more of these 8 COE motifs to maintain <italic>cfi-1</italic> expression in cholinergic MNs.</p><p>Previous studies in the nervous system have shown that a TF can maintain its own expression via transcriptional activation either by itself (positive auto-regulation), or in partnership with other TFs (<xref ref-type="bibr" rid="bib48">Leyva-Díaz and Hobert, 2019</xref>; <xref ref-type="bibr" rid="bib71">Scott et al., 2005</xref>; <xref ref-type="bibr" rid="bib85">Xue et al., 1992</xref>). We found though that <italic>cfi-1</italic> does not auto-regulate and UNC-3 binding at the distal enhancer occurs normally in <italic>cfi-1</italic> null mutants (<xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1</xref>), excluding a potential involvement of CFI-1 in its own maintenance.</p></sec><sec id="s2-6"><title>LIN-39 (Scr/Dfd/HOX4-5) and MAB-5 (Antp/HOX6-8) control <italic>cfi-1</italic> expression in cholinergic MNs through the same distal enhancer</title><p>If UNC-3 exerts a maintenance role, what are the factors that initiate <italic>cfi-1</italic> expression in MNs? Previous work showed that two Hox proteins, LIN-39 (Scr/Dfd/HOX4-5) and MAB-5 (Antp/HOX6-8), control <italic>cfi-1</italic> expression in MNs (<xref ref-type="bibr" rid="bib46">Kratsios et al., 2017</xref>). However, analysis was performed at the last larval stage (L4) and transgenic <italic>cfi-1</italic> reporter animals were used. Hence, it is unclear whether LIN-39 and MAB-5 are required for initiation of endogenous <italic>cfi-1</italic>.</p><p>Because <italic>lin-39; mab-5</italic> double null mutants are viable (<xref ref-type="bibr" rid="bib49">Liu and Fire, 2000</xref>), we performed a longitudinal analysis and found that expression of the endogenous <italic>mNG::AID::cfi-1</italic> reporter in cholinergic MNs is severely affected at embryonic (3-fold), larval (L2, L4) and adult (D1) stages (<xref ref-type="fig" rid="fig5">Figure 5A–C</xref>). Since onset of <italic>cfi-1</italic> expression occurs at the 3-fold embryonic stage (<xref ref-type="fig" rid="fig4">Figure 4B</xref>), these results suggest LIN-39 and MAB-5 are required for <italic>cfi-1</italic> initiation. Conversely, initiation of <italic>cfi-1</italic> expression is not affected in a null mutant of <italic>unc-3</italic> (<xref ref-type="fig" rid="fig5">Figure 5B–C</xref>). Moreover, available ChIP-Seq data from modENCODE (<xref ref-type="bibr" rid="bib4">Boyle et al., 2014</xref>) indicate that LIN-39 and MAB-5 bind to the <italic>cfi-1</italic> distal enhancer (<xref ref-type="fig" rid="fig5">Figure 5A</xref>). Expression of a 2.5 kb transgenic <italic>cfi-1</italic> reporter (reporter #7) that carries the distal enhancer is significantly affected in <italic>lin-39; mab-5</italic> double mutants at early larval (L2) stages (<xref ref-type="fig" rid="fig5">Figure 5A,D</xref>). These results strongly suggest that LIN-39 and MAB-5 activate <italic>cfi-1</italic> expression directly. Although the DNA sequence of the MAB-5 binding site is not known, mutation of a single, bioinformatically predicted LIN-39 binding site (wild-type: aaTTGAtg &gt;mutated: aaGGGGtg) within the enhancer led to a decrease in reporter gene expression at L2 (<xref ref-type="fig" rid="fig5">Figure 5A,E</xref>). This decrease was weaker compared to <italic>lin-39; mab-5</italic> double mutants (<xref ref-type="fig" rid="fig5">Figure 5C</xref>), likely due to compensation by MAB-5. Indeed, LIN-39 and MAB-5 appear to act synergistically because endogenous <italic>cfi-1</italic> expression (<italic>mNG::AID::cfi-1</italic>) is mildly affected in <italic>lin-39</italic> single mutants, but severely affected in <italic>lin-39; mab-5</italic> double mutants (<xref ref-type="fig" rid="fig5">Figure 5F</xref>). We conclude that the Hox proteins LIN-39 and MAB-5 are necessary for <italic>cfi-1</italic> initiation in cholinergic MNs (left panel, <xref ref-type="fig" rid="fig5">Figure 5G</xref>), and act through the same distal enhancer utilized by UNC-3 to maintain <italic>cfi-1</italic> (right panel, <xref ref-type="fig" rid="fig5">Figure 5G</xref>).</p><fig-group><fig id="fig5" position="float"><label>Figure 5.</label><caption><title>UNC-3 and Hox control <italic>cfi-1</italic> expression in cholinergic MNs.</title><p>(<bold>A</bold>) A snapshot of UNC-3 (L2 stage), LIN-39 (L3 stage), and MAB-5 (L2 stage) ChIP-Seq signals at the <italic>cfi-1</italic> locus. UNC-3, LIN-39, and MAB-5 bind to the same <italic>cfi-1</italic> enhancer (highlighted in gray). Below: Schematics illustrating the reporters used in the rest of the figure. (<bold>B</bold>) Representative images showing the expression of the <italic>mNG::AID::cfi-1</italic> in WT (same images shown in <xref ref-type="fig" rid="fig4">Figure 4B</xref>), <italic>unc-3 (n3435)</italic>, and <italic>lin-39 (n1760); mab-5 (e1239)</italic> animals during 3-fold embryonic, L2, L4, and day 1 adult stages. <italic>cfi-1</italic> is expressed in four cholinergic MN subtypes (DA, DB, VA, and VB). DA and DB are born embryonically, while VA and VB are born post-embryonically. Areas highlighted in dashed boxes are enlarged and presented on the right side of each picture. mNG+ MNs are annotated with arrowheads. Scale bars, 5 μm (3-fold embryos); 20 μm (larvae and adults). (<bold>C</bold>) Quantification of the number of cholinergic MNs expressing the endogenous <italic>cfi-1</italic> reporter (<italic>mNG::AID::cfi-1)</italic> in WT animals, <italic>unc-3 (n3435)</italic> mutants, <italic>lin-39 (n1760); mab-5 (e1239)</italic> double mutants, and <italic>unc-3 (n3435); lin-39 (n1760); mab-5 (e1239)</italic> triple mutants during 3-fold embryonic, L2, L4, and day 1 adult stages (N ⩾ 12). N.S.: not significant, ***p&lt;0.001. A red fluorescent marker (<italic>ttr-39::mCherry</italic>) for GABAergic MNs was used to exclude these neurons from the quantification. Cholinergic MNs expressing <italic>cfi-1</italic> were positive for mNG and negative for mCherry. (<bold>D</bold>) Quantification of the expression of transgenic <italic>cfi-1</italic> reporter #7 in WT and <italic>lin-39 (n1760); mab-5 (e1239)</italic> animals at L2 stage (N = 13). Reporter expression is strongly affected in <italic>lin-39 (-); mab-5 (-)</italic> double mutants. ***p&lt;0.001. (<bold>E</bold>) Quantification of the WT transgenic reporter #8 and the same reporter with the LIN-39 binding site mutated (point mutations) at larval (<bold>L2</bold>) and adult (<bold>D3</bold>) stages (N ⩾ 13). *p&lt;0.05. (<bold>F</bold>) Quantification of the expression of the <italic>mNG::AID::cfi-1</italic> allele in WT animals, <italic>lin-39 (n1760)</italic> single mutants, and <italic>lin-39 (n1760); mab-5 (e1239)</italic> double mutants at the L2 stage (N ⩾ 12). While the number of cholinergic MNs with <italic>cfi-1</italic> expression is mildly decreased in <italic>lin-39</italic> single mutants, more severe effects are observed in double mutants. ***p&lt;0.001. (<bold>G</bold>) Schematic summarizing the mechanisms underlying initiation and maintenance of <italic>cfi-1</italic> expression in cholinergic MNs.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-59464-fig5-v1.tif"/></fig><fig id="fig5s1" position="float" specific-use="child-fig"><label>Figure 5—figure supplement 1.</label><caption><title>Auxin-inducible depletion of LIN-39 at larval stage 4 (<bold>L4</bold>) does not affect <italic>cfi-1</italic> expression in nerve cord MNs.</title><p>(<bold>A</bold>) Representative images showing expression of LIN-39::mNG::AID after treatment with ethanol and auxin (negative control). LIN-39::mNG::AID is degraded and mNG fluorescent signal becomes undetectable in MNs, when worms are imaged after 4 days of auxin treatment. Arrowheads indicate MN nuclei in the nerve cord. (<bold>B</bold>) Knock-down of <italic>lin-39::mNG::AID</italic> starting at the L4 stage (onset of auxin treatment at L4) did not affect <italic>cfi-1<sup>2.5kb</sup>::RFP</italic> expression in adult animals 4 days later (N ⩾ 13). N.S.: not significant. The number of MNs expressing <italic>cfi-1<sup>2.5kb</sup>::RFP</italic> was quantified.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-59464-fig5-figsupp1-v1.tif"/></fig><fig id="fig5s2" position="float" specific-use="child-fig"><label>Figure 5—figure supplement 2.</label><caption><title>CFI-1 is required post-embryonically to maintain DA and DB neuronal identities.</title><p>(<bold>A</bold>) CFI-1 regulates DA and DB MN identity by repressing the glutamate receptor subunit <italic>glr-4/GluR</italic> and possibly other genes. In <italic>cfi-1 (-)</italic> mutants, <italic>glr-4/GluR</italic> becomes ectopically activated by UNC-3 in DA and DB MNs, and these neurons adopt a mixed molecular identity. (<bold>B</bold>) Quantification of the number of MNs expressing <italic>glr-4::RFP</italic> in <italic>mNG::AID::cfi-1</italic> worms, worms carrying the <italic>cfi-1</italic> enhancer deletion (<italic>mNG::AID::cfi-1 <sup>Δ enhancer (769 bp)</sup>)</italic>, worms with mutated COE motifs (<italic>mNG::AID::cfi-1<sup>8 COE motifs mut</sup></italic>), as well as in <italic>cfi-1</italic> null mutants at L2, L4, and day 2 adult stages (N = 15). N.S.: not significant, *** p &lt; 0.001. The remaining expression of <italic>cfi-1</italic> in ~ 15 MNs of <italic>mNG::AID::cfi-1<sup>8 COE motifs mut</sup></italic> animals (<xref ref-type="fig" rid="fig4">Figure 4F</xref>) is likely the reason for not observing <italic>glr-4/GluR</italic> ectopic expression in MNs of these animals. (<bold>C</bold>) Representative images showing expression of mNG::AID::CFI-1 after treatment with ethanol and auxin. Upon two days of continuous auxin treatment (onset of treatment at L1), mNG::AID::CFI-1 is degraded and mNG expression in MNs (arrowheads) becomes undetectable. (<bold>D</bold>) Quantification of MNs expressing <italic>glr-4::RFP</italic> was performed on L4 worms (2 days after the onset of auxin treatment). Some mild hypomorphic effects in the expression of <italic>glr-4::RFP</italic> was observed in the EtOH group (negative control), potentially due to mild reduction in CFI-1 levels triggered by TIR1 even in the absence of auxin. A significant increase in the number of MNs expressing <italic>glr-4::RFP</italic> was evident in auxin-treated worms in comparison to control animals. WT and <italic>cfi-1 (-)</italic> data are also provided for comparison. N ⩾ 20. N.S.: not significant, **p&lt;0.01.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-59464-fig5-figsupp2-v1.tif"/></fig><fig id="fig5s3" position="float" specific-use="child-fig"><label>Figure 5—figure supplement 3.</label><caption><title>Hox proteins and UNC-3 control <italic>bnc-1</italic> expression in VA and VB neurons.</title><p>(<bold>A</bold>) Schematic summarizing the expression of <italic>bnc-1/Bnc1</italic> and <italic>unc-3/Ebf</italic> in MN subtypes of the <italic>C. elegans</italic> ventral nerve cord. (<bold>B</bold>) A snapshot of UNC-3 ChIP-Seq and input (negative control) signals at the <italic>cis-</italic>regulatory region of <italic>bnc-1</italic>. (<bold>C</bold>) Quantification of expression of the endogenous reporter <italic>bnc-1::mNG::AID</italic> in WT, <italic>unc-3 (n3435)</italic>, and <italic>lin-39 (n1760); mab-5 (e1239)</italic> animals during L2, L4, and day 1 adult stages (N ⩾ 12). ***p&lt;0.001. (<bold>D</bold>) Representative images of the endogenous reporter <italic>bnc-1::mNG::AID</italic> in WT, <italic>unc-3 (e151)</italic>, and <italic>lin-39 (n1760); mab-5 (e1239)</italic> animals during L2, L4, and day 1 adult stages. <italic>bnc-1</italic> is expressed in two cholinergic MN subtypes (VA and VB). Areas highlighted in dashed boxes are enlarged and presented on the right side of each picture. Arrowheads point to nuclei of VA and VB neurons that express the reporter. Above the white dashed line lies the intestine, which is autofluorescent in the green channel. Scale bar, 20 μm.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-59464-fig5-figsupp3-v1.tif"/></fig></fig-group><p>Because LIN-39 and MAB-5 are continuously expressed – from embryo through adulthood – in cholinergic MNs (<xref ref-type="bibr" rid="bib19">Feng et al., 2020</xref>), it is likely that these Hox proteins, like UNC-3, are also required for maintenance. To test this, we used the AID system and depleted the endogenous LIN-39 protein at the last larval stage (L4) by using a previously described <italic>lin-39::mNG::AID</italic> allele (<xref ref-type="bibr" rid="bib19">Feng et al., 2020</xref>; <xref ref-type="bibr" rid="bib89">Zhang et al., 2015</xref>). However, expression of <italic>cfi-1</italic> was unaffected in the adult (<xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1</xref>). This negative result could be attributed to low and undetectable levels of LIN-39 and/or functional compensation by MAB-5. We therefore used <italic>lin-39; mab-5</italic> double (null) mutants and crossed them to <italic>unc-3</italic> null animals. Of note, Hox genes (<italic>lin-39, mab-5)</italic> and <italic>unc-3</italic> do not cross-regulate their expression (<xref ref-type="bibr" rid="bib46">Kratsios et al., 2017</xref>). If Hox proteins, similar to UNC-3, are required for <italic>cfi-1</italic> maintenance in cholinergic MNs, stronger effects should be present in <italic>unc-3; lin-39; mab-5</italic> triple mutants compared to <italic>unc-3</italic> single mutants. Indeed, we found this to be the case in day 1 adult animals (graph on the right, <xref ref-type="fig" rid="fig5">Figure 5C</xref>). Supporting a maintenance role for Hox, mutation of the LIN-39 binding site within the <italic>cfi-1</italic> enhancer (reporter #8) led to a sustained decrease in reporter gene expression from L2 to adult stages (<xref ref-type="fig" rid="fig5">Figure 5E</xref>).</p><p>Together, our findings suggest the Hox proteins LIN-39 and MAB-5 control initiation and maintenance of <italic>cfi-1</italic> in cholinergic MNs via the same distal <italic>cis</italic>-regulatory region (enhancer) utilized by UNC-3 to maintain <italic>cfi-1</italic> (<xref ref-type="fig" rid="fig5">Figure 5G</xref>). However, this region bears distinct UNC-3 and LIN-39 binding sites.</p></sec><sec id="s2-7"><title><italic>cfi-1/Arid3a</italic> is required post-embryonically to maintain MN subtype identity</title><p>Expression of <italic>cfi-1</italic> in cholinergic MNs (DA, DB, VA, VB) is maintained throughout life by Hox and UNC-3 (<xref ref-type="fig" rid="fig5">Figure 5G</xref>). But why is it important to ensure continuous <italic>cfi-1</italic> expression? Although its function in VA and VB remains unknown, CFI-1 is required during early development to establish the identity of DA and DB subtypes by acting as a transcriptional repressor (<xref ref-type="bibr" rid="bib41">Kerk et al., 2017</xref>). In <italic>cfi-1</italic> null animals, glutamate receptor subunit 4 (<italic>glr-4/GluR),</italic> a terminal identity gene normally activated by UNC-3 in another MN subtype (SAB), becomes ectopically expressed in DA and DB neurons (<xref ref-type="fig" rid="fig5s2">Figure 5—figure supplement 2</xref>). In animals lacking <italic>cfi-1</italic> expression specifically in MNs at all stages (<italic>mNG::AID::cfi-1<sup>Δ enhancer (769 bp)</sup>,</italic> <xref ref-type="fig" rid="fig4">Figure 4A–B</xref>), we also observed ectopic <italic>glr-4</italic> expression in these neurons (<xref ref-type="fig" rid="fig5s2">Figure 5—figure supplement 2</xref>). Hence, early global removal of <italic>cfi-1,</italic> or MN-specific loss of <italic>cfi-1</italic> both lead to DA and DB neurons adopting a mixed identity. However, whether CFI-1 is required post-embryonically to continuously prevent DA and DB from obtaining a mixed identity is not known.</p><p>To enable CFI-1 protein depletion selectively at post-embryonic stages, we used the <italic>mNG::AID::cfi-1</italic> reporter allele (<xref ref-type="fig" rid="fig4">Figure 4A</xref>), which also serves as a conditional allele as it carries the auxin-inducible degron (AID) (<xref ref-type="bibr" rid="bib89">Zhang et al., 2015</xref>). Auxin administration at the first larval (L1) stage resulted in efficient depletion of <italic>mNG::AID::cfi-1</italic> expression, which was undetectable 2 days later (<xref ref-type="fig" rid="fig5s2">Figure 5—figure supplement 2</xref>). At the L3 stage (2 days upon continuous auxin treatment), we observed ectopic expression of <italic>glr-4</italic> in DA and DB neurons. These results suggest that CFI-1 is required post-embryonically to prevent DA and DB neurons from adopting mixed identity, underscoring the critical role of UNC-3 and Hox in maintaining <italic>cfi-1</italic> expression (<xref ref-type="fig" rid="fig5">Figure 5G</xref>).</p></sec><sec id="s2-8"><title>Minimal disruption of temporal modularity in UNC-3 function leads to locomotion defects</title><p>Animals carrying <italic>unc-3</italic> null alleles display severe locomotion defects (<xref ref-type="bibr" rid="bib19">Feng et al., 2020</xref>), likely due to combined defects in the expression of UNC-3 targets from both ‘initiation and maintenance’ and ‘maintenance-only’ modules (<xref ref-type="fig" rid="fig3">Figure 3C</xref>). Genes from the ‘initiation and maintenance’ module include (among others) terminal identity genes coding for ACh biosynthesis components (<xref ref-type="fig" rid="fig3">Figure 3A</xref>). Hence, it is conceivable that loss of <italic>unc-3</italic> can lead to defects in ACh biosynthesis, likely contributing to locomotion defects. However, it is unclear whether, in cholinergic MNs, the maintained expression of any of the UNC-3 targets from the ‘maintenance-only’ module is critical for locomotion. To test this, we focused on c<italic>fi-1/Arid3a</italic> and used the CRISPR-engineered allele (<italic>mNG::AID::cfi-1 <sup>8 COE motifs mut</sup></italic>) that selectively affects maintenance, but not initiation, of <italic>cfi-1</italic> expression in cholinergic MNs (<xref ref-type="fig" rid="fig4">Figure 4E–F</xref>). This allele minimally disrupts temporal modularity in UNC-3 function because UNC-3 can still control all its targets from both modules (<xref ref-type="fig" rid="fig3">Figure 3C</xref>), except one (<italic>cfi-1</italic>). As controls, we used animals carrying: (a) the endogenous <italic>cfi-1</italic> reporter allele (<italic>mNG::AID::cfi-1),</italic> (b) a putative null <italic>cfi-1</italic> allele (<italic>ot786</italic>) (<xref ref-type="bibr" rid="bib41">Kerk et al., 2017</xref>), in which <italic>cfi-1</italic> activity is affected in MNs and other neuron types of the motor circuit (<xref ref-type="bibr" rid="bib60">Pereira et al., 2015</xref>; <xref ref-type="bibr" rid="bib72">Shaham and Bargmann, 2002</xref>), and (<bold>c</bold>) a deletion of the distal enhancer (<italic>mNG::AID::cfi-1<sup>Δenhancer(769 bp)</sup></italic>), in which both initiation and maintenance of <italic>cfi-1</italic> are abrogated in nerve cord MNs (<xref ref-type="fig" rid="fig6">Figure 6A</xref>). We performed a high-resolution behavioral analysis of freely moving adult (day 2) animals of the above genotypes using automated multi-worm tracking technology (<xref ref-type="bibr" rid="bib34">Javer et al., 2018b</xref>; <xref ref-type="bibr" rid="bib86">Yemini et al., 2013</xref>). We found several features related to <italic>C. elegans</italic> locomotion (<italic>e.g.,</italic> body curvature, velocity) severely affected in <italic>cfi-1 (ot786)</italic> putative null animals (<xref ref-type="fig" rid="fig6">Figure 6B–G</xref>). Compared to <italic>cfi-1</italic> null mutants, animals carrying the <italic>mNG::AID::cfi-1 <sup>8 COE motifs mut</sup></italic> allele (selective disruption of <italic>cfi-1</italic> maintenance) display milder, but statistically significant locomotion defects in the adult (<xref ref-type="fig" rid="fig6">Figure 6B–G</xref>). As expected, these defects were also present in animals carrying the <italic>mNG::AID::cfi-1 <sup>Δenhancer (769 bp)</sup></italic> allele, in which both initiation and maintenance of <italic>cfi-1</italic> expression is affected. In summary, we specifically disrupted in cholinergic MNs the maintained expression of a single UNC-3 target (<italic>cfi-1</italic> from the ‘maintenance-only’ module) by using the <italic>mNG::AID::cfi-1 <sup>8 COE motifs mut</sup></italic> allele and observed locomotion defects. This analysis suggests that minimal disruption of temporal modularity in UNC-3 function can affect animal behavior.</p><fig id="fig6" position="float"><label>Figure 6.</label><caption><title>Minimal disruption of temporal modularity in UNC-3 function leads to locomotion defects.</title><p>(<bold>A</bold>) Schematics illustrating four <italic>cfi-1</italic> alleles tested for behavioral analysis. (<bold>B–G</bold>) Examples of six locomotion features significantly disrupted in animals carrying a putative null (<italic>ot786</italic>) allele for <italic>cfi-1</italic>. Locomotion analysis was performed on day 2 adult worms. Animals lacking <italic>cfi-1</italic> expression (initiation and maintenance) specifically in MNs (<italic>mNG::AID::cfi-1 <sup>Δenhancer (769 bp)</sup></italic>) and animals unable to maintain <italic>cfi-1</italic> expression in cholinergic MNs (<italic>mNG::AID::cfi-1<sup>8 COE motifs mut</sup></italic>) display locomotion defects when compared to control <italic>mNG::AID::cfi-1</italic> animals. As expected, these defects are milder when compared to animals carrying the <italic>cfi-1</italic> (<italic>ot786</italic>) allele. Panels B-F show locomotion features related to body curvature, whereas panel G shows radial velocity of the neck. A detailed description of each locomotion feature is provided below. (<bold>B</bold>) curvature_std_mid-body_w_backward_abs_10th: 10th percentile of the absolute value of the standard deviation of the curvature of the mid-body, while worm is moving backwards. (<bold>C</bold>) curvature_tail_w_backward_abs_90th: 90th percentile of the absolute value of the curvature of the tail, while worm is moving backwards. (<bold>D</bold>) curvature_std_mid-body_w_backward_50th: 50th percentile of the standard deviation of the curvature of the mid-body, while worm is moving backwards. (<bold>E</bold>) curvature_std_hips_abs_10th: 10th percentile of the absolute value of the standard deviation of the curvature of the hips. (<bold>F</bold>) curvature_std_hips_abs_50th: 50th percentile of the absolute value of the standard deviation of the curvature of the hips. (<bold>G</bold>) d_rel_to_body_radial_vel_neck_w_forward_90th: 90th percentile of the derivative of radial velocity of the neck relative to the centroid of the mid-body points, while worm is moving forwards.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-59464-fig6-v1.tif"/></fig></sec><sec id="s2-9"><title>Hox proteins and UNC-3 control <italic>bnc-1/BNC</italic> expression in cholinergic MNs</title><p>Our <italic>cis</italic>-regulatory analysis suggested that five TFs (<italic>cfi-1/Arid3a, bnc-1/BNC1-2, mab-9/Tbx20, ceh-44/CUX1-2, nhr-40/nuclear hormone receptor)</italic> require UNC-3 selectively for maintenance (<xref ref-type="fig" rid="fig3">Figure 3B</xref>). An in-depth analysis of <italic>cfi-1/Arid3a</italic> revealed that Hox proteins (LIN-39, MAB-5) and UNC-3 ensure the continuous expression of <italic>cfi-1</italic> in subsets of <italic>unc-3</italic>-positive MNs (<xref ref-type="fig" rid="fig3">Figures 3</xref>–<xref ref-type="fig" rid="fig5">5</xref>). We next asked whether a similar mechanism applies to the regulation of <italic>bnc-1</italic>/BNC, which is also expressed in a subset of <italic>unc-3</italic>-positive MNs (VA, VB) and prevents them from adopting a mixed identity (<xref ref-type="fig" rid="fig5s3">Figure 5—figure supplement 3</xref>; <xref ref-type="bibr" rid="bib41">Kerk et al., 2017</xref>). Using an endogenous reporter allele (<italic>bnc-1::mNG::AID</italic>), we found that LIN-39 and MAB-5 are required for <italic>bnc-1</italic> expression at all stages examined (L2, L4, day 1 adult; <xref ref-type="fig" rid="fig5s3">Figure 5—figure supplement 3</xref>), suggesting a role for Hox in <italic>bnc-1</italic> initiation and maintenance. Next, we found that UNC-3 is absolutely required for <italic>bnc-1</italic> maintenance in the adult (day 1), albeit weaker effects were also observed at L2 and L4 (<xref ref-type="fig" rid="fig5s3">Figure 5—figure supplement 3</xref>). Similar to <italic>cfi-1</italic>, these findings strongly suggest that endogenous <italic>bnc-1</italic> expression depends on Hox and UNC-3.</p></sec><sec id="s2-10"><title>Temporal modularity of UNC-30/PITX function in GABAergic MNs</title><p>Is temporal modularity observed in the function of other terminal selectors? To address this, we focused on UNC-30/PITX, the terminal selector of GABAergic MN (DD, VD) identity in the <italic>C. elegans</italic> nerve cord (<xref ref-type="fig" rid="fig7">Figure 7A</xref>; <xref ref-type="bibr" rid="bib36">Jin et al., 1994</xref>). UNC-30/PITX is known to directly activate the expression of several terminal identity genes (e.g., <italic>unc-25</italic>/GAD [glutamic acid decarboxylase], <italic>unc-47</italic>/VGAT [vesicular GABA transporter])(<xref ref-type="bibr" rid="bib16">Eastman et al., 1999</xref>), but a longitudinal analysis of target gene expression in <italic>unc-30</italic> null animals is lacking. Using reporter strains and methodologies similar to those used for UNC-3, we found that terminal identity gene (<italic>unc-25</italic>/GAD, <italic>unc-47</italic>/VGAT) expression is affected in GABAergic MNs of <italic>unc-30</italic> mutants at all stages examined (3-fold embryo, L2, L4, adult [day 1]) (<xref ref-type="fig" rid="fig7">Figure 7B,D</xref>), suggesting a requirement for initiation and maintenance. As mentioned earlier (<xref ref-type="fig" rid="fig4">Figure 4C</xref>), <italic>cfi-1</italic> is also expressed in GABAergic MNs (<xref ref-type="fig" rid="fig7">Figure 7A</xref>). Since UNC-3 is required for <italic>cfi-1</italic> maintenance in cholinergic MNs, we asked whether UNC-30/PITX plays a similar role to maintain <italic>cfi-1</italic> expression in GABAergic MNs. We found no effect at the embryonic stage (3-fold), but progressively stronger effects at larval (L2, L4) and adult (day 1) stages (<xref ref-type="fig" rid="fig7">Figure 7C</xref>), indicating that, in GABAergic MNs, UNC-30/PITX is selectively required for the maintenance, but not initiation of <italic>cfi-1</italic> expression. Taken together, our findings indicate that, like UNC-3 in cholinergic MNs (<xref ref-type="fig" rid="fig3">Figure 3C</xref>), the function of UNC-30 in GABAergic MNs is organized into two modules (module #1: initiation and maintenance; module #2: maintenance-only) (<xref ref-type="fig" rid="fig7">Figure 7D–E</xref>), suggesting temporal modularity may be a shared feature among terminal selector type-TFs.</p><fig id="fig7" position="float"><label>Figure 7.</label><caption><title>Temporal modularity in UNC-30/Pitx function in GABAergic MNs.</title><p>(<bold>A</bold>) Schematic summarizing the expression of <italic>cfi-1/Arid3a, unc-3/Ebf, unc-30/Pitx, unc-25/GAD,</italic> and <italic>unc-47/VGAT</italic> in MN subtypes of the <italic>C. elegans</italic> ventral nerve cord. (<bold>B</bold>) Schematic showing time of birth and cell body position of GABAergic nerve cord MNs. DD neurons are born embryonically. VD neurons are born post-embryonically. (<bold>C</bold>) Bioinformatic analyses predict 4 UNC-30 binding sites (yellow boxes) in the <italic>cfi-1</italic> enhancer. The location of UNC-3 and LIN-39 binding sites are also shown. (<bold>D</bold>) Top: snapshots of UNC-30 ChIP-Seq and input (negative control) signals at the <italic>cis</italic>-regulatory regions of 2 GABAergic terminal identity genes (<italic>unc-25/GAD, unc-47/VGAT</italic>). Bottom: quantification of the expression of transgenic reporters in WT and <italic>unc-30 (e191)</italic> animals at four different developmental stages – 3-fold embryo, L2, L4, and day 1 adults (N = 15). UNC-30 is required for both initiation and maintenance of <italic>unc-25/GAD</italic> and <italic>unc-47/VGAT</italic>. ***p&lt;0.001. (<bold>E</bold>) Top: a snapshot of UNC-3 ChIP-Seq and UNC-30 ChIP-Seq signals at the <italic>cfi-1</italic> locus. Bottom: quantification of the number of MNs expressing the endogenous reporter <italic>mNG::AID::cfi-1</italic> in WT and <italic>unc-30 (e191)</italic> animals. All <italic>cfi-1</italic>-expressing MNs in the ventral cord (cholinergic and GABAergic MNs) were counted in 3-fold embryos due to a lack of a specific marker that labels GABAergic MNs in embryos. Expression of <italic>cfi-1</italic> specifically in GABA neurons was quantified at L2, L4, and day 1 adult stages (N ⩾ 12). At those stages, cholinergic MNs were identified based on a fluorescent marker (<italic>cho-1::mChOpti</italic>), which are ruled out during scoring. GABAergic MNs were scored positive for <italic>cfi-1</italic> expression when the <italic>mNG::AID::cfi-1</italic> (green) expression co-localized with <italic>ttr-39::mCherry</italic> (red). N.S.: not significant, ***p&lt;0.001.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-59464-fig7-v1.tif"/></fig><p>To gain mechanistic insights, we analyzed available UNC-30 ChIP-Seq data at the L2 stage (<xref ref-type="bibr" rid="bib88">Yu et al., 2017</xref>). UNC-30 binds to the <italic>cis</italic>-regulatory region of terminal identity genes (<italic>unc-25</italic>/GAD, <italic>unc-47</italic>/VAGT) (<xref ref-type="fig" rid="fig7">Figure 7D</xref>), confirming previous observations (<xref ref-type="bibr" rid="bib16">Eastman et al., 1999</xref>). UNC-30 also binds to the same distal enhancer of <italic>cfi-1</italic> in GABAergic MNs, as UNC-3 does in cholinergic MNs (<xref ref-type="fig" rid="fig7">Figure 7E</xref>). However, the UNC-30 binding sites are distinct from the UNC-3 sites in this enhancer (<xref ref-type="fig" rid="fig7">Figure 7C</xref>). CRISPR-mediated deletion of this enhancer abolished <italic>cfi-1</italic> expression in both cholinergic and GABAergic MNs (<xref ref-type="fig" rid="fig4">Figure 4A–B</xref>). This finding suggests that maintenance of <italic>cfi-1</italic> expression in two different neuron types relies on the same enhancer receiving UNC-30/PITX input in GABAergic MNs and UNC-3/EBF input in cholinergic MNs. Interestingly, these results provide an example of ‘enhancer pleiotropy’ (<xref ref-type="bibr" rid="bib69">Sabarís et al., 2019</xref>), in which the same <italic>cis</italic>-regulatory element is used to control gene expression in different neuron types.</p></sec></sec><sec id="s3" sec-type="discussion"><title>Discussion</title><p>Terminal selectors are continuously expressed TFs that determine the identity and function of individual neuron types (<xref ref-type="bibr" rid="bib26">Hobert, 2008</xref>; <xref ref-type="bibr" rid="bib29">Hobert, 2016b</xref>). However, the breadth of biological processes controlled by terminal selectors remains unclear. Moreover, whether terminal selectors control an identical suite of target genes across different life stages, or the suite of targets can change over time is largely unexplored. Filling such knowledge gaps can help us understand how cellular identity is established during development and maintained throughout life, a fundamental goal in the field of developmental biology. In this study, we focus on UNC-3/Ebf, the terminal selector of cholinergic MNs in the <italic>C. elegans</italic> nerve cord. Through ChIP-Seq, we identify in an unbiased manner the direct targets of UNC-3, uncovering the breadth of biological processes potentially controlled by this terminal selector. Unexpectedly, we find two groups of target genes with distinct temporal requirements for UNC-3 in cholinergic MNs. One group encodes different classes of proteins (e.g., receptors, transporters) that require UNC-3 activation at all life stages examined. However, a second group exclusively encodes MN-specific TFs that selectively require UNC-3 for maintenance of their expression at late larval and adult stages. Hence, the suite of UNC-3 targets in cholinergic MNs is partially modified across different life stages, a phenomenon we term ‘temporal modularity’ in terminal selector function. Minimal disruption of this modularity by selectively removing the ability of UNC-3 to maintain expression of a single target gene (the TF <italic>cfi-1/Arid3a</italic> from the second group) led to locomotion defects, highlighting the necessity of temporal modularity for animal behavior.</p><sec id="s3-1"><title>Temporal modularity in terminal selector function may represent a general principle for neuronal subtype diversity</title><p>Why is there a need for temporal modularity in the function of continuously expressed TFs, such as terminal selectors? The case of UNC-3 suggests that temporal modularity is necessary for generating and maintaining neuronal subtype diversity. UNC-3 is continuously expressed in six MN subtypes (SAB, DA, DB, VA, VB, AS) of the <italic>C. elegans</italic> ventral nerve cord (<xref ref-type="fig" rid="fig4">Figure 4C</xref>; <xref ref-type="bibr" rid="bib60">Pereira et al., 2015</xref>). However, most UNC-3 targets from either module (modules # 1 and #2, <xref ref-type="fig" rid="fig3">Figure 3C</xref>) are expressed in some, but not all, of these subtypes. By ensuring the continuous expression of genes from module #1 (‘initiation and maintenance’ module, <xref ref-type="fig" rid="fig3">Figure 3C</xref>), such as terminal identity genes [(<xref ref-type="bibr" rid="bib44">Kratsios et al., 2011</xref>) and this study], UNC-3 consolidates the unique identity of each MN subtype. However, target genes from module #2 (‘maintenance-only’ module, <xref ref-type="fig" rid="fig3">Figure 3C</xref>) escape initiation by UNC-3, but do require UNC-3 for maintenance. Interestingly, all module #2 targets code for TFs (<italic>cfi-1/Arid3a, bnc-1/BNC1-2, mab-9/Tbx20, ceh-44/Cux1, nhr-40</italic>), specifically expressed in subsets of the six subtypes (SAB, DA, DB, VA, VB, AS) (<xref ref-type="bibr" rid="bib41">Kerk et al., 2017</xref> and this study). Three of these factors (<italic>cfi-1/Arid3a, bnc-1/Bnc1, mab-9/Tbx20)</italic> are thought to act as transcriptional repressors to prevent the adoption of mixed MN identity (<xref ref-type="bibr" rid="bib41">Kerk et al., 2017</xref>). For example, loss of <italic>cfi-1</italic> during early development results in ‘mixed’ identity of DA and DB subtypes, as these cells, in addition to their normal molecular signature, also acquire expression of genes (e.g., <italic>glr-4</italic>/GluR) normally expressed in other MNs (<xref ref-type="fig" rid="fig5s2">Figure 5—figure supplement 2</xref>). Through protein depletion experiments at post-embryonic stages, we show here that CFI-1 is continuously required to prevent DA and DB neurons from acquiring a mixed identity. Hence, UNC-3 indirectly maintains the unique identity of individual MN subtypes (DA, DB) by selectively maintaining expression of the TF <italic>cfi-1</italic> (from module #2) during late larval and adult stages. In addition, UNC-3 acts directly to control DA and DB identity by ensuring the continuous expression of <italic>unc-129/TGFb</italic>, a DA- and DB-specific terminal identity gene (from module #1) (<xref ref-type="fig" rid="fig3">Figure 3A</xref>, <xref ref-type="fig" rid="fig5s2">Figure 5—figure supplement 2</xref>). Hence, temporal modularity in UNC-3 function can be envisioned as a ‘double safety’ mechanism for the generation and maintenance of MN diversity.</p><p>The mechanism of temporal modularity may represent a general paradigm of how terminal selectors establish and maintain subtype identity within a class of functionally related neurons. Indeed, the same terminal selector is often continuously expressed in multiple subtypes of a given neuronal class (<xref ref-type="bibr" rid="bib30">Hobert and Kratsios, 2019</xref>). In mice, for example, the terminal selectors Nurr1 and Pet-1 are expressed in several subtypes of dopaminergic and serotonergic neurons, respectively (<xref ref-type="bibr" rid="bib38">Kadkhodaei et al., 2009</xref>; <xref ref-type="bibr" rid="bib59">Okaty et al., 2015</xref>). However, future studies are needed to determine whether temporal modularity in the function of these terminal selectors is necessary for establishing and maintaining neuronal subtype identity.</p></sec><sec id="s3-2"><title>Temporal modularity offers key insights into how terminal selectors control neuronal identity over time</title><p>The prevailing hypothesis of how terminal selectors establish and maintain neuronal identity is that they bind constantly, from development through adulthood, on the <italic>cis</italic>-regulatory region of terminal identity genes, and thereby continuously activate their expression (<xref ref-type="bibr" rid="bib13">Deneris and Hobert, 2014</xref>; <xref ref-type="bibr" rid="bib26">Hobert, 2008</xref>; <xref ref-type="bibr" rid="bib30">Hobert and Kratsios, 2019</xref>). For most terminal selectors, however, biochemical evidence for binding and longitudinal analysis of terminal selector mutant animals are currently lacking. Our analysis on module #1 genes (e.g., terminal identity genes) supports the aforementioned hypothesis; ChIP-Seq for UNC-3 demonstrated binding on these genes (<xref ref-type="fig" rid="fig3">Figure 3A,C</xref>). Moreover, our longitudinal genetic analysis combined with the UNC-3 protein depletion experiments in adult MNs demonstrate that UNC-3 is continuously required to maintain terminal identity gene expression.</p><p>Interestingly, the analysis on module #2 genes provides new mechanistic insights into how terminal selectors control neuronal identity over time. Instead of constantly activating the same set of genes, as predicted by the above hypothesis, terminal selectors can also partially modify the suite of their target genes at different life stages (temporal modularity), suggesting their function can be more dynamic than previously thought. This is based on the finding that UNC-3 is selectively required for maintenance, not initiation, of five conserved TF-encoding genes from module #2 (<italic>cfi-1/Arid3a, bnc-1/BNC1-2, mab-9/Tbx20, ceh-44/Cux1, nhr-40)</italic> (<xref ref-type="fig" rid="fig3">Figure 3B–C</xref>). Hence, some targets (module #1) require constant UNC-3 input from development through adulthood, whereas others (module #2) require UNC-3 only for maintenance.</p><p>By honing in on one TF (<italic>cfi-1/Arid3a)</italic> downstream of UNC-3, we identify a mechanism that potentially enables initiation and maintenance of module #2 genes (<xref ref-type="fig" rid="fig5">Figure 5G</xref>). That is, the Hox proteins LIN-39 and MAB-5 control initiation of <italic>cfi-1/Arid3a</italic> in cholinergic MNs independently of UNC-3, but <italic>cfi-1</italic> maintenance in these same neurons depends on both Hox and UNC-3 (<xref ref-type="fig" rid="fig5">Figure 5G</xref>). Mechanistically, we propose that Hox-dependent initiation and Hox/UNC-3-dependent maintenance of <italic>cfi-1</italic> are ‘funneled’ through the same distal enhancer, which bears both Hox and UNC-3 binding sites. This suggests embryonic initiation and post-embryonic maintenance of expression of a particular gene, in a specific cell type, can be achieved by distinct TF combinations acting upon the same <italic>cis</italic>-regulatory region (enhancer) (<xref ref-type="fig" rid="fig5">Figure 5G</xref>). This somewhat surprising mechanism differs from previous fly and mouse studies reporting distinct and physically separated <italic>cis</italic>-regulatory regions necessary for either initiation or maintenance of cell type-specific gene expression (<xref ref-type="bibr" rid="bib17">Ellmeier et al., 2002</xref>; <xref ref-type="bibr" rid="bib37">Johnson et al., 2011</xref>; <xref ref-type="bibr" rid="bib53">Manzanares et al., 2001</xref>; <xref ref-type="bibr" rid="bib62">Pfeffer et al., 2002</xref>; <xref ref-type="bibr" rid="bib68">Rhee et al., 2016</xref>).</p><p>In summary, our findings critically extend the mechanisms underlying UNC-3 function. Previous work demonstrated that, in cholinergic MNs, UNC-3 not only activates expression of terminal identity genes (<xref ref-type="bibr" rid="bib44">Kratsios et al., 2011</xref>), but also prevents alternative neuronal identities (<xref ref-type="bibr" rid="bib19">Feng et al., 2020</xref>). Here, we report that the suite of UNC-3 targets in these neurons can be partially modified at different life stages, offering key insights into how terminal selectors control neuronal identity over time.</p></sec><sec id="s3-3"><title>Hox proteins collaborate with stage-specific TFs to establish and maintain MN terminal identity</title><p>During early neuronal development, Hox proteins are essential for cell survival, neuronal diversity, and circuit assembly (<xref ref-type="bibr" rid="bib1">Baek et al., 2013</xref>; <xref ref-type="bibr" rid="bib7">Catela et al., 2016</xref>; <xref ref-type="bibr" rid="bib18">Estacio-Gómez and Díaz-Benjumea, 2014</xref>; <xref ref-type="bibr" rid="bib40">Karlsson et al., 2010</xref>; <xref ref-type="bibr" rid="bib57">Miguel-Aliaga and Thor, 2004</xref>; <xref ref-type="bibr" rid="bib58">Moris-Sanz et al., 2015</xref>; <xref ref-type="bibr" rid="bib63">Philippidou and Dasen, 2013</xref>). However, their post-embryonic neuronal functions remain elusive. Moreover, Hox proteins are often continuously expressed in multiple cell types of a given body region (<xref ref-type="bibr" rid="bib1">Baek et al., 2013</xref>; <xref ref-type="bibr" rid="bib32">Hutlet et al., 2016</xref>; <xref ref-type="bibr" rid="bib76">Takahashi et al., 2004</xref>), raising the question of how do they achieve cell type-specificity in their function. Our findings on mid-body Hox proteins LIN-39 and MAB-5 begin to address this question.</p><p>LIN-39 and MAB-5 are continuously expressed in multiple cell types located at the <italic>C. elegans</italic> mid-body region (<xref ref-type="bibr" rid="bib10">Clark et al., 1993</xref>; <xref ref-type="bibr" rid="bib12">Cowing and Kenyon, 1992</xref>; <xref ref-type="bibr" rid="bib19">Feng et al., 2020</xref>; <xref ref-type="bibr" rid="bib52">Maloof and Kenyon, 1998</xref>). We find that LIN-39 and MAB-5 exert a cell type-specific function; they are required to initiate (in embryo) and maintain (post-embryonically) <italic>cfi-1</italic> expression in specific subsets of cholinergic MNs (DA, DB, VA, VB; <xref ref-type="fig" rid="fig4">Figure 4C</xref>). Such specificity likely arises through collaboration with distinct TFs responsible for either initiation or maintenance of <italic>cfi-1</italic> (<xref ref-type="fig" rid="fig5">Figure 5G</xref>). Supporting this scenario, Hox (LIN-39, MAB-5) and UNC-3 are co-expressed in DA, DB, VA, and VB neurons (<xref ref-type="bibr" rid="bib19">Feng et al., 2020</xref>). Moreover, UNC-3 is selectively required for <italic>cfi-1</italic> maintenance (not initiation) in these neurons (<xref ref-type="fig" rid="fig5">Figure 5G</xref>). We surmise that other, yet-to-be-identified factors collaborate with Hox proteins at early stages to initiate <italic>cfi-1</italic> expression specifically in DA, DB, VA, and VB neurons. Such initiation-specific factors likely act through the same distal enhancer because its deletion completely abolished <italic>cfi-1</italic> expression in these neurons at early (and late) stages (<xref ref-type="fig" rid="fig4">Figures 4D</xref> and <xref ref-type="fig" rid="fig5">5G</xref>). In summary, we propose that Hox proteins collaborate with distinct TFs over time, that is, initiation-specific factors and the terminal selector UNC-3, to ensure continuous expression of <italic>cfi-1/Arid3a</italic> in specific subtypes of cholinergic MNs. This mechanism may extend to the regulation of terminal identity genes, as we previously showed that LIN-39 and UNC-3 are required to maintain expression of <italic>acr-2/</italic> human CHRNA1 (acetylcholine receptor subunit) and <italic>unc-77/</italic> human NALCN (sodium channel) in cholinergic MNs (<xref ref-type="bibr" rid="bib19">Feng et al., 2020</xref>). Altogether, these findings offer mechanistic insights into the recently proposed hypothesis that Hox proteins in <italic>C. elegans</italic> collaborate with terminal selectors to establish and maintain neuronal terminal identity (<xref ref-type="bibr" rid="bib46">Kratsios et al., 2017</xref>; <xref ref-type="bibr" rid="bib90">Zheng et al., 2015</xref>).</p></sec><sec id="s3-4"><title>Limitations of this study</title><p>By conducting a longitudinal analysis for 14 UNC-3 target genes, we identified two groups with distinct temporal requirements (modules #1 and #2 in <xref ref-type="fig" rid="fig3">Figure 3C</xref>). It is likely though that UNC-3 temporally controls other targets through additional modules. For example, animals lacking <italic>unc-3</italic> display severe axon guidance defects in cholinergic MNs (<xref ref-type="bibr" rid="bib66">Prasad et al., 1998</xref>), but the underlying mechanisms remain unknown. Since axon guidance molecules are often expressed in a transient fashion during early neuronal development, we speculate that UNC-3 may transiently activate expression of such molecules, a possibility that would add another temporal module in UNC-3 function. Another likely scenario is an ‘initiation-only’ module where UNC-3 is responsible only for onset, but not maintenance, of a yet-to-be-identified set of targets.</p><p>In addition, the breadth of biological processes controlled by terminal selectors remains largely unknown. Our ChIP-Seq analysis potentially implicates UNC-3 in a range of biological processes. First, this dataset significantly extends previous reports on the role of UNC-3 in neuronal terminal identity (<xref ref-type="bibr" rid="bib42">Kim et al., 2005</xref>; <xref ref-type="bibr" rid="bib44">Kratsios et al., 2011</xref>) by identifying hundreds of terminal identity genes (42.18% of total ChIP-Seq hits) as putative UNC-3 targets. Second, the ChIP-Seq dataset suggests new roles for UNC-3 in neuronal metabolic pathways (24.14% of UNC-3 target genes code for enzymes) and gene regulatory networks (24.07% of UNC-3 targets are TFs and nucleic acid-binding proteins). However, future RNA-Sequencing studies in <italic>unc-3</italic>-depleted MNs are necessary to correlate gene expression changes with UNC-3 ChIP-Seq data, and thereby identify <italic>bona fide</italic> targets and biological processes under direct UNC-3 control. Such analysis may also uncover any indirect effects on gene expression in <italic>unc-3</italic>-depleted MNs, perhaps arising due to a partial cell fate transformation previously reported for these neurons (<xref ref-type="bibr" rid="bib19">Feng et al., 2020</xref>).</p></sec><sec id="s3-5"><title>Temporal modularity may be a shared feature among continuously expressed TFs</title><p>This study suggests that the suite of targets of two <italic>C. elegans</italic> terminal selectors (UNC-3/Ebf and UNC-30/Pitx) can be modified over time, providing evidence for temporal modularity in their function. Given that terminal selectors, as well as other neuron type-specific TFs with continuous expression, have been described in both invertebrate and vertebrate species (<xref ref-type="bibr" rid="bib13">Deneris and Hobert, 2014</xref>; <xref ref-type="bibr" rid="bib30">Hobert and Kratsios, 2019</xref>; <xref ref-type="bibr" rid="bib54">Mayer et al., 2018</xref>; <xref ref-type="bibr" rid="bib56">Mi et al., 2018</xref>), it will be interesting to determine the potential generality of the temporal mechanism described here. Supporting this possibility, the terminal selector of serotonergic neurons in mice (Pet-1) activates expression of serotonin biosynthesis proteins during development, but appears to switch transcriptional targets at later life stages (<xref ref-type="bibr" rid="bib84">Wyler et al., 2016</xref>). Outside the nervous system, cell type-specific TFs with continuous expression have been described in worms, flies and mice (<xref ref-type="bibr" rid="bib64">Pikkarainen et al., 2004</xref>; <xref ref-type="bibr" rid="bib75">Soler et al., 2012</xref>; <xref ref-type="bibr" rid="bib83">Wiesenfahrt et al., 2016</xref>; <xref ref-type="bibr" rid="bib92">Zhou et al., 2017</xref>). Future studies will determine whether the principle of temporal modularity is widely employed for the control of cell type identity.</p></sec></sec><sec id="s4" sec-type="materials|methods"><title>Materials and methods</title><table-wrap id="keyresource" position="anchor"><label>Key resources table</label><table frame="hsides" rules="groups"><thead><tr><th>Reagent type (species) <break/>or resource</th><th>Designation</th><th>Source or reference</th><th>Identifiers</th><th>Additional information</th></tr></thead><tbody><tr><td valign="top">Gene <break/>(<italic>Caenorhabditis elegans</italic>)</td><td valign="top"><italic>unc-3</italic></td><td valign="top">Wormbase</td><td valign="top">WBGene00006743</td><td valign="top"/></tr><tr><td valign="top">Gene <break/>(<italic>C. elegans</italic>)</td><td valign="top"><italic>cfi-1</italic></td><td valign="top">Wormbase</td><td valign="top">WBGene00000476</td><td valign="top"/></tr><tr><td valign="top">Gene <break/>(<italic>C. elegans</italic>)</td><td valign="top"><italic>unc-30</italic></td><td valign="top">Wormbase</td><td valign="top">WBGene00006766</td><td valign="top"/></tr><tr><td valign="top">Gene <break/>(<italic>C. elegans</italic>)</td><td valign="top"><italic>lin-39</italic></td><td valign="top">Wormbase</td><td valign="top">WBGene00003024</td><td valign="top"/></tr><tr><td valign="top">Gene <break/>(<italic>C. elegans</italic>)</td><td valign="top">mab-5</td><td valign="top">Wormbase</td><td valign="top">WBGene00003102</td><td valign="top"/></tr><tr><td valign="top">Strain, strain <break/>background <break/>(<italic>C. elegans</italic>)</td><td valign="top"><italic>unc-3 (n3435)</italic></td><td valign="top">Bob Horvitz <break/>(MIT, Cambridge MA)</td><td valign="top">MT10785</td><td valign="top">Null Allele: deletion</td></tr><tr><td valign="top">Strain, strain <break/>background <break/>(<italic>C. elegans</italic>)</td><td valign="top"><italic>unc-3 (e151)</italic></td><td valign="top">Caenorhabditis <break/>Genetics Center</td><td valign="top">CB151</td><td valign="top">Allele: substitution</td></tr><tr><td valign="top">Strain, strain <break/>background <break/>(<italic>C. elegans</italic>)</td><td valign="top"><italic>lin-39 (n1760)</italic> <break/><italic>mab-5 (e1239)/ht2 III;</italic> <break/><italic>lgIs58 [[gcy-32::gfp]] V</italic></td><td valign="top">Caenorhabditis <break/>Genetics Center</td><td valign="top">LE4023</td><td valign="top"/></tr><tr><td valign="top">Strain, strain <break/>background <break/>(<italic>C. elegans</italic>)</td><td valign="top"><italic>lin-39 (n1760)/dpy-17</italic> <break/>(<italic>e164</italic>) <italic>unc-32</italic> <break/>(<italic>e189</italic>) <italic>III</italic></td><td valign="top">Caenorhabditis <break/>Genetics Center</td><td valign="top">MT4009</td><td valign="top">Null Allele: substitution</td></tr><tr><td valign="top">Strain, strain <break/>background <break/>(<italic>C. elegans</italic>)</td><td valign="top"><italic>unc-30 (e191)</italic></td><td valign="top">Caenorhabditis <break/>Genetics Center</td><td valign="top">CB845</td><td valign="top">Allele: substitution</td></tr><tr><td valign="top">Strain, strain <break/>background <break/>(<italic>C. elegans</italic>)</td><td valign="top"><italic>cfi-1 (ot786)</italic></td><td valign="top">This paper. <break/>Kratsios lab <break/>(University of <break/>Chicago, IL, USA).</td><td valign="top">KRA464</td><td valign="top">Null Allele: substitution - <break/>R to STOP (39); Strain <break/>was 3x backcrossed</td></tr><tr><td valign="top">Strain, strain <break/>background <break/>(<italic>C. elegans</italic>)</td><td valign="top"><italic>unc-3</italic> <break/>(<italic>ot839 [unc-3::gfp]</italic>) <italic>X</italic></td><td valign="top">Oliver Hobert <break/>(Columbia University, <break/>New York NY)</td><td valign="top">OH13990</td><td valign="top">CRISPR-generated allele</td></tr><tr><td valign="top">Strain, strain <break/>background <break/>(<italic>C. elegans</italic>)</td><td valign="top"><italic>cfi-1 (kas16</italic> <break/><italic>[mNG::AID::cfi-1]) I</italic></td><td valign="top">This paper. <break/>Kratsios lab <break/>(University of <break/>Chicago, IL, USA).</td><td valign="top">KRA345</td><td valign="top">CRISPR-generated allele; See <break/>Materials and methods - Targeted <break/>genome editing</td></tr><tr><td valign="top">Strain, strain <break/>background <break/>(<italic>C. elegans</italic>)</td><td valign="top"><italic>bnc-1 (ot845</italic> <break/><italic>[bnc-1::mNGAID]) V</italic></td><td valign="top"><xref ref-type="bibr" rid="bib41">Kerk et al., 2017</xref></td><td valign="top">OH14070</td><td valign="top">CRISPR-generated allele</td></tr><tr><td valign="top">Strain, strain <break/>background <break/>(<italic>C. elegans</italic>)</td><td valign="top"><italic>lin-39 (kas9</italic> <break/><italic>[lin-39::mNG::AID]) III</italic></td><td valign="top"><xref ref-type="bibr" rid="bib19">Feng et al., 2020</xref> <break/>Jan 3. doi:<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.7554/eLife.50065">10.7554/eLife.50065</ext-link></td><td valign="top">KRA467</td><td valign="top">CRISPR-generated allele</td></tr><tr><td valign="top">Strain, strain <break/>background <break/>(<italic>C. elegans</italic>)</td><td valign="top"><italic>unc-3 (ot837</italic> <break/><italic>[unc-3::mNG::AID]) X;</italic> <break/><italic>ieSi57 [Peft-3::TIR1::</italic> <break/><italic>mRuby::unc-54 3’ UTR,</italic> <break/><italic>cb-unc-119(+)] II</italic></td><td valign="top">This paper. <break/>Kratsios lab <break/>(University of <break/>Chicago, IL, USA).</td><td valign="top">KRA376</td><td valign="top">CRISPR-generated allele</td></tr><tr><td valign="top">Strain, strain <break/>background <break/>(<italic>C. elegans</italic>)</td><td valign="top"><italic>cfi-1 (syb1812</italic> <break/><italic>[A4e_enhancer deletion</italic> <break/><italic>−13,264–12,495 from</italic> <break/><italic>cfi-1 ATG in kas16]</italic> <break/><italic>kas16[cfi-1::mNG::AID]) I</italic></td><td valign="top">This paper. <break/>Kratsios lab <break/>(University of <break/>Chicago, IL, USA).</td><td valign="top">PHX1812</td><td valign="top">See Materials and methods - <break/>Targeted genome editing, <break/>and <xref ref-type="fig" rid="fig4">Figure 4A</xref> legend</td></tr><tr><td valign="top">Strain, strain <break/>background <break/>(<italic>C. elegans</italic>)</td><td valign="top"><italic>cfi-1 (syb1856 [8 COE</italic> <break/><italic>motifs mut in A4e] kas16</italic> <break/><italic>[cfi-1::mNG::AID]) I</italic></td><td valign="top">This paper. <break/>Kratsios lab <break/>(University of <break/>Chicago, IL, USA).</td><td valign="top">PHX1856</td><td valign="top">See Materials and methods - <break/>Targeted genome editing, <break/>and <xref ref-type="fig" rid="fig4">Figure 4E</xref> legend</td></tr><tr><td valign="top">Strain, strain <break/>background <break/>(<italic>C. elegans</italic>)</td><td valign="top"><italic>otIs544 [cho-1(fosmid)::</italic> <break/><italic>SL2::mCherry::H2B +</italic> <break/><italic>pha-1(+)]</italic></td><td valign="top">Oliver Hobert <break/>(Columbia University, <break/>New York NY)</td><td valign="top">OH13646</td><td valign="top"/></tr><tr><td valign="top">Strain, strain <break/>background <break/>(<italic>C. elegans</italic>)</td><td valign="top"><italic>juIs14 [acr-2p::GFP +</italic> <break/><italic>lin-15(+)] IV.</italic></td><td valign="top">Caenorhabditis <break/>Genetics Center</td><td valign="top">CZ631</td><td valign="top"/></tr><tr><td valign="top">Strain, strain <break/>background <break/>(<italic>C. elegans</italic>)</td><td valign="top"><italic>otIs426 [Punc-17_1 kb::</italic> <break/><italic>YFP, Pmyo-2::GFP]</italic></td><td valign="top">Oliver Hobert <break/>(Columbia University, <break/>New York NY)</td><td valign="top">OH11454</td><td valign="top"/></tr><tr><td valign="top">Strain, strain <break/>background <break/>(<italic>C. elegans</italic>)</td><td valign="top"><italic>evIs82b [unc-129::</italic> <break/><italic>GFP + dpy-20(+)] IV.</italic></td><td valign="top">Oliver Hobert <break/>(Columbia University, <break/>New York NY)</td><td valign="top">OH1894</td><td valign="top"/></tr><tr><td valign="top">Strain, strain <break/>background <break/>(<italic>C. elegans</italic>)</td><td valign="top"><italic>otIs476 [glr-4 prom::</italic> <break/><italic>TagRFP + pha-1(+)]</italic></td><td valign="top"><xref ref-type="bibr" rid="bib41">Kerk et al., 2017</xref></td><td valign="top">OH12052</td><td valign="top"/></tr><tr><td valign="top">Strain, strain <break/>background <break/>(<italic>C. elegans</italic>)</td><td valign="top"><italic>otIs477 [glr-4 prom::</italic> <break/><italic>TagRFP + pha-1(+)]</italic></td><td valign="top">Oliver Hobert <break/>(Columbia University, <break/>New York NY)</td><td valign="top">OH12053</td><td valign="top"/></tr><tr><td valign="top">Strain, strain <break/>background <break/>(<italic>C. elegans</italic>)</td><td valign="top"><italic>vsIs48 [unc-17::GFP]</italic></td><td valign="top">Caenorhabditis <break/>Genetics Center</td><td valign="top">LX929</td><td valign="top"/></tr><tr><td valign="top">Genetic reagent <break/>(<italic>C. elegans</italic>)</td><td valign="top"><italic>Pcfi-1_8.17 kb::GFP</italic></td><td valign="top"><xref ref-type="bibr" rid="bib72">Shaham and Bargmann, 2002</xref></td><td valign="top">nsEx37</td><td valign="top">See <xref ref-type="fig" rid="fig4">Figure 4A</xref> legend</td></tr><tr><td valign="top">Genetic reagent <break/>(<italic>C. elegans</italic>)</td><td valign="top"><italic>cfi-1_−11,329 bp</italic> <break/><italic>−13,824 bp::RFP</italic></td><td valign="top">This paper. <break/>Kratsios lab <break/>(University of <break/>Chicago, IL, USA).</td><td valign="top">kasEx12 <break/>kasEx182 <break/>kasEx183</td><td valign="top">See Materials and methods, <break/>and <xref ref-type="fig" rid="fig4">Figure 4A</xref> legend</td></tr><tr><td valign="top">Genetic reagent <break/>(<italic>C. elegans</italic>)</td><td valign="top"><italic>cfi-1_2.77 kb(993 bp</italic> <break/><italic>to 3,764 bp)::rfp</italic></td><td valign="top">This paper. <break/>Kratsios lab <break/>(University of <break/>Chicago, IL, USA).</td><td valign="top">kasEx184 <break/>kasEx185 <break/>kasEx186</td><td valign="top">See Materials and methods, <break/>and <xref ref-type="fig" rid="fig4">Figure 4A</xref> legend</td></tr><tr><td valign="top">Genetic reagent <break/>(<italic>C. elegans</italic>)</td><td valign="top"><italic>cfi-1_1.72 kb (547 bp</italic> <break/><italic>to −1,173 bp)::rfp</italic></td><td valign="top">This paper. <break/>Kratsios lab <break/>(University of <break/>Chicago, IL, USA).</td><td valign="top">kasEx187 <break/>kasEx188 <break/>kasEx189</td><td valign="top">See Materials and methods, <break/>and <xref ref-type="fig" rid="fig4">Figure 4A</xref> legend</td></tr><tr><td valign="top">Genetic reagent <break/>(<italic>C. elegans</italic>)</td><td valign="top"><italic>cfi-1_1.71 kb (−1,164 bp</italic> <break/><italic>to −2,875 bp): :rfp</italic></td><td valign="top">This paper. <break/>Kratsios lab <break/>(University of <break/>Chicago, IL, USA).</td><td valign="top">kasEx190 <break/>kasEx191 <break/>kasEx192</td><td valign="top">See Materials and methods, <break/>and <xref ref-type="fig" rid="fig4">Figure 4A</xref> legend</td></tr><tr><td valign="top">Genetic reagent <break/>(<italic>C. elegans</italic>)</td><td valign="top"><italic>cfi-1_3.27 kb(−2,865 bp</italic> <break/><italic>to −6,141 bp)::rfp</italic></td><td valign="top">This paper. <break/>Kratsios lab <break/>(University of <break/>Chicago, IL, USA).</td><td valign="top">kasEx193 <break/>kasEx194 <break/>kasEx195</td><td valign="top">See Materials and methods, <break/>and <xref ref-type="fig" rid="fig4">Figure 4A</xref> legend</td></tr><tr><td valign="top">Genetic reagent <break/>(<italic>C. elegans</italic>)</td><td valign="top"><italic>cfi-1_3.18 kb(−8,162 bp</italic> <break/><italic>to −11,346 bp): :rfp</italic></td><td valign="top">This paper. <break/>Kratsios lab <break/>(University of <break/>Chicago, IL, USA).</td><td valign="top">kasEx196 <break/>kasEx197</td><td valign="top">See Materials and methods, <break/>and <xref ref-type="fig" rid="fig4">Figure 4A</xref> legend</td></tr><tr><td valign="top">Genetic reagent <break/>(<italic>C. elegans</italic>)</td><td valign="top"><italic>cfi-1_552 bp(−11,329 bp</italic> <break/><italic>to −11,881 bp): :rfp</italic></td><td valign="top">This paper. <break/>Kratsios lab <break/>(University of <break/>Chicago, IL, USA).</td><td valign="top">kasEx198 <break/>kasEx199 <break/>kasEx200</td><td valign="top">See Materials and methods, <break/>and <xref ref-type="fig" rid="fig4">Figure 4A</xref> legend</td></tr><tr><td valign="top">Genetic reagent <break/>(<italic>C. elegans</italic>)</td><td valign="top"><italic>cfi-1_383 bp(−11,851 bp</italic> <break/><italic>to −12,234 bp): :rfp</italic></td><td valign="top">This paper. <break/>Kratsios lab <break/>(University of <break/>Chicago, IL, USA).</td><td valign="top">kasEx201 <break/>kasEx202 <break/>kasEx203</td><td valign="top">See Materials and methods, <break/>and <xref ref-type="fig" rid="fig4">Figure 4A</xref> legend</td></tr><tr><td valign="top">Genetic reagent <break/>(<italic>C. elegans</italic>)</td><td valign="top"><italic>cfi-1_499 bp(−12,223 bp</italic> <break/><italic>to −12,722 bp)::rfp</italic></td><td valign="top">This paper. <break/>Kratsios lab <break/>(University of <break/>Chicago, IL, USA).</td><td valign="top">kasEx204 <break/>kasEx205</td><td valign="top">See Materials and methods, <break/>and <xref ref-type="fig" rid="fig4">Figure 4A</xref> legend</td></tr><tr><td valign="top">Genetic reagent <break/>(<italic>C. elegans</italic>)</td><td valign="top"><italic>cfi-1_579 bp(−12,705 bp</italic> <break/><italic>to −13,284 bp)::rfp</italic></td><td valign="top">This paper. <break/>Kratsios lab <break/>(University of <break/>Chicago, IL, USA).</td><td valign="top">kasEx206 <break/>kasEx207 <break/>kasEx208</td><td valign="top">See Materials and methods, <break/>and <xref ref-type="fig" rid="fig4">Figure 4A</xref> legend</td></tr><tr><td valign="top">Genetic reagent <break/>(<italic>C. elegans</italic>)</td><td valign="top">cfi-1_561 bp(−13,263 bp <break/>to −13,824 bp)::rfp</td><td valign="top">This paper. <break/>Kratsios lab <break/>(University of <break/>Chicago, IL, USA).</td><td valign="top">kasEx209 <break/>kasEx210</td><td valign="top">See Materials and methods, <break/>and <xref ref-type="fig" rid="fig4">Figure 4A</xref> legend</td></tr><tr><td valign="top">Genetic reagent <break/>(<italic>C. elegans</italic>)</td><td valign="top"><italic>nhr-1 (peak 1,–7455</italic> <break/><italic>to −5853)::RFP::</italic> <break/><italic>unc-54 3'UTR</italic></td><td valign="top">This paper. <break/>Kratsios lab <break/>(University of <break/>Chicago, IL, USA).</td><td valign="top">kasEx211</td><td valign="top">See Materials and methods <break/>- Generation of transgenic <break/>animals carrying <break/>transcriptional fusion reporters</td></tr><tr><td valign="top">Genetic reagent <break/>(<italic>C. elegans</italic>)</td><td valign="top"><italic>nhr-1 (peak 2,–893 to</italic> <break/><italic>+1535)::RFP::</italic> <break/><italic>unc-54 3'UTR</italic></td><td valign="top">This paper. <break/>Kratsios lab <break/>(University of <break/>Chicago, IL, USA).</td><td valign="top">kasEx212 <break/>kasEx213</td><td valign="top">See Materials and methods <break/>- Generation of transgenic <break/>animals carrying <break/>transcriptional fusion reporters</td></tr><tr><td valign="top">Genetic reagent <break/>(<italic>C. elegans</italic>)</td><td valign="top"><italic>nhr-40 (peak 1, +938 to</italic> <break/><italic>+1846)::RFP::</italic> <break/><italic>unc-54 3'UTR</italic></td><td valign="top">This paper. <break/>Kratsios lab <break/>(University of <break/>Chicago, IL, USA).</td><td valign="top">kasEx214 <break/>kasEx215</td><td valign="top">See Materials and methods <break/>- Generation of transgenic <break/>animals carrying <break/>transcriptional fusion reporters</td></tr><tr><td valign="top">Genetic reagent <break/>(<italic>C. elegans</italic>)</td><td valign="top"><italic>nhr-40 (peak 2, +4360</italic> <break/><italic>to +5522)::RFP::</italic> <break/><italic>unc-54 3'UTR</italic></td><td valign="top">This paper. <break/>Kratsios lab <break/>(University of <break/>Chicago, IL, USA).</td><td valign="top">kasEx216 <break/>kasEx217</td><td valign="top">See Materials and methods <break/>- Generation of transgenic <break/>animals carrying transcriptional <break/>fusion reporters</td></tr><tr><td valign="top">Genetic reagent <break/>(<italic>C. elegans</italic>)</td><td valign="top"><italic>zfh-2::rfp</italic> (12,048 bp <break/>to 13,549 bp)</td><td valign="top">This paper. <break/>Kratsios lab <break/>(University of <break/>Chicago, IL, USA).</td><td valign="top">kasEx218 <break/>kasEx219</td><td valign="top">See Materials and methods <break/>- Generation of transgenic <break/>animals carrying transcriptional <break/>fusion reporters</td></tr><tr><td valign="top">Genetic reagent <break/>(<italic>C. elegans</italic>)</td><td valign="top"><italic>nhr-49 (−803 to +58)::</italic> <break/><italic>RFP::unc-54 3'UTR</italic></td><td valign="top">This paper. <break/>Kratsios lab <break/>(University of <break/>Chicago, IL, USA).</td><td valign="top">kasEx220 <break/>kasEx221</td><td valign="top">See Materials and methods <break/>- Generation of transgenic <break/>animals carrying transcriptional <break/>fusion reporters</td></tr><tr><td valign="top">Genetic reagent <break/>(<italic>C. elegans</italic>)</td><td valign="top"><italic>nhr-19 (+1250 to</italic> <break/><italic>+2302)::RFP::unc-54</italic> <break/><italic>3'UTR</italic></td><td valign="top">This paper. <break/>Kratsios lab <break/>(University of <break/>Chicago, IL, USA).</td><td valign="top">kasEx222 <break/>kasEx223</td><td valign="top">See Materials and methods <break/>- Generation of transgenic <break/>animals carrying transcriptional <break/>fusion reporters</td></tr><tr><td valign="top">Genetic reagent <break/>(<italic>C. elegans</italic>)</td><td valign="top"><italic>ccch-3 (Peak 1, 0 to</italic> <break/><italic>−387)::RFP::</italic> <break/><italic>unc-54 3’UTR</italic></td><td valign="top">This paper. <break/>Kratsios lab <break/>(University of <break/>Chicago, IL, USA).</td><td valign="top">kasEx224 <break/>kasEx225</td><td valign="top">See Materials and methods <break/>- Generation of transgenic <break/>animals carrying transcriptional <break/>fusion reporters</td></tr><tr><td valign="top">Genetic reagent <break/>(<italic>C. elegans</italic>)</td><td valign="top"><italic>ztf-17 (Peak 1, 0 to</italic> <break/><italic>−1034)::RFP::</italic> <break/><italic>unc-54 3’UTR</italic></td><td valign="top">This paper. <break/>Kratsios lab <break/>(University of <break/>Chicago, IL, USA).</td><td valign="top">kasEx226 <break/>kasEx227</td><td valign="top">See Materials and methods <break/>- Generation of transgenic <break/>animals carrying transcriptional <break/>fusion reporters</td></tr><tr><td valign="top">Genetic reagent <break/>(<italic>C. elegans</italic>)</td><td valign="top"><italic>ztf-26 (Peak 1,–1341</italic> <break/><italic>to +753)::RFP::</italic> <break/><italic>unc-54 3’UTR</italic></td><td valign="top">This paper. <break/>Kratsios lab <break/>(University of <break/>Chicago, IL, USA).</td><td valign="top">kasEx228 <break/>kasEx229</td><td valign="top">See Materials and methods <break/>- Generation of transgenic <break/>animals carrying transcriptional <break/>fusion reporters</td></tr><tr><td valign="top">Genetic reagent <break/>(<italic>C. elegans</italic>)</td><td valign="top"><italic>ztf-26 (Peak 2, +909</italic> <break/><italic>to +3394)::RFP::</italic> <break/><italic>unc-54 3’UTR</italic></td><td valign="top">This paper. <break/>Kratsios lab <break/>(University of <break/>Chicago, IL, USA).</td><td valign="top">kasEx230 <break/>kasEx231</td><td valign="top">See Materials and methods <break/>- Generation of transgenic <break/>animals carrying transcriptional <break/>fusion reporters</td></tr><tr><td valign="top">Genetic reagent <break/>(<italic>C. elegans</italic>)</td><td valign="top"><italic>mab-9 (−5569 to</italic> <break/><italic>−3768)::RFP::unc-54</italic> <break/><italic>3'UTR</italic></td><td valign="top">This paper. <break/>Kratsios lab <break/>(University of <break/>Chicago, IL, USA).</td><td valign="top">kasEx232 <break/>kasEx233</td><td valign="top">See Materials and methods <break/>- Generation of transgenic <break/>animals carrying transcriptional <break/>fusion reporters</td></tr><tr><td valign="top">Genetic reagent <break/>(<italic>C. elegans</italic>)</td><td valign="top"><italic>ceh-44 (1,605 bp</italic> <break/><italic>to 3,111 bp): :rfp</italic></td><td valign="top">This paper. <break/>Kratsios lab <break/>(University of <break/>Chicago, IL, USA).</td><td valign="top">kasEx234 <break/>kasEx235</td><td valign="top">See Materials and methods <break/>- Generation of transgenic <break/>animals carrying transcriptional <break/>fusion reporters</td></tr><tr><td valign="top">Antibody</td><td valign="top">anti-GFP (Rabbit <break/>polyclonal)</td><td valign="top">Abcam</td><td valign="top">Ab290</td><td valign="top">Dilution: 1:1000; RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_303395">AB_303395</ext-link></td></tr><tr><td valign="top">Commercial assay or kit</td><td valign="top">Dynabeads <break/>Protein G</td><td valign="top">Invitrogen</td><td valign="top">1004D</td><td valign="top"/></tr><tr><td valign="top">Commercial assay or kit</td><td valign="top">Gibson Assembly <break/>Cloning Kit</td><td valign="top">NEB</td><td valign="top">#5510S</td><td valign="top"/></tr><tr><td valign="top">Commercial assay or kit</td><td valign="top">QIAquick PCR <break/>Purification Kit</td><td valign="top">QIAGEN</td><td valign="top">#28104</td><td valign="top"/></tr><tr><td valign="top">Commercial assay or kit</td><td valign="top">Ampure XP beads</td><td valign="top">Beckman Coulter <break/>Life Sciences</td><td valign="top">A63881</td><td valign="top"/></tr><tr><td valign="top">Chemical compound, <break/>drug</td><td valign="top">cOmplete ULTRA <break/>Protease Inhibitor <break/>Cocktail</td><td valign="top">Roche</td><td valign="top">#05892970001</td><td valign="top"/></tr><tr><td valign="top">Chemical compound, <break/>drug</td><td valign="top">Auxin <break/>(indole-3-acetic acid)</td><td valign="top">Alfa Aesar</td><td valign="top">#10196875</td><td valign="top"/></tr><tr><td valign="top">Software, algorithm</td><td valign="top">ZEN</td><td valign="top">ZEISS</td><td valign="top">Version 2.3.69.1000, <break/>Blue edition</td><td valign="top">RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/SCR_013672">SCR_013672</ext-link></td></tr><tr><td valign="top">Software, algorithm</td><td valign="top">Image J</td><td valign="top">Image J</td><td valign="top">Version 1.52i</td><td valign="top">RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/SCR_003070">SCR_003070</ext-link></td></tr><tr><td valign="top">Software, algorithm</td><td valign="top">Adobe Photoshop CS6</td><td valign="top">Adobe</td><td valign="top">Version 13.0 × 64</td><td valign="top"/></tr><tr><td valign="top">Software, algorithm</td><td valign="top">Adobe Illustrator CS6</td><td valign="top">Adobe</td><td valign="top">Version 16.0.0 × 64</td><td valign="top"/></tr></tbody></table></table-wrap><sec id="s4-1"><title><italic>C. elegans</italic> strain culture</title><p>Worms were grown at 20C or 25°C on nematode growth media (NGM) plates supplied with <italic>E. coli</italic> OP50 as food source (<xref ref-type="bibr" rid="bib5">Brenner, 1974</xref>). A list of all <italic>C. elegans</italic> strains used is provided in Key Resources Table.</p></sec><sec id="s4-2"><title>Generation of transgenic animals carrying transcriptional fusion reporters</title><p>Reporter gene fusions for <italic>cis</italic>-regulatory analyses and validation of newly identified UNC-3 target genes were made with PCR fusion (<xref ref-type="bibr" rid="bib25">Hobert, 2002</xref>). Genomic regions were amplified and fused to the coding sequence of <italic>tagrfp</italic> followed by the <italic>unc-54</italic> 3’ UTR. To mutate the LIN-39 binding motif, the reporter fusion was first introduced into the pCR-XL-TOPO vector using the TOPO XL PCR cloning kit (Invitrogen). Then, mutagenesis PCR was performed, and single clones containing plasmids that carry the desired mutation were isolated. PCR fusion DNA fragments were injected into young adult <italic>pha-1(e2123)</italic> hermaphrodites at 50 ng/µl together with <italic>pha-1</italic> (pBX plasmid) as co-injection marker (50 ng/µl).</p></sec><sec id="s4-3"><title>Chromatin immunoprecipitation (ChIP)</title><p>ChIP assay was performed as previously described (<xref ref-type="bibr" rid="bib88">Yu et al., 2017</xref>; <xref ref-type="bibr" rid="bib91">Zhong et al., 2010</xref>) with the following modifications. Synchronized L1 <italic>unc-3 (ot839 [unc-3::gfp])</italic> worms and N2 worms were cultured on 10 cm plates seeded with OP50 at 20°C overnight. Late L2 worms were cross-linked and resuspended in FA buffer supplemented with protease inhibitors (150 mM NaCl, 10 μl 0.1 M PMSF, 100 μl 10% SDS, 500 μl 20% N-Lauroyl sarsosine sodium, 2 tablets of cOmplete ULTRA Protease Inhibitor Cocktail [Roche Cat.# 05892970001] in 10 ml FA buffer). For each IP experiment, 200 μl worm pellet was collected. The sample was then sonicated using a Covaris S220 at the following settings: 200 W Peak Incident Power, 20% Duty Factor, 200 Cycles per Burst for 1 min. Samples were transferred to centrifuge tubes and spun at the highest speed for 15 min. The supernatant was transferred to a new tube, and 5% of the material was saved as input and stored at −20°C. The remainder was incubated with 2 μl GFP antibody (Abcam Cat.# ab290) at 4°C overnight. Wild-type (N2) worms do not carry the GFP tag and serve as negative control. The <italic>unc-3 (ot839 [unc-3::gfp])</italic> CRIPSR generated allele was used in order to immunoprecipitate the endogenous UNC-3 protein. On the next day, 20 μl Dynabeads Protein G (1004D) was added to the immunocomplex, which was then incubated for 2 hr at 4°C. The beads then were washed at 4°C twice with 150 mM NaCl FA buffer (5 min each), and once with 1M NaCl FA buffer (5 min). The beads were transferred to a new centrifuge tube and washed twice with 500 mM NaCl FA buffer (10 min each), once with TEL buffer (0.25 M LiCl, 1% NP-40, 1% sodium deoxycholate, 1 mM EDTA, 10 mM Tris-HCl, pH 8.0) for 10 min, and twice with TE buffer (5 min each). The immunocomplex was then eluted in 200 μl elution buffer (1% SDS in TE with 250 mM NaCl) by incubating at 65°C for 20 min. The saved input samples were thawed and treated with the ChIP samples as follows. One (1) μl of 20 mg/ml proteinase K was added to each sample and the samples were incubated at 55°C for 2 hr then 65°C overnight (12–20 hr) to reverse cross-link. The immonuprecipitated DNA was purified with Ampure XP beads (A63881) according to manufacturer’s instructions.</p></sec><sec id="s4-4"><title>ChIP-sequencing data analysis</title><p>Unique reads were mapped to the <italic>C. elegans</italic> genome (ce10) with bowtie2 (<xref ref-type="bibr" rid="bib47">Langmead and Salzberg, 2012</xref>). Peak calling was then performed with MACS2 (minimum q-value cutoff for peak detection: 0.005). For visualization purposes, the sequencing depth was normalized to 1x genome coverage using bamCoverage provided by deepTools (<xref ref-type="bibr" rid="bib67">Ramírez et al., 2016</xref>), and peak signals were shown in IGV. Heatmap of peak coverage in regard to UNC-3 enrichment center was generated with NGSplot (<xref ref-type="bibr" rid="bib73">Shen et al., 2014</xref>). The average profile of peaks binding to TSS region was generated with ChIPseeker (<xref ref-type="bibr" rid="bib87">Yu et al., 2015</xref>). To study the distribution of peaks genome-wide, the peaks were annotated using annotatePeaks.pl provided by Homer (<xref ref-type="bibr" rid="bib24">Heinz et al., 2010</xref>), and each peak was assigned to a gene with the nearest TSS. For de novo motif discovery, sequences containing 100 bp around the centers of each peak (from −50 bp to +50 bp) were extracted and supplied to findMotifsGenome.pl provided by Homer.</p></sec><sec id="s4-5"><title>Protein class ontology analysis using PANTHER</title><p>Protein class ontology analysis was performed on 1,478 UNC-3-bound genes out of the 3502 protein-coding genes. The number of genes is significantly lower than the number of peaks because PANTHER analysis only considers genes with known protein class terms.</p></sec><sec id="s4-6"><title>Targeted genome editing</title><p>The <italic>cfi-1</italic> endogenous reporter strain <italic>kas16 [mNG::AID::cfi-1]</italic> was generated by employing CRISPR/Cas9 genome editing, inserting the <italic>mNG::3xFLAG::AID</italic> cassette immediately after the ATG of <italic>cfi-1</italic>. The <italic>cfi-1</italic> enhancer knock-out allele <italic>mNG::AID::cfi-1<sup>Δenhancer (769 bp)</sup></italic> was generated by using two guide RNAs flanking the <italic>cfi-1</italic> enhancer to guide excision of the genomic region, which was then followed by homology dependent repair (HDR) to create a 769 bp deletion (−11,329 bp to −12,097 bp). The UNC-3 binding motif mutation allele <italic>mNG::AID::cfi-1<sup>8 COE motifs mut</sup></italic> was generated by creating nucleotide substitutions in the repair template, which carries homology arms complementary to the <italic>cfi-1</italic> enhancer region and is then introduced into the genome through HDR.</p></sec><sec id="s4-7"><title>Microscopy</title><p>Imaging slides were prepared by anesthetizing worms with sodium azide (NaN<sub>3</sub>, 100 mM) and mounting them on a 4% agarose pad on glass slides. Images were taken with an automated fluorescence microscope (Zeiss, Axio Imager Z2). Images containing several Z-stacks (0.50 µm intervals between stacks) were taken with Zeiss Axiocam 503 mono using the ZEN software (Version 2.3.69.1000, Blue edition). Representative images are shown following max-projection of 2–5 µm Z-stacks using the maximum intensity projection type. Image reconstruction was performed with Image J (<xref ref-type="bibr" rid="bib70">Schindelin et al., 2012</xref>).</p></sec><sec id="s4-8"><title>MN subtype identification</title><p>The identification of specific MN subtypes expressing a given UNC-3 target gene was assessed based on the following: (a) co-localization with fluorescent reporters that label specific MN subtypes; (b) Invariant position of neuronal cell bodies along the ventral nerve cord; (c) Birth order of specific MN subtypes (e.g. during embryogenesis or post-embryogenesis); (d) Total cell numbers in each MN subtype.</p></sec><sec id="s4-9"><title>Bioinformatic prediction of binding motifs</title><p>Information of the LIN-39 binding motif is curated in the Catalog of Inferred Sequence Binding Preferences database (<ext-link ext-link-type="uri" xlink:href="http://cisbp.ccbr.utoronto.ca">http://cisbp.ccbr.utoronto.ca</ext-link>). To predict and identify LIN-39 binding motifs and UNC-3 binding motifs (identified in this paper) in the <italic>cfi-1</italic> enhancer (−11,391 bp to −12,146 bp), we utilized tools provided by MEME (Multiple Expectation maximization for Motif Elicitation) bioinformatics suite (<ext-link ext-link-type="uri" xlink:href="http://meme-suite.org/">http://meme-suite.org/</ext-link>), and performed Find Individual Motif Occurrences (FIMO) motif scanning analysis.</p></sec><sec id="s4-10"><title>Temporally controlled protein degradation</title><p>Temporally controlled protein degradation was achieved with the AID system (<xref ref-type="bibr" rid="bib89">Zhang et al., 2015</xref>). TIR1 expression was driven by the ubiquitously active <italic>eft-3</italic> promoter in the transgene <italic>ieSi57 [eft-3prom::tir1],</italic> or a transgene that drives TIR1 selectively in neurons (<italic>otTi28</italic>). To induce degradation of proteins (LIN-39, CFI-1, UNC-3), the following alleles were used: <italic>lin-39 (kas9 [lin-39::mNG::AID]), cfi-1 (kas16 [mNG::AID::cfi-1]),</italic> and <italic>unc-3 (ot837 [unc-3::mNG::AID]).</italic> Worms at specific developmental stages (see figure legends for details) were grown at 20°C on NGM plates coated with 4 nM auxin (indole-3-acetic acid [IAA] dissolved in ethanol) or ethanol (negative control) for 1 day or 4 days before tested (see figure legends for more details). All plates were shielded from light.</p></sec><sec id="s4-11"><title>Worm tracking</title><p>Worms were maintained as mixed stage populations by chunking on NGM plates with <italic>E. coli</italic> OP50 as the food source. Worms were bleached and the eggs were allowed to hatch in M9 buffer to arrest as L1 larvae. L1 larvae were refed on OP50 and allowed to grow to day 2 of adulthood. On the day of tracking, five worms were picked from the incubated plates to each of the imaging plates (see below) and allowed to habituate for 30 min before recording for 15 min. Imaging plates are 35 mm plates with 3.5 mL of low-peptone (0.013% Difco Bacto) NGM agar (2% Bio/Agar, BioGene) to limit bacteria growth. Plates are stored at 4°C for at least two days before use. Imaging plates are seeded with 50 μl of a 1:10 dilution of OP50 in M9 the day before tracking and left to dry overnight with the lid on at room temperature.</p></sec><sec id="s4-12"><title>Behavioral feature extraction and analysis</title><p>All videos were analyzed using Tierpsy Tracker to extract each worm’s position and posture over time (<xref ref-type="bibr" rid="bib33">Javer et al., 2018a</xref>). These postural data were then converted into a set of behavioral features selected from a large set of features as previously described (<xref ref-type="bibr" rid="bib34">Javer et al., 2018b</xref>). For each strain comparison, we performed unpaired two-sample t-tests independently for each feature. The false discovery rate was controlled at 5% across all strain and feature comparisons using the Benjamini Yekutieli procedure (<xref ref-type="bibr" rid="bib2">Benjamini and Yekutieli, 2001</xref>).</p></sec><sec id="s4-13"><title>Statistical analysis</title><p>For data quantification, graphs show values expressed as mean ± standard error mean (SEM) of animals. The statistical analyses were performed using the unpaired t-test (two-tailed). Calculations were performed using the GraphPad QuickCalcs online software (<ext-link ext-link-type="uri" xlink:href="http://www.graphpad.com/quickcalcs/">http://www.graphpad.com/quickcalcs/</ext-link>). Differences with p&lt;0.05 were considered significant.</p></sec></sec></body><back><ack id="ack"><title>Acknowledgements</title><p>We thank the <italic>Caenorhabditis</italic> Genetics Center (CGC), which is funded by NIH Office of Research Infrastructure Programs (P40 OD010440), for providing strains. We thank the lab of Oliver Hobert for providing the OH14930 strain and Kaiyuan Tang for generating reporter gene constructs. We are grateful to Edwin Ferguson, Oliver Hobert, Daniele Canzio, Catarina Catela, and Weidong Feng for comments on this manuscript. This work was supported by a training grant [University of Chicago Initiative for Maximizing Student Development (IMSD), 2R25GM109439-06] to AO, a training grant (T32 GM007183) to EC, a Whitehall Foundation grant to PK, grants from National Institute of Neurological Disorders and Stroke (NINDS) of the NIH (Award Numbers R00NS084988 and R21NS108505) to PK, and a Medical Research Council grant MC-A658-5TY30 to AEXB.</p></ack><sec id="s5" sec-type="additional-information"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interests</title><fn fn-type="COI-statement" id="conf1"><p>No competing interests declared</p></fn></fn-group><fn-group content-type="author-contribution"><title>Author contributions</title><fn fn-type="con" id="con1"><p>Conceptualization, Data curation, Formal analysis, Investigation, Visualization, Methodology, Writing - original draft, Writing - review and editing</p></fn><fn fn-type="con" id="con2"><p>Formal analysis, Validation, Investigation</p></fn><fn fn-type="con" id="con3"><p>Formal analysis, Validation, Investigation</p></fn><fn fn-type="con" id="con4"><p>Investigation</p></fn><fn fn-type="con" id="con5"><p>Investigation</p></fn><fn fn-type="con" id="con6"><p>Investigation</p></fn><fn fn-type="con" id="con7"><p>Investigation</p></fn><fn fn-type="con" id="con8"><p>Investigation</p></fn><fn fn-type="con" id="con9"><p>Project administration, Writing - review and editing</p></fn><fn fn-type="con" id="con10"><p>Conceptualization, Supervision, Funding acquisition, Investigation, Writing - original draft, Project administration, Writing - review and editing</p></fn></fn-group></sec><sec id="s6" sec-type="supplementary-material"><title>Additional files</title><supplementary-material id="supp1"><label>Supplementary file 1.</label><caption><title>Table summarizing UNC-3 ChIP-Seq signal distribution at the <italic>cis-</italic>regulatory regions of previously identified UNC-3 targets.</title></caption><media mime-subtype="docx" mimetype="application" xlink:href="elife-59464-supp1-v1.docx"/></supplementary-material><supplementary-material id="supp2"><label>Supplementary file 2.</label><caption><title>Table summarizing the results of protein class ontology analysis on novel target genes of UNC-3.</title><p>In total, 1425 genes are classified into 25 protein classes.</p></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-59464-supp2-v1.xlsx"/></supplementary-material><supplementary-material id="supp3"><label>Supplementary file 3.</label><caption><title>UNC-3 binds to the <italic>cis</italic>-regulatory region of numerous genes expressed in cholinergic MNs.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-59464-supp3-v1.xlsx"/></supplementary-material><supplementary-material id="transrepform"><label>Transparent reporting form</label><media mime-subtype="docx" mimetype="application" xlink:href="elife-59464-transrepform-v1.docx"/></supplementary-material></sec><sec id="s7" sec-type="data-availability"><title>Data availability</title><p>Sequencing data have been deposited in GEO under accession code GSE143165. Moreover, all data generated or analysed during this study are included in the manuscript and supporting files.</p><p>The following dataset was generated:</p><p><element-citation id="dataset1" publication-type="data" specific-use="isSupplementedBy"><person-group person-group-type="author"><name><surname>Li</surname><given-names>Y</given-names></name><name><surname>Kratsios</surname><given-names>P</given-names></name></person-group><year iso-8601-date="2020">2020</year><data-title>ChIP-Sequencing data for the transcription factor UNC-3/Ebf</data-title><source>NCBI Gene Expression Omnibus</source><pub-id assigning-authority="NCBI" pub-id-type="accession" xlink:href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE143165">GSE143165</pub-id></element-citation></p></sec><ref-list><title>References</title><ref id="bib1"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Baek</surname> <given-names>M</given-names></name><name><surname>Enriquez</surname> <given-names>J</given-names></name><name><surname>Mann</surname> <given-names>RS</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Dual role for hox genes and hox co-factors in conferring leg motoneuron survival and identity in <italic>Drosophila</italic></article-title><source>Development</source><volume>140</volume><fpage>2027</fpage><lpage>2038</lpage><pub-id pub-id-type="doi">10.1242/dev.090902</pub-id><pub-id pub-id-type="pmid">23536569</pub-id></element-citation></ref><ref id="bib2"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Benjamini</surname> <given-names>Y</given-names></name><name><surname>Yekutieli</surname> <given-names>D</given-names></name></person-group><year iso-8601-date="2001">2001</year><article-title>The control of the false discovery rate in multiple testing under dependency</article-title><source>The Annals of Statistics</source><volume>29</volume><fpage>1165</fpage><lpage>1188</lpage><pub-id pub-id-type="doi">10.2307/2674075</pub-id></element-citation></ref><ref id="bib3"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Blackburn</surname> <given-names>PR</given-names></name><name><surname>Barnett</surname> <given-names>SS</given-names></name><name><surname>Zimmermann</surname> <given-names>MT</given-names></name><name><surname>Cousin</surname> <given-names>MA</given-names></name><name><surname>Kaiwar</surname> <given-names>C</given-names></name><name><surname>Pinto E Vairo</surname> <given-names>F</given-names></name><name><surname>Niu</surname> <given-names>Z</given-names></name><name><surname>Ferber</surname> <given-names>MJ</given-names></name><name><surname>Urrutia</surname> <given-names>RA</given-names></name><name><surname>Selcen</surname> <given-names>D</given-names></name><name><surname>Klee</surname> <given-names>EW</given-names></name><name><surname>Pichurin</surname> <given-names>PN</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Novel de novo variant in <italic>EBF3</italic> is likely to impact DNA binding in a patient with a neurodevelopmental disorder and expanded phenotypes: patient report, in silico functional assessment, and review of published cases</article-title><source>Molecular Case Studies</source><volume>3</volume><elocation-id>a001743</elocation-id><pub-id pub-id-type="doi">10.1101/mcs.a001743</pub-id><pub-id pub-id-type="pmid">28487885</pub-id></element-citation></ref><ref id="bib4"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Boyle</surname> <given-names>AP</given-names></name><name><surname>Araya</surname> <given-names>CL</given-names></name><name><surname>Brdlik</surname> <given-names>C</given-names></name><name><surname>Cayting</surname> <given-names>P</given-names></name><name><surname>Cheng</surname> <given-names>C</given-names></name><name><surname>Cheng</surname> <given-names>Y</given-names></name><name><surname>Gardner</surname> <given-names>K</given-names></name><name><surname>Hillier</surname> <given-names>LW</given-names></name><name><surname>Janette</surname> <given-names>J</given-names></name><name><surname>Jiang</surname> <given-names>L</given-names></name><name><surname>Kasper</surname> <given-names>D</given-names></name><name><surname>Kawli</surname> <given-names>T</given-names></name><name><surname>Kheradpour</surname> <given-names>P</given-names></name><name><surname>Kundaje</surname> <given-names>A</given-names></name><name><surname>Li</surname> <given-names>JJ</given-names></name><name><surname>Ma</surname> <given-names>L</given-names></name><name><surname>Niu</surname> <given-names>W</given-names></name><name><surname>Rehm</surname> <given-names>EJ</given-names></name><name><surname>Rozowsky</surname> <given-names>J</given-names></name><name><surname>Slattery</surname> <given-names>M</given-names></name><name><surname>Spokony</surname> <given-names>R</given-names></name><name><surname>Terrell</surname> <given-names>R</given-names></name><name><surname>Vafeados</surname> <given-names>D</given-names></name><name><surname>Wang</surname> <given-names>D</given-names></name><name><surname>Weisdepp</surname> <given-names>P</given-names></name><name><surname>Wu</surname> <given-names>YC</given-names></name><name><surname>Xie</surname> <given-names>D</given-names></name><name><surname>Yan</surname> <given-names>KK</given-names></name><name><surname>Feingold</surname> <given-names>EA</given-names></name><name><surname>Good</surname> <given-names>PJ</given-names></name><name><surname>Pazin</surname> <given-names>MJ</given-names></name><name><surname>Huang</surname> <given-names>H</given-names></name><name><surname>Bickel</surname> <given-names>PJ</given-names></name><name><surname>Brenner</surname> <given-names>SE</given-names></name><name><surname>Reinke</surname> <given-names>V</given-names></name><name><surname>Waterston</surname> <given-names>RH</given-names></name><name><surname>Gerstein</surname> <given-names>M</given-names></name><name><surname>White</surname> <given-names>KP</given-names></name><name><surname>Kellis</surname> <given-names>M</given-names></name><name><surname>Snyder</surname> <given-names>M</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Comparative analysis of regulatory information and circuits across distant species</article-title><source>Nature</source><volume>512</volume><fpage>453</fpage><lpage>456</lpage><pub-id pub-id-type="doi">10.1038/nature13668</pub-id><pub-id pub-id-type="pmid">25164757</pub-id></element-citation></ref><ref id="bib5"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brenner</surname> <given-names>S</given-names></name></person-group><year iso-8601-date="1974">1974</year><article-title>The genetics of <italic>Caenorhabditis elegans</italic></article-title><source>Genetics</source><volume>77</volume><fpage>71</fpage><lpage>94</lpage><pub-id pub-id-type="pmid">4366476</pub-id></element-citation></ref><ref id="bib6"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brozová</surname> <given-names>E</given-names></name><name><surname>Simecková</surname> <given-names>K</given-names></name><name><surname>Kostrouch</surname> <given-names>Z</given-names></name><name><surname>Rall</surname> <given-names>JE</given-names></name><name><surname>Kostrouchová</surname> <given-names>M</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>NHR-40, a <italic>Caenorhabditis elegans</italic> supplementary nuclear receptor, regulates embryonic and early larval development</article-title><source>Mechanisms of Development</source><volume>123</volume><fpage>689</fpage><lpage>701</lpage><pub-id pub-id-type="doi">10.1016/j.mod.2006.06.006</pub-id><pub-id pub-id-type="pmid">16920335</pub-id></element-citation></ref><ref id="bib7"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Catela</surname> <given-names>C</given-names></name><name><surname>Shin</surname> <given-names>MM</given-names></name><name><surname>Lee</surname> <given-names>DH</given-names></name><name><surname>Liu</surname> <given-names>JP</given-names></name><name><surname>Dasen</surname> <given-names>JS</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Hox proteins coordinate motor neuron differentiation and connectivity programs through ret/Gfrα genes</article-title><source>Cell Reports</source><volume>14</volume><fpage>1901</fpage><lpage>1915</lpage><pub-id pub-id-type="doi">10.1016/j.celrep.2016.01.067</pub-id><pub-id pub-id-type="pmid">26904955</pub-id></element-citation></ref><ref id="bib8"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Catela</surname> <given-names>C</given-names></name><name><surname>Kratsios</surname> <given-names>P</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Transcriptional mechanisms of motor neuron development in vertebrates and invertebrates</article-title><source>Developmental Biology</source><volume>S0012-1606</volume><fpage>30472</fpage><lpage>30474</lpage><pub-id pub-id-type="doi">10.1016/j.ydbio.2019.08.022</pub-id><pub-id pub-id-type="pmid">31479648</pub-id></element-citation></ref><ref id="bib9"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chao</surname> <given-names>HT</given-names></name><name><surname>Davids</surname> <given-names>M</given-names></name><name><surname>Burke</surname> <given-names>E</given-names></name><name><surname>Pappas</surname> <given-names>JG</given-names></name><name><surname>Rosenfeld</surname> <given-names>JA</given-names></name><name><surname>McCarty</surname> <given-names>AJ</given-names></name><name><surname>Davis</surname> <given-names>T</given-names></name><name><surname>Wolfe</surname> <given-names>L</given-names></name><name><surname>Toro</surname> <given-names>C</given-names></name><name><surname>Tifft</surname> <given-names>C</given-names></name><name><surname>Xia</surname> <given-names>F</given-names></name><name><surname>Stong</surname> <given-names>N</given-names></name><name><surname>Johnson</surname> <given-names>TK</given-names></name><name><surname>Warr</surname> <given-names>CG</given-names></name><name><surname>Yamamoto</surname> <given-names>S</given-names></name><name><surname>Adams</surname> <given-names>DR</given-names></name><name><surname>Markello</surname> <given-names>TC</given-names></name><name><surname>Gahl</surname> <given-names>WA</given-names></name><name><surname>Bellen</surname> <given-names>HJ</given-names></name><name><surname>Wangler</surname> <given-names>MF</given-names></name><name><surname>Malicdan</surname> <given-names>MCV</given-names></name><collab>Undiagnosed Diseases Network</collab></person-group><year iso-8601-date="2017">2017</year><article-title>A syndromic neurodevelopmental disorder caused by de novo variants in EBF3</article-title><source>The American Journal of Human Genetics</source><volume>100</volume><fpage>128</fpage><lpage>137</lpage><pub-id pub-id-type="doi">10.1016/j.ajhg.2016.11.018</pub-id><pub-id pub-id-type="pmid">28017372</pub-id></element-citation></ref><ref id="bib10"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Clark</surname> <given-names>SG</given-names></name><name><surname>Chisholm</surname> <given-names>AD</given-names></name><name><surname>Horvitz</surname> <given-names>HR</given-names></name></person-group><year iso-8601-date="1993">1993</year><article-title>Control of cell fates in the central body region of <italic>C. elegans</italic> by the homeobox gene lin-39</article-title><source>Cell</source><volume>74</volume><fpage>43</fpage><lpage>55</lpage><pub-id pub-id-type="doi">10.1016/0092-8674(93)90293-Y</pub-id><pub-id pub-id-type="pmid">8101475</pub-id></element-citation></ref><ref id="bib11"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Corbo</surname> <given-names>JC</given-names></name><name><surname>Lawrence</surname> <given-names>KA</given-names></name><name><surname>Karlstetter</surname> <given-names>M</given-names></name><name><surname>Myers</surname> <given-names>CA</given-names></name><name><surname>Abdelaziz</surname> <given-names>M</given-names></name><name><surname>Dirkes</surname> <given-names>W</given-names></name><name><surname>Weigelt</surname> <given-names>K</given-names></name><name><surname>Seifert</surname> <given-names>M</given-names></name><name><surname>Benes</surname> <given-names>V</given-names></name><name><surname>Fritsche</surname> <given-names>LG</given-names></name><name><surname>Weber</surname> <given-names>BH</given-names></name><name><surname>Langmann</surname> <given-names>T</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>CRX ChIP-seq reveals the cis-regulatory architecture of mouse photoreceptors</article-title><source>Genome Research</source><volume>20</volume><fpage>1512</fpage><lpage>1525</lpage><pub-id pub-id-type="doi">10.1101/gr.109405.110</pub-id><pub-id pub-id-type="pmid">20693478</pub-id></element-citation></ref><ref id="bib12"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cowing</surname> <given-names>DW</given-names></name><name><surname>Kenyon</surname> <given-names>C</given-names></name></person-group><year iso-8601-date="1992">1992</year><article-title>Expression of the homeotic gene mab-5 during <italic>Caenorhabditis elegans</italic> embryogenesis</article-title><source>Development</source><volume>116</volume><fpage>481</fpage><lpage>490</lpage><pub-id pub-id-type="pmid">1363090</pub-id></element-citation></ref><ref id="bib13"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Deneris</surname> <given-names>ES</given-names></name><name><surname>Hobert</surname> <given-names>O</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Maintenance of postmitotic neuronal cell identity</article-title><source>Nature Neuroscience</source><volume>17</volume><fpage>899</fpage><lpage>907</lpage><pub-id pub-id-type="doi">10.1038/nn.3731</pub-id><pub-id pub-id-type="pmid">24929660</pub-id></element-citation></ref><ref id="bib14"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Doe</surname> <given-names>CQ</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Temporal patterning in the <italic>Drosophila</italic> CNS</article-title><source>Annual Review of Cell and Developmental Biology</source><volume>33</volume><fpage>219</fpage><lpage>240</lpage><pub-id pub-id-type="doi">10.1146/annurev-cellbio-111315-125210</pub-id><pub-id pub-id-type="pmid">28992439</pub-id></element-citation></ref><ref id="bib15"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dubois</surname> <given-names>L</given-names></name><name><surname>Vincent</surname> <given-names>A</given-names></name></person-group><year iso-8601-date="2001">2001</year><article-title>The COE--collier/Olf1/EBF--transcription factors: structural conservation and diversity of developmental functions</article-title><source>Mechanisms of Development</source><volume>108</volume><fpage>3</fpage><lpage>12</lpage><pub-id pub-id-type="doi">10.1016/S0925-4773(01)00486-5</pub-id><pub-id pub-id-type="pmid">11578857</pub-id></element-citation></ref><ref id="bib16"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Eastman</surname> <given-names>C</given-names></name><name><surname>Horvitz</surname> <given-names>HR</given-names></name><name><surname>Jin</surname> <given-names>Y</given-names></name></person-group><year iso-8601-date="1999">1999</year><article-title>Coordinated transcriptional regulation of the <italic>unc-25</italic> glutamic acid decarboxylase and the <italic>unc-47</italic> GABA vesicular transporter by the <italic>Caenorhabditis elegans</italic> UNC-30 homeodomain protein</article-title><source>The Journal of Neuroscience</source><volume>19</volume><fpage>6225</fpage><lpage>6234</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.19-15-06225.1999</pub-id><pub-id pub-id-type="pmid">10414952</pub-id></element-citation></ref><ref id="bib17"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ellmeier</surname> <given-names>W</given-names></name><name><surname>Sunshine</surname> <given-names>MJ</given-names></name><name><surname>Maschek</surname> <given-names>R</given-names></name><name><surname>Littman</surname> <given-names>DR</given-names></name></person-group><year iso-8601-date="2002">2002</year><article-title>Combined deletion of CD8 locus cis-regulatory elements affects initiation but not maintenance of CD8 expression</article-title><source>Immunity</source><volume>16</volume><fpage>623</fpage><lpage>634</lpage><pub-id pub-id-type="doi">10.1016/S1074-7613(02)00309-6</pub-id><pub-id pub-id-type="pmid">12049715</pub-id></element-citation></ref><ref id="bib18"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Estacio-Gómez</surname> <given-names>A</given-names></name><name><surname>Díaz-Benjumea</surname> <given-names>FJ</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Roles of <italic>hox</italic> genes in the patterning of the central nervous system of <italic>Drosophila</italic></article-title><source>Fly</source><volume>8</volume><fpage>26</fpage><lpage>32</lpage><pub-id pub-id-type="doi">10.4161/fly.27424</pub-id><pub-id pub-id-type="pmid">24406332</pub-id></element-citation></ref><ref id="bib19"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Feng</surname> <given-names>W</given-names></name><name><surname>Li</surname> <given-names>Y</given-names></name><name><surname>Dao</surname> <given-names>P</given-names></name><name><surname>Aburas</surname> <given-names>J</given-names></name><name><surname>Islam</surname> <given-names>P</given-names></name><name><surname>Elbaz</surname> <given-names>B</given-names></name><name><surname>Kolarzyk</surname> <given-names>A</given-names></name><name><surname>Brown</surname> <given-names>AE</given-names></name><name><surname>Kratsios</surname> <given-names>P</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>A terminal selector prevents a hox transcriptional switch to safeguard motor neuron identity throughout life</article-title><source>eLife</source><volume>9</volume><elocation-id>e50065</elocation-id><pub-id pub-id-type="doi">10.7554/eLife.50065</pub-id><pub-id pub-id-type="pmid">31902393</pub-id></element-citation></ref><ref id="bib20"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Flames</surname> <given-names>N</given-names></name><name><surname>Hobert</surname> <given-names>O</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Gene regulatory logic of dopamine neuron differentiation</article-title><source>Nature</source><volume>458</volume><fpage>885</fpage><lpage>889</lpage><pub-id pub-id-type="doi">10.1038/nature07929</pub-id><pub-id pub-id-type="pmid">19287374</pub-id></element-citation></ref><ref id="bib21"><element-citation publication-type="confproc"><person-group person-group-type="author"><name><surname>García-Bellido</surname> <given-names>A</given-names></name></person-group><year iso-8601-date="1975">1975</year><article-title>Genetic control of wing disc development in <italic>Drosophila</italic></article-title><conf-name>Ciba Foundation Symposium</conf-name><fpage>161</fpage><lpage>182</lpage><pub-id pub-id-type="doi">10.1002/9780470720110.ch8</pub-id></element-citation></ref><ref id="bib22"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Greig</surname> <given-names>LC</given-names></name><name><surname>Woodworth</surname> <given-names>MB</given-names></name><name><surname>Galazo</surname> <given-names>MJ</given-names></name><name><surname>Padmanabhan</surname> <given-names>H</given-names></name><name><surname>Macklis</surname> <given-names>JD</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Molecular logic of neocortical projection neuron specification, development and diversity</article-title><source>Nature Reviews Neuroscience</source><volume>14</volume><fpage>755</fpage><lpage>769</lpage><pub-id pub-id-type="doi">10.1038/nrn3586</pub-id><pub-id pub-id-type="pmid">24105342</pub-id></element-citation></ref><ref id="bib23"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Harms</surname> <given-names>FL</given-names></name><name><surname>Girisha</surname> <given-names>KM</given-names></name><name><surname>Hardigan</surname> <given-names>AA</given-names></name><name><surname>Kortüm</surname> <given-names>F</given-names></name><name><surname>Shukla</surname> <given-names>A</given-names></name><name><surname>Alawi</surname> <given-names>M</given-names></name><name><surname>Dalal</surname> <given-names>A</given-names></name><name><surname>Brady</surname> <given-names>L</given-names></name><name><surname>Tarnopolsky</surname> <given-names>M</given-names></name><name><surname>Bird</surname> <given-names>LM</given-names></name><name><surname>Ceulemans</surname> <given-names>S</given-names></name><name><surname>Bebin</surname> <given-names>M</given-names></name><name><surname>Bowling</surname> <given-names>KM</given-names></name><name><surname>Hiatt</surname> <given-names>SM</given-names></name><name><surname>Lose</surname> <given-names>EJ</given-names></name><name><surname>Primiano</surname> <given-names>M</given-names></name><name><surname>Chung</surname> <given-names>WK</given-names></name><name><surname>Juusola</surname> <given-names>J</given-names></name><name><surname>Akdemir</surname> <given-names>ZC</given-names></name><name><surname>Bainbridge</surname> <given-names>M</given-names></name><name><surname>Charng</surname> <given-names>WL</given-names></name><name><surname>Drummond-Borg</surname> <given-names>M</given-names></name><name><surname>Eldomery</surname> <given-names>MK</given-names></name><name><surname>El-Hattab</surname> <given-names>AW</given-names></name><name><surname>Saleh</surname> <given-names>MAM</given-names></name><name><surname>Bézieau</surname> <given-names>S</given-names></name><name><surname>Cogné</surname> <given-names>B</given-names></name><name><surname>Isidor</surname> <given-names>B</given-names></name><name><surname>Küry</surname> <given-names>S</given-names></name><name><surname>Lupski</surname> <given-names>JR</given-names></name><name><surname>Myers</surname> <given-names>RM</given-names></name><name><surname>Cooper</surname> <given-names>GM</given-names></name><name><surname>Kutsche</surname> <given-names>K</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Mutations in EBF3 disturb transcriptional profiles and cause intellectual disability, ataxia, and facial dysmorphism</article-title><source>The American Journal of Human Genetics</source><volume>100</volume><fpage>117</fpage><lpage>127</lpage><pub-id pub-id-type="doi">10.1016/j.ajhg.2016.11.012</pub-id><pub-id pub-id-type="pmid">28017373</pub-id></element-citation></ref><ref id="bib24"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Heinz</surname> <given-names>S</given-names></name><name><surname>Benner</surname> <given-names>C</given-names></name><name><surname>Spann</surname> <given-names>N</given-names></name><name><surname>Bertolino</surname> <given-names>E</given-names></name><name><surname>Lin</surname> <given-names>YC</given-names></name><name><surname>Laslo</surname> <given-names>P</given-names></name><name><surname>Cheng</surname> <given-names>JX</given-names></name><name><surname>Murre</surname> <given-names>C</given-names></name><name><surname>Singh</surname> <given-names>H</given-names></name><name><surname>Glass</surname> <given-names>CK</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Simple combinations of lineage-determining transcription factors prime cis-regulatory elements required for macrophage and B cell identities</article-title><source>Molecular Cell</source><volume>38</volume><fpage>576</fpage><lpage>589</lpage><pub-id pub-id-type="doi">10.1016/j.molcel.2010.05.004</pub-id><pub-id pub-id-type="pmid">20513432</pub-id></element-citation></ref><ref id="bib25"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hobert</surname> <given-names>O</given-names></name></person-group><year iso-8601-date="2002">2002</year><article-title>PCR fusion-based approach to create reporter gene constructs for expression analysis in transgenic <italic>C. elegans</italic></article-title><source>BioTechniques</source><volume>32</volume><fpage>728</fpage><lpage>730</lpage><pub-id pub-id-type="doi">10.2144/02324bm01</pub-id><pub-id pub-id-type="pmid">11962590</pub-id></element-citation></ref><ref id="bib26"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hobert</surname> <given-names>O</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Regulatory logic of neuronal diversity: terminal selector genes and selector motifs</article-title><source>PNAS</source><volume>105</volume><fpage>20067</fpage><lpage>20071</lpage><pub-id pub-id-type="doi">10.1073/pnas.0806070105</pub-id><pub-id pub-id-type="pmid">19104055</pub-id></element-citation></ref><ref id="bib27"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hobert</surname> <given-names>O</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Regulation of terminal differentiation programs in the nervous system</article-title><source>Annual Review of Cell and Developmental Biology</source><volume>27</volume><fpage>681</fpage><lpage>696</lpage><pub-id pub-id-type="doi">10.1146/annurev-cellbio-092910-154226</pub-id><pub-id pub-id-type="pmid">21985672</pub-id></element-citation></ref><ref id="bib28"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hobert</surname> <given-names>O</given-names></name></person-group><year iso-8601-date="2016">2016a</year><article-title>A map of terminal regulators of neuronal identity in <italic>Caenorhabditis elegans</italic></article-title><source>Wiley Interdisciplinary Reviews: Developmental Biology</source><volume>5</volume><fpage>474</fpage><lpage>498</lpage><pub-id pub-id-type="doi">10.1002/wdev.233</pub-id><pub-id pub-id-type="pmid">27136279</pub-id></element-citation></ref><ref id="bib29"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hobert</surname> <given-names>O</given-names></name></person-group><year iso-8601-date="2016">2016b</year><article-title>Terminal selectors of neuronal identity</article-title><source>Current Topics in Developmental Biology</source><volume>116</volume><fpage>455</fpage><lpage>475</lpage><pub-id pub-id-type="doi">10.1016/bs.ctdb.2015.12.007</pub-id><pub-id pub-id-type="pmid">26970634</pub-id></element-citation></ref><ref id="bib30"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hobert</surname> <given-names>O</given-names></name><name><surname>Kratsios</surname> <given-names>P</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Neuronal identity control by terminal selectors in worms, flies, and chordates</article-title><source>Current Opinion in Neurobiology</source><volume>56</volume><fpage>97</fpage><lpage>105</lpage><pub-id pub-id-type="doi">10.1016/j.conb.2018.12.006</pub-id><pub-id pub-id-type="pmid">30665084</pub-id></element-citation></ref><ref id="bib31"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Housset</surname> <given-names>M</given-names></name><name><surname>Samuel</surname> <given-names>A</given-names></name><name><surname>Ettaiche</surname> <given-names>M</given-names></name><name><surname>Bemelmans</surname> <given-names>A</given-names></name><name><surname>Béby</surname> <given-names>F</given-names></name><name><surname>Billon</surname> <given-names>N</given-names></name><name><surname>Lamonerie</surname> <given-names>T</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Loss of Otx2 in the adult retina disrupts retinal pigment epithelium function, causing photoreceptor degeneration</article-title><source>Journal of Neuroscience</source><volume>33</volume><fpage>9890</fpage><lpage>9904</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.1099-13.2013</pub-id><pub-id pub-id-type="pmid">23761884</pub-id></element-citation></ref><ref id="bib32"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hutlet</surname> <given-names>B</given-names></name><name><surname>Theys</surname> <given-names>N</given-names></name><name><surname>Coste</surname> <given-names>C</given-names></name><name><surname>Ahn</surname> <given-names>MT</given-names></name><name><surname>Doshishti-Agolli</surname> <given-names>K</given-names></name><name><surname>Lizen</surname> <given-names>B</given-names></name><name><surname>Gofflot</surname> <given-names>F</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Systematic expression analysis of hox genes at adulthood reveals novel patterns in the central nervous system</article-title><source>Brain Structure and Function</source><volume>221</volume><fpage>1223</fpage><lpage>1243</lpage><pub-id pub-id-type="doi">10.1007/s00429-014-0965-8</pub-id><pub-id pub-id-type="pmid">25527350</pub-id></element-citation></ref><ref id="bib33"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Javer</surname> <given-names>A</given-names></name><name><surname>Currie</surname> <given-names>M</given-names></name><name><surname>Lee</surname> <given-names>CW</given-names></name><name><surname>Hokanson</surname> <given-names>J</given-names></name><name><surname>Li</surname> <given-names>K</given-names></name><name><surname>Martineau</surname> <given-names>CN</given-names></name><name><surname>Yemini</surname> <given-names>E</given-names></name><name><surname>Grundy</surname> <given-names>LJ</given-names></name><name><surname>Li</surname> <given-names>C</given-names></name><name><surname>Ch'ng</surname> <given-names>Q</given-names></name><name><surname>Schafer</surname> <given-names>WR</given-names></name><name><surname>Nollen</surname> <given-names>EAA</given-names></name><name><surname>Kerr</surname> <given-names>R</given-names></name><name><surname>Brown</surname> <given-names>AEX</given-names></name></person-group><year iso-8601-date="2018">2018a</year><article-title>An open-source platform for analyzing and sharing worm-behavior data</article-title><source>Nature Methods</source><volume>15</volume><fpage>645</fpage><lpage>646</lpage><pub-id pub-id-type="doi">10.1038/s41592-018-0112-1</pub-id><pub-id pub-id-type="pmid">30171234</pub-id></element-citation></ref><ref id="bib34"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Javer</surname> <given-names>A</given-names></name><name><surname>Ripoll-Sánchez</surname> <given-names>L</given-names></name><name><surname>Brown</surname> <given-names>AEX</given-names></name></person-group><year iso-8601-date="2018">2018b</year><article-title>Powerful and interpretable behavioural features for quantitative phenotyping of <italic>Caenorhabditis elegans</italic></article-title><source>Philosophical Transactions of the Royal Society B: Biological Sciences</source><volume>373</volume><elocation-id>20170375</elocation-id><pub-id pub-id-type="doi">10.1098/rstb.2017.0375</pub-id><pub-id pub-id-type="pmid">30201839</pub-id></element-citation></ref><ref id="bib35"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jessell</surname> <given-names>TM</given-names></name></person-group><year iso-8601-date="2000">2000</year><article-title>Neuronal specification in the spinal cord: inductive signals and transcriptional codes</article-title><source>Nature Reviews Genetics</source><volume>1</volume><fpage>20</fpage><lpage>29</lpage><pub-id pub-id-type="doi">10.1038/35049541</pub-id><pub-id pub-id-type="pmid">11262869</pub-id></element-citation></ref><ref id="bib36"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jin</surname> <given-names>Y</given-names></name><name><surname>Hoskins</surname> <given-names>R</given-names></name><name><surname>Horvitz</surname> <given-names>HR</given-names></name></person-group><year iso-8601-date="1994">1994</year><article-title>Control of type-D GABAergic neuron differentiation by <italic>C. elegans</italic> UNC-30 homeodomain protein</article-title><source>Nature</source><volume>372</volume><fpage>780</fpage><lpage>783</lpage><pub-id pub-id-type="doi">10.1038/372780a0</pub-id><pub-id pub-id-type="pmid">7997265</pub-id></element-citation></ref><ref id="bib37"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Johnson</surname> <given-names>SA</given-names></name><name><surname>Harmon</surname> <given-names>KJ</given-names></name><name><surname>Smiley</surname> <given-names>SG</given-names></name><name><surname>Still</surname> <given-names>FM</given-names></name><name><surname>Kavaler</surname> <given-names>J</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Discrete regulatory regions control early and late expression of D-Pax2 during external sensory organ development</article-title><source>Developmental Dynamics</source><volume>240</volume><fpage>1769</fpage><lpage>1778</lpage><pub-id pub-id-type="doi">10.1002/dvdy.22672</pub-id><pub-id pub-id-type="pmid">21644243</pub-id></element-citation></ref><ref id="bib38"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kadkhodaei</surname> <given-names>B</given-names></name><name><surname>Ito</surname> <given-names>T</given-names></name><name><surname>Joodmardi</surname> <given-names>E</given-names></name><name><surname>Mattsson</surname> <given-names>B</given-names></name><name><surname>Rouillard</surname> <given-names>C</given-names></name><name><surname>Carta</surname> <given-names>M</given-names></name><name><surname>Muramatsu</surname> <given-names>S</given-names></name><name><surname>Sumi-Ichinose</surname> <given-names>C</given-names></name><name><surname>Nomura</surname> <given-names>T</given-names></name><name><surname>Metzger</surname> <given-names>D</given-names></name><name><surname>Chambon</surname> <given-names>P</given-names></name><name><surname>Lindqvist</surname> <given-names>E</given-names></name><name><surname>Larsson</surname> <given-names>NG</given-names></name><name><surname>Olson</surname> <given-names>L</given-names></name><name><surname>Björklund</surname> <given-names>A</given-names></name><name><surname>Ichinose</surname> <given-names>H</given-names></name><name><surname>Perlmann</surname> <given-names>T</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Nurr1 is required for maintenance of maturing and adult midbrain dopamine neurons</article-title><source>Journal of Neuroscience</source><volume>29</volume><fpage>15923</fpage><lpage>15932</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.3910-09.2009</pub-id><pub-id pub-id-type="pmid">20016108</pub-id></element-citation></ref><ref id="bib39"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kadkhodaei</surname> <given-names>B</given-names></name><name><surname>Alvarsson</surname> <given-names>A</given-names></name><name><surname>Schintu</surname> <given-names>N</given-names></name><name><surname>Ramsköld</surname> <given-names>D</given-names></name><name><surname>Volakakis</surname> <given-names>N</given-names></name><name><surname>Joodmardi</surname> <given-names>E</given-names></name><name><surname>Yoshitake</surname> <given-names>T</given-names></name><name><surname>Kehr</surname> <given-names>J</given-names></name><name><surname>Decressac</surname> <given-names>M</given-names></name><name><surname>Björklund</surname> <given-names>A</given-names></name><name><surname>Sandberg</surname> <given-names>R</given-names></name><name><surname>Svenningsson</surname> <given-names>P</given-names></name><name><surname>Perlmann</surname> <given-names>T</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Transcription factor Nurr1 maintains fiber integrity and nuclear-encoded mitochondrial gene expression in dopamine neurons</article-title><source>PNAS</source><volume>110</volume><fpage>2360</fpage><lpage>2365</lpage><pub-id pub-id-type="doi">10.1073/pnas.1221077110</pub-id><pub-id pub-id-type="pmid">23341612</pub-id></element-citation></ref><ref id="bib40"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Karlsson</surname> <given-names>D</given-names></name><name><surname>Baumgardt</surname> <given-names>M</given-names></name><name><surname>Thor</surname> <given-names>S</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Segment-specific neuronal subtype specification by the integration of anteroposterior and temporal cues</article-title><source>PLOS Biology</source><volume>8</volume><elocation-id>e1000368</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pbio.1000368</pub-id><pub-id pub-id-type="pmid">20485487</pub-id></element-citation></ref><ref id="bib41"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kerk</surname> <given-names>SY</given-names></name><name><surname>Kratsios</surname> <given-names>P</given-names></name><name><surname>Hart</surname> <given-names>M</given-names></name><name><surname>Mourao</surname> <given-names>R</given-names></name><name><surname>Hobert</surname> <given-names>O</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Diversification of <italic>C. elegans</italic> motor neuron identity via selective effector gene repression</article-title><source>Neuron</source><volume>93</volume><fpage>80</fpage><lpage>98</lpage><pub-id pub-id-type="doi">10.1016/j.neuron.2016.11.036</pub-id><pub-id pub-id-type="pmid">28056346</pub-id></element-citation></ref><ref id="bib42"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname> <given-names>K</given-names></name><name><surname>Colosimo</surname> <given-names>ME</given-names></name><name><surname>Yeung</surname> <given-names>H</given-names></name><name><surname>Sengupta</surname> <given-names>P</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>The UNC-3 olf/EBF protein represses alternate neuronal programs to specify chemosensory neuron identity</article-title><source>Developmental Biology</source><volume>286</volume><fpage>136</fpage><lpage>148</lpage><pub-id pub-id-type="doi">10.1016/j.ydbio.2005.07.024</pub-id><pub-id pub-id-type="pmid">16143323</pub-id></element-citation></ref><ref id="bib43"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Konstantinides</surname> <given-names>N</given-names></name><name><surname>Kapuralin</surname> <given-names>K</given-names></name><name><surname>Fadil</surname> <given-names>C</given-names></name><name><surname>Barboza</surname> <given-names>L</given-names></name><name><surname>Satija</surname> <given-names>R</given-names></name><name><surname>Desplan</surname> <given-names>C</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Phenotypic convergence: distinct transcription factors regulate common terminal features</article-title><source>Cell</source><volume>174</volume><fpage>622</fpage><lpage>635</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2018.05.021</pub-id><pub-id pub-id-type="pmid">29909983</pub-id></element-citation></ref><ref id="bib44"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kratsios</surname> <given-names>P</given-names></name><name><surname>Stolfi</surname> <given-names>A</given-names></name><name><surname>Levine</surname> <given-names>M</given-names></name><name><surname>Hobert</surname> <given-names>O</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Coordinated regulation of cholinergic motor neuron traits through a conserved terminal selector gene</article-title><source>Nature Neuroscience</source><volume>15</volume><fpage>205</fpage><lpage>214</lpage><pub-id pub-id-type="doi">10.1038/nn.2989</pub-id><pub-id pub-id-type="pmid">22119902</pub-id></element-citation></ref><ref id="bib45"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kratsios</surname> <given-names>P</given-names></name><name><surname>Pinan-Lucarré</surname> <given-names>B</given-names></name><name><surname>Kerk</surname> <given-names>SY</given-names></name><name><surname>Weinreb</surname> <given-names>A</given-names></name><name><surname>Bessereau</surname> <given-names>JL</given-names></name><name><surname>Hobert</surname> <given-names>O</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Transcriptional coordination of synaptogenesis and neurotransmitter signaling</article-title><source>Current Biology</source><volume>25</volume><fpage>1282</fpage><lpage>1295</lpage><pub-id pub-id-type="doi">10.1016/j.cub.2015.03.028</pub-id><pub-id pub-id-type="pmid">25913400</pub-id></element-citation></ref><ref id="bib46"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kratsios</surname> <given-names>P</given-names></name><name><surname>Kerk</surname> <given-names>SY</given-names></name><name><surname>Catela</surname> <given-names>C</given-names></name><name><surname>Liang</surname> <given-names>J</given-names></name><name><surname>Vidal</surname> <given-names>B</given-names></name><name><surname>Bayer</surname> <given-names>EA</given-names></name><name><surname>Feng</surname> <given-names>W</given-names></name><name><surname>De La Cruz</surname> <given-names>ED</given-names></name><name><surname>Croci</surname> <given-names>L</given-names></name><name><surname>Consalez</surname> <given-names>GG</given-names></name><name><surname>Mizumoto</surname> <given-names>K</given-names></name><name><surname>Hobert</surname> <given-names>O</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>An intersectional gene regulatory strategy defines subclass diversity of <italic>C. elegans</italic> motor neurons</article-title><source>eLife</source><volume>6</volume><elocation-id>e25751</elocation-id><pub-id pub-id-type="doi">10.7554/eLife.25751</pub-id><pub-id pub-id-type="pmid">28677525</pub-id></element-citation></ref><ref id="bib47"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Langmead</surname> <given-names>B</given-names></name><name><surname>Salzberg</surname> <given-names>SL</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Fast gapped-read alignment with bowtie 2</article-title><source>Nature Methods</source><volume>9</volume><fpage>357</fpage><lpage>359</lpage><pub-id pub-id-type="doi">10.1038/nmeth.1923</pub-id><pub-id pub-id-type="pmid">22388286</pub-id></element-citation></ref><ref id="bib48"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Leyva-Díaz</surname> <given-names>E</given-names></name><name><surname>Hobert</surname> <given-names>O</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Transcription factor autoregulation is required for acquisition and maintenance of neuronal identity</article-title><source>Development</source><volume>146</volume><elocation-id>dev177378</elocation-id><pub-id pub-id-type="doi">10.1242/dev.177378</pub-id><pub-id pub-id-type="pmid">31227642</pub-id></element-citation></ref><ref id="bib49"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname> <given-names>J</given-names></name><name><surname>Fire</surname> <given-names>A</given-names></name></person-group><year iso-8601-date="2000">2000</year><article-title>Overlapping roles of two hox genes and the exd ortholog ceh-20 in diversification of the <italic>C. elegans</italic> postembryonic mesoderm</article-title><source>Development</source><volume>127</volume><fpage>5179</fpage><lpage>5190</lpage><pub-id pub-id-type="pmid">11060243</pub-id></element-citation></ref><ref id="bib50"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lodato</surname> <given-names>S</given-names></name><name><surname>Arlotta</surname> <given-names>P</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Generating neuronal diversity in the mammalian cerebral cortex</article-title><source>Annual Review of Cell and Developmental Biology</source><volume>31</volume><fpage>699</fpage><lpage>720</lpage><pub-id pub-id-type="doi">10.1146/annurev-cellbio-100814-125353</pub-id><pub-id pub-id-type="pmid">26359774</pub-id></element-citation></ref><ref id="bib51"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lopes</surname> <given-names>R</given-names></name><name><surname>Verhey van Wijk</surname> <given-names>N</given-names></name><name><surname>Neves</surname> <given-names>G</given-names></name><name><surname>Pachnis</surname> <given-names>V</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Transcription factor LIM homeobox 7 (Lhx7) maintains subtype identity of cholinergic interneurons in the mammalian striatum</article-title><source>PNAS</source><volume>109</volume><fpage>3119</fpage><lpage>3124</lpage><pub-id pub-id-type="doi">10.1073/pnas.1109251109</pub-id><pub-id pub-id-type="pmid">22315402</pub-id></element-citation></ref><ref id="bib52"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Maloof</surname> <given-names>JN</given-names></name><name><surname>Kenyon</surname> <given-names>C</given-names></name></person-group><year iso-8601-date="1998">1998</year><article-title>The hox gene lin-39 is required during <italic>C. elegans</italic> vulval induction to select the outcome of Ras signaling</article-title><source>Development</source><volume>125</volume><fpage>181</fpage><lpage>190</lpage><pub-id pub-id-type="pmid">9486792</pub-id></element-citation></ref><ref id="bib53"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Manzanares</surname> <given-names>M</given-names></name><name><surname>Bel-Vialar</surname> <given-names>S</given-names></name><name><surname>Ariza-McNaughton</surname> <given-names>L</given-names></name><name><surname>Ferretti</surname> <given-names>E</given-names></name><name><surname>Marshall</surname> <given-names>H</given-names></name><name><surname>Maconochie</surname> <given-names>MM</given-names></name><name><surname>Blasi</surname> <given-names>F</given-names></name><name><surname>Krumlauf</surname> <given-names>R</given-names></name></person-group><year iso-8601-date="2001">2001</year><article-title>Independent regulation of initiation and maintenance phases of Hoxa3 expression in the vertebrate hindbrain involve auto- and cross-regulatory mechanisms</article-title><source>Development</source><volume>128</volume><fpage>3595</fpage><lpage>3607</lpage><pub-id pub-id-type="pmid">11566863</pub-id></element-citation></ref><ref id="bib54"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mayer</surname> <given-names>C</given-names></name><name><surname>Hafemeister</surname> <given-names>C</given-names></name><name><surname>Bandler</surname> <given-names>RC</given-names></name><name><surname>Machold</surname> <given-names>R</given-names></name><name><surname>Batista Brito</surname> <given-names>R</given-names></name><name><surname>Jaglin</surname> <given-names>X</given-names></name><name><surname>Allaway</surname> <given-names>K</given-names></name><name><surname>Butler</surname> <given-names>A</given-names></name><name><surname>Fishell</surname> <given-names>G</given-names></name><name><surname>Satija</surname> <given-names>R</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Developmental diversification of cortical inhibitory interneurons</article-title><source>Nature</source><volume>555</volume><fpage>457</fpage><lpage>462</lpage><pub-id pub-id-type="doi">10.1038/nature25999</pub-id><pub-id pub-id-type="pmid">29513653</pub-id></element-citation></ref><ref id="bib55"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mi</surname> <given-names>H</given-names></name><name><surname>Muruganujan</surname> <given-names>A</given-names></name><name><surname>Casagrande</surname> <given-names>JT</given-names></name><name><surname>Thomas</surname> <given-names>PD</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Large-scale gene function analysis with the PANTHER classification system</article-title><source>Nature Protocols</source><volume>8</volume><fpage>1551</fpage><lpage>1566</lpage><pub-id pub-id-type="doi">10.1038/nprot.2013.092</pub-id><pub-id pub-id-type="pmid">23868073</pub-id></element-citation></ref><ref id="bib56"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mi</surname> <given-names>D</given-names></name><name><surname>Li</surname> <given-names>Z</given-names></name><name><surname>Lim</surname> <given-names>L</given-names></name><name><surname>Li</surname> <given-names>M</given-names></name><name><surname>Moissidis</surname> <given-names>M</given-names></name><name><surname>Yang</surname> <given-names>Y</given-names></name><name><surname>Gao</surname> <given-names>T</given-names></name><name><surname>Hu</surname> <given-names>TX</given-names></name><name><surname>Pratt</surname> <given-names>T</given-names></name><name><surname>Price</surname> <given-names>DJ</given-names></name><name><surname>Sestan</surname> <given-names>N</given-names></name><name><surname>Marín</surname> <given-names>O</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Early emergence of cortical interneuron diversity in the mouse embryo</article-title><source>Science</source><volume>360</volume><fpage>81</fpage><lpage>85</lpage><pub-id pub-id-type="doi">10.1126/science.aar6821</pub-id><pub-id pub-id-type="pmid">29472441</pub-id></element-citation></ref><ref id="bib57"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Miguel-Aliaga</surname> <given-names>I</given-names></name><name><surname>Thor</surname> <given-names>S</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>Segment-specific prevention of pioneer neuron apoptosis by cell-autonomous, postmitotic hox gene activity</article-title><source>Development</source><volume>131</volume><fpage>6093</fpage><lpage>6105</lpage><pub-id pub-id-type="doi">10.1242/dev.01521</pub-id><pub-id pub-id-type="pmid">15537690</pub-id></element-citation></ref><ref id="bib58"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Moris-Sanz</surname> <given-names>M</given-names></name><name><surname>Estacio-Gómez</surname> <given-names>A</given-names></name><name><surname>Sánchez-Herrero</surname> <given-names>E</given-names></name><name><surname>Díaz-Benjumea</surname> <given-names>FJ</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>The study of the Bithorax-complex genes in patterning CCAP neurons reveals a temporal control of neuronal differentiation by Abd-B</article-title><source>Biology Open</source><volume>4</volume><fpage>1132</fpage><lpage>1142</lpage><pub-id pub-id-type="doi">10.1242/bio.012872</pub-id><pub-id pub-id-type="pmid">26276099</pub-id></element-citation></ref><ref id="bib59"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Okaty</surname> <given-names>BW</given-names></name><name><surname>Freret</surname> <given-names>ME</given-names></name><name><surname>Rood</surname> <given-names>BD</given-names></name><name><surname>Brust</surname> <given-names>RD</given-names></name><name><surname>Hennessy</surname> <given-names>ML</given-names></name><name><surname>deBairos</surname> <given-names>D</given-names></name><name><surname>Kim</surname> <given-names>JC</given-names></name><name><surname>Cook</surname> <given-names>MN</given-names></name><name><surname>Dymecki</surname> <given-names>SM</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Multi-Scale molecular deconstruction of the serotonin neuron system</article-title><source>Neuron</source><volume>88</volume><fpage>774</fpage><lpage>791</lpage><pub-id pub-id-type="doi">10.1016/j.neuron.2015.10.007</pub-id><pub-id pub-id-type="pmid">26549332</pub-id></element-citation></ref><ref id="bib60"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pereira</surname> <given-names>L</given-names></name><name><surname>Kratsios</surname> <given-names>P</given-names></name><name><surname>Serrano-Saiz</surname> <given-names>E</given-names></name><name><surname>Sheftel</surname> <given-names>H</given-names></name><name><surname>Mayo</surname> <given-names>AE</given-names></name><name><surname>Hall</surname> <given-names>DH</given-names></name><name><surname>White</surname> <given-names>JG</given-names></name><name><surname>LeBoeuf</surname> <given-names>B</given-names></name><name><surname>Garcia</surname> <given-names>LR</given-names></name><name><surname>Alon</surname> <given-names>U</given-names></name><name><surname>Hobert</surname> <given-names>O</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>A cellular and regulatory map of the cholinergic nervous system of <italic>C. elegans</italic></article-title><source>eLife</source><volume>4</volume><elocation-id>e12432</elocation-id><pub-id pub-id-type="doi">10.7554/eLife.12432</pub-id><pub-id pub-id-type="pmid">26705699</pub-id></element-citation></ref><ref id="bib61"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Perry</surname> <given-names>M</given-names></name><name><surname>Konstantinides</surname> <given-names>N</given-names></name><name><surname>Pinto-Teixeira</surname> <given-names>F</given-names></name><name><surname>Desplan</surname> <given-names>C</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Generation and evolution of neural cell types and circuits: insights from the <italic>Drosophila</italic> Visual System</article-title><source>Annual Review of Genetics</source><volume>51</volume><fpage>501</fpage><lpage>527</lpage><pub-id pub-id-type="doi">10.1146/annurev-genet-120215-035312</pub-id><pub-id pub-id-type="pmid">28961025</pub-id></element-citation></ref><ref id="bib62"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pfeffer</surname> <given-names>PL</given-names></name><name><surname>Payer</surname> <given-names>B</given-names></name><name><surname>Reim</surname> <given-names>G</given-names></name><name><surname>di Magliano</surname> <given-names>MP</given-names></name><name><surname>Busslinger</surname> <given-names>M</given-names></name></person-group><year iso-8601-date="2002">2002</year><article-title>The activation and maintenance of Pax2 expression at the mid-hindbrain boundary is controlled by separate enhancers</article-title><source>Development</source><volume>129</volume><fpage>307</fpage><lpage>318</lpage><pub-id pub-id-type="pmid">11807024</pub-id></element-citation></ref><ref id="bib63"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Philippidou</surname> <given-names>P</given-names></name><name><surname>Dasen</surname> <given-names>JS</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Hox genes: choreographers in neural development, architects of circuit organization</article-title><source>Neuron</source><volume>80</volume><fpage>12</fpage><lpage>34</lpage><pub-id pub-id-type="doi">10.1016/j.neuron.2013.09.020</pub-id><pub-id pub-id-type="pmid">24094100</pub-id></element-citation></ref><ref id="bib64"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pikkarainen</surname> <given-names>S</given-names></name><name><surname>Tokola</surname> <given-names>H</given-names></name><name><surname>Kerkelä</surname> <given-names>R</given-names></name><name><surname>Ruskoaho</surname> <given-names>H</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>GATA transcription factors in the developing and adult heart</article-title><source>Cardiovascular Research</source><volume>63</volume><fpage>196</fpage><lpage>207</lpage><pub-id pub-id-type="doi">10.1016/j.cardiores.2004.03.025</pub-id><pub-id pub-id-type="pmid">15249177</pub-id></element-citation></ref><ref id="bib65"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pocock</surname> <given-names>R</given-names></name><name><surname>Mione</surname> <given-names>M</given-names></name><name><surname>Hussain</surname> <given-names>S</given-names></name><name><surname>Maxwell</surname> <given-names>S</given-names></name><name><surname>Pontecorvi</surname> <given-names>M</given-names></name><name><surname>Aslam</surname> <given-names>S</given-names></name><name><surname>Gerrelli</surname> <given-names>D</given-names></name><name><surname>Sowden</surname> <given-names>JC</given-names></name><name><surname>Woollard</surname> <given-names>A</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Neuronal function of Tbx20 conserved from Nematodes to vertebrates</article-title><source>Developmental Biology</source><volume>317</volume><fpage>671</fpage><lpage>685</lpage><pub-id pub-id-type="doi">10.1016/j.ydbio.2008.02.015</pub-id><pub-id pub-id-type="pmid">18358469</pub-id></element-citation></ref><ref id="bib66"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Prasad</surname> <given-names>BC</given-names></name><name><surname>Ye</surname> <given-names>B</given-names></name><name><surname>Zackhary</surname> <given-names>R</given-names></name><name><surname>Schrader</surname> <given-names>K</given-names></name><name><surname>Seydoux</surname> <given-names>G</given-names></name><name><surname>Reed</surname> <given-names>RR</given-names></name></person-group><year iso-8601-date="1998">1998</year><article-title>unc-3, a gene required for axonal guidance in <italic>Caenorhabditis elegans</italic> encodes a member of the O/E family of transcription factors</article-title><source>Development</source><volume>125</volume><fpage>1561</fpage><lpage>1568</lpage><pub-id pub-id-type="pmid">9502737</pub-id></element-citation></ref><ref id="bib67"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ramírez</surname> <given-names>F</given-names></name><name><surname>Ryan</surname> <given-names>DP</given-names></name><name><surname>Grüning</surname> <given-names>B</given-names></name><name><surname>Bhardwaj</surname> <given-names>V</given-names></name><name><surname>Kilpert</surname> <given-names>F</given-names></name><name><surname>Richter</surname> <given-names>AS</given-names></name><name><surname>Heyne</surname> <given-names>S</given-names></name><name><surname>Dündar</surname> <given-names>F</given-names></name><name><surname>Manke</surname> <given-names>T</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>deepTools2: a next generation web server for deep-sequencing data analysis</article-title><source>Nucleic Acids Research</source><volume>44</volume><fpage>W160</fpage><lpage>W165</lpage><pub-id pub-id-type="doi">10.1093/nar/gkw257</pub-id><pub-id pub-id-type="pmid">27079975</pub-id></element-citation></ref><ref id="bib68"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rhee</surname> <given-names>HS</given-names></name><name><surname>Closser</surname> <given-names>M</given-names></name><name><surname>Guo</surname> <given-names>Y</given-names></name><name><surname>Bashkirova</surname> <given-names>EV</given-names></name><name><surname>Tan</surname> <given-names>GC</given-names></name><name><surname>Gifford</surname> <given-names>DK</given-names></name><name><surname>Wichterle</surname> <given-names>H</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Expression of terminal effector genes in mammalian neurons is maintained by a dynamic relay of transient enhancers</article-title><source>Neuron</source><volume>92</volume><fpage>1252</fpage><lpage>1265</lpage><pub-id pub-id-type="doi">10.1016/j.neuron.2016.11.037</pub-id><pub-id pub-id-type="pmid">27939581</pub-id></element-citation></ref><ref id="bib69"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sabarís</surname> <given-names>G</given-names></name><name><surname>Laiker</surname> <given-names>I</given-names></name><name><surname>Preger-Ben Noon</surname> <given-names>E</given-names></name><name><surname>Frankel</surname> <given-names>N</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Actors with multiple roles: pleiotropic enhancers and the paradigm of enhancer modularity</article-title><source>Trends in Genetics</source><volume>35</volume><fpage>423</fpage><lpage>433</lpage><pub-id pub-id-type="doi">10.1016/j.tig.2019.03.006</pub-id><pub-id pub-id-type="pmid">31005339</pub-id></element-citation></ref><ref id="bib70"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schindelin</surname> <given-names>J</given-names></name><name><surname>Arganda-Carreras</surname> <given-names>I</given-names></name><name><surname>Frise</surname> <given-names>E</given-names></name><name><surname>Kaynig</surname> <given-names>V</given-names></name><name><surname>Longair</surname> <given-names>M</given-names></name><name><surname>Pietzsch</surname> <given-names>T</given-names></name><name><surname>Preibisch</surname> <given-names>S</given-names></name><name><surname>Rueden</surname> <given-names>C</given-names></name><name><surname>Saalfeld</surname> <given-names>S</given-names></name><name><surname>Schmid</surname> <given-names>B</given-names></name><name><surname>Tinevez</surname> <given-names>JY</given-names></name><name><surname>White</surname> <given-names>DJ</given-names></name><name><surname>Hartenstein</surname> <given-names>V</given-names></name><name><surname>Eliceiri</surname> <given-names>K</given-names></name><name><surname>Tomancak</surname> <given-names>P</given-names></name><name><surname>Cardona</surname> <given-names>A</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Fiji: an open-source platform for biological-image analysis</article-title><source>Nature Methods</source><volume>9</volume><fpage>676</fpage><lpage>682</lpage><pub-id pub-id-type="doi">10.1038/nmeth.2019</pub-id><pub-id pub-id-type="pmid">22743772</pub-id></element-citation></ref><ref id="bib71"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Scott</surname> <given-names>MM</given-names></name><name><surname>Krueger</surname> <given-names>KC</given-names></name><name><surname>Deneris</surname> <given-names>ES</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>A differentially autoregulated Pet-1 enhancer region is a critical target of the transcriptional cascade that governs serotonin neuron development</article-title><source>Journal of Neuroscience</source><volume>25</volume><fpage>2628</fpage><lpage>2636</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.4979-04.2005</pub-id><pub-id pub-id-type="pmid">15758173</pub-id></element-citation></ref><ref id="bib72"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shaham</surname> <given-names>S</given-names></name><name><surname>Bargmann</surname> <given-names>CI</given-names></name></person-group><year iso-8601-date="2002">2002</year><article-title>Control of neuronal subtype identity by the <italic>C. elegans</italic> ARID protein CFI-1</article-title><source>Genes &amp; Development</source><volume>16</volume><fpage>972</fpage><lpage>983</lpage><pub-id pub-id-type="doi">10.1101/gad.976002</pub-id><pub-id pub-id-type="pmid">11959845</pub-id></element-citation></ref><ref id="bib73"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shen</surname> <given-names>L</given-names></name><name><surname>Shao</surname> <given-names>N</given-names></name><name><surname>Liu</surname> <given-names>X</given-names></name><name><surname>Nestler</surname> <given-names>E</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Ngs.plot: quick mining and visualization of next-generation sequencing data by integrating genomic databases</article-title><source>BMC Genomics</source><volume>15</volume><elocation-id>284</elocation-id><pub-id pub-id-type="doi">10.1186/1471-2164-15-284</pub-id><pub-id pub-id-type="pmid">24735413</pub-id></element-citation></ref><ref id="bib74"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sleven</surname> <given-names>H</given-names></name><name><surname>Welsh</surname> <given-names>SJ</given-names></name><name><surname>Yu</surname> <given-names>J</given-names></name><name><surname>Churchill</surname> <given-names>MEA</given-names></name><name><surname>Wright</surname> <given-names>CF</given-names></name><name><surname>Henderson</surname> <given-names>A</given-names></name><name><surname>Horvath</surname> <given-names>R</given-names></name><name><surname>Rankin</surname> <given-names>J</given-names></name><name><surname>Vogt</surname> <given-names>J</given-names></name><name><surname>Magee</surname> <given-names>A</given-names></name><name><surname>McConnell</surname> <given-names>V</given-names></name><name><surname>Green</surname> <given-names>A</given-names></name><name><surname>King</surname> <given-names>MD</given-names></name><name><surname>Cox</surname> <given-names>H</given-names></name><name><surname>Armstrong</surname> <given-names>L</given-names></name><name><surname>Lehman</surname> <given-names>A</given-names></name><name><surname>Nelson</surname> <given-names>TN</given-names></name><name><surname>Williams</surname> <given-names>J</given-names></name><name><surname>Clouston</surname> <given-names>P</given-names></name><name><surname>Hagman</surname> <given-names>J</given-names></name><name><surname>Németh</surname> <given-names>AH</given-names></name><collab>Deciphering Developmental Disorders study</collab><collab>CAUSES study</collab></person-group><year iso-8601-date="2017">2017</year><article-title>De novo mutations in EBF3 cause a neurodevelopmental syndrome</article-title><source>The American Journal of Human Genetics</source><volume>100</volume><fpage>138</fpage><lpage>150</lpage><pub-id pub-id-type="doi">10.1016/j.ajhg.2016.11.020</pub-id><pub-id pub-id-type="pmid">28017370</pub-id></element-citation></ref><ref id="bib75"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Soler</surname> <given-names>C</given-names></name><name><surname>Han</surname> <given-names>J</given-names></name><name><surname>Taylor</surname> <given-names>MV</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>The conserved transcription factor Mef2 has multiple roles in adult <italic>Drosophila</italic> musculature formation</article-title><source>Development</source><volume>139</volume><fpage>1270</fpage><lpage>1275</lpage><pub-id pub-id-type="doi">10.1242/dev.077875</pub-id><pub-id pub-id-type="pmid">22357930</pub-id></element-citation></ref><ref id="bib76"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Takahashi</surname> <given-names>Y</given-names></name><name><surname>Hamada</surname> <given-names>J</given-names></name><name><surname>Murakawa</surname> <given-names>K</given-names></name><name><surname>Takada</surname> <given-names>M</given-names></name><name><surname>Tada</surname> <given-names>M</given-names></name><name><surname>Nogami</surname> <given-names>I</given-names></name><name><surname>Hayashi</surname> <given-names>N</given-names></name><name><surname>Nakamori</surname> <given-names>S</given-names></name><name><surname>Monden</surname> <given-names>M</given-names></name><name><surname>Miyamoto</surname> <given-names>M</given-names></name><name><surname>Katoh</surname> <given-names>H</given-names></name><name><surname>Moriuchi</surname> <given-names>T</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>Expression profiles of 39 HOX genes in normal human adult organs and anaplastic thyroid Cancer cell lines by quantitative real-time RT-PCR system</article-title><source>Experimental Cell Research</source><volume>293</volume><fpage>144</fpage><lpage>153</lpage><pub-id pub-id-type="doi">10.1016/j.yexcr.2003.09.024</pub-id><pub-id pub-id-type="pmid">14729064</pub-id></element-citation></ref><ref id="bib77"><element-citation publication-type="preprint"><person-group person-group-type="author"><name><surname>Taylor</surname> <given-names>SR</given-names></name><name><surname>Santpere</surname> <given-names>G</given-names></name><name><surname>Reilly</surname> <given-names>M</given-names></name><name><surname>Glenwinkel</surname> <given-names>L</given-names></name><name><surname>Poff</surname> <given-names>A</given-names></name><name><surname>McWhirter</surname> <given-names>R</given-names></name><name><surname>Xu</surname> <given-names>C</given-names></name><name><surname>Weireb</surname> <given-names>A</given-names></name><name><surname>Basavaraju</surname> <given-names>M</given-names></name><name><surname>Cook</surname> <given-names>SJ</given-names></name><name><surname>Barrett</surname> <given-names>A</given-names></name><name><surname>Abrams</surname> <given-names>A</given-names></name><name><surname>Vidal</surname> <given-names>B</given-names></name><name><surname>Cros</surname> <given-names>C</given-names></name><name><surname>Rafi</surname> <given-names>I</given-names></name><name><surname>Sestan</surname> <given-names>N</given-names></name><name><surname>Hammarlund</surname> <given-names>M</given-names></name><name><surname>Hobert</surname> <given-names>O</given-names></name><name><surname>Miller</surname> <given-names>DM</given-names></name> </person-group><year iso-8601-date="2019">2019</year><article-title>Expression profiling of the mature <italic>C. elegans</italic> nervous system by single-cell RNA-Sequencing</article-title><source>bioRxiv</source><pub-id pub-id-type="doi">10.1101/737577</pub-id></element-citation></ref><ref id="bib78"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Treiber</surname> <given-names>N</given-names></name><name><surname>Treiber</surname> <given-names>T</given-names></name><name><surname>Zocher</surname> <given-names>G</given-names></name><name><surname>Grosschedl</surname> <given-names>R</given-names></name></person-group><year iso-8601-date="2010">2010a</year><article-title>Structure of an Ebf1:dna complex reveals unusual DNA recognition and structural homology with rel proteins</article-title><source>Genes &amp; Development</source><volume>24</volume><fpage>2270</fpage><lpage>2275</lpage><pub-id pub-id-type="doi">10.1101/gad.1976610</pub-id><pub-id pub-id-type="pmid">20876732</pub-id></element-citation></ref><ref id="bib79"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Treiber</surname> <given-names>T</given-names></name><name><surname>Mandel</surname> <given-names>EM</given-names></name><name><surname>Pott</surname> <given-names>S</given-names></name><name><surname>Györy</surname> <given-names>I</given-names></name><name><surname>Firner</surname> <given-names>S</given-names></name><name><surname>Liu</surname> <given-names>ET</given-names></name><name><surname>Grosschedl</surname> <given-names>R</given-names></name></person-group><year iso-8601-date="2010">2010b</year><article-title>Early B cell factor 1 regulates B cell gene networks by activation, repression, and transcription- independent poising of chromatin</article-title><source>Immunity</source><volume>32</volume><fpage>714</fpage><lpage>725</lpage><pub-id pub-id-type="doi">10.1016/j.immuni.2010.04.013</pub-id><pub-id pub-id-type="pmid">20451411</pub-id></element-citation></ref><ref id="bib80"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname> <given-names>MM</given-names></name><name><surname>Tsai</surname> <given-names>RY</given-names></name><name><surname>Schrader</surname> <given-names>KA</given-names></name><name><surname>Reed</surname> <given-names>RR</given-names></name></person-group><year iso-8601-date="1993">1993</year><article-title>Genes encoding components of the olfactory signal transduction cascade contain a DNA binding site that may direct neuronal expression</article-title><source>Molecular and Cellular Biology</source><volume>13</volume><fpage>5805</fpage><lpage>5813</lpage><pub-id pub-id-type="doi">10.1128/MCB.13.9.5805</pub-id><pub-id pub-id-type="pmid">7689152</pub-id></element-citation></ref><ref id="bib81"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname> <given-names>SS</given-names></name><name><surname>Tsai</surname> <given-names>RY</given-names></name><name><surname>Reed</surname> <given-names>RR</given-names></name></person-group><year iso-8601-date="1997">1997</year><article-title>The characterization of the Olf-1/EBF-like HLH transcription factor family: implications in olfactory gene regulation and neuronal development</article-title><source>The Journal of Neuroscience</source><volume>17</volume><fpage>4149</fpage><lpage>4158</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.17-11-04149.1997</pub-id><pub-id pub-id-type="pmid">9151732</pub-id></element-citation></ref><ref id="bib82"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname> <given-names>MM</given-names></name><name><surname>Reed</surname> <given-names>RR</given-names></name></person-group><year iso-8601-date="1993">1993</year><article-title>Molecular cloning of the olfactory neuronal transcription factor Olf-1 by genetic selection in yeast</article-title><source>Nature</source><volume>364</volume><fpage>121</fpage><lpage>126</lpage><pub-id pub-id-type="doi">10.1038/364121a0</pub-id><pub-id pub-id-type="pmid">8321284</pub-id></element-citation></ref><ref id="bib83"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wiesenfahrt</surname> <given-names>T</given-names></name><name><surname>Berg</surname> <given-names>JY</given-names></name><name><surname>Osborne Nishimura</surname> <given-names>E</given-names></name><name><surname>Robinson</surname> <given-names>AG</given-names></name><name><surname>Goszczynski</surname> <given-names>B</given-names></name><name><surname>Lieb</surname> <given-names>JD</given-names></name><name><surname>McGhee</surname> <given-names>JD</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>The function and regulation of the GATA factor ELT-2 in the <italic>C. elegans</italic> endoderm</article-title><source>Development</source><volume>143</volume><fpage>483</fpage><lpage>491</lpage><pub-id pub-id-type="doi">10.1242/dev.130914</pub-id><pub-id pub-id-type="pmid">26700680</pub-id></element-citation></ref><ref id="bib84"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wyler</surname> <given-names>SC</given-names></name><name><surname>Spencer</surname> <given-names>WC</given-names></name><name><surname>Green</surname> <given-names>NH</given-names></name><name><surname>Rood</surname> <given-names>BD</given-names></name><name><surname>Crawford</surname> <given-names>L</given-names></name><name><surname>Craige</surname> <given-names>C</given-names></name><name><surname>Gresch</surname> <given-names>P</given-names></name><name><surname>McMahon</surname> <given-names>DG</given-names></name><name><surname>Beck</surname> <given-names>SG</given-names></name><name><surname>Deneris</surname> <given-names>E</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Pet-1 switches transcriptional targets postnatally to regulate maturation of serotonin neuron excitability</article-title><source>The Journal of Neuroscience</source><volume>36</volume><fpage>1758</fpage><lpage>1774</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.3798-15.2016</pub-id><pub-id pub-id-type="pmid">26843655</pub-id></element-citation></ref><ref id="bib85"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xue</surname> <given-names>D</given-names></name><name><surname>Finney</surname> <given-names>M</given-names></name><name><surname>Ruvkun</surname> <given-names>G</given-names></name><name><surname>Chalfie</surname> <given-names>M</given-names></name></person-group><year iso-8601-date="1992">1992</year><article-title>Regulation of the mec-3 gene by the <italic>C. elegans</italic> homeoproteins UNC-86 and MEC-3</article-title><source>The EMBO Journal</source><volume>11</volume><fpage>4969</fpage><lpage>4979</lpage><pub-id pub-id-type="doi">10.1002/j.1460-2075.1992.tb05604.x</pub-id><pub-id pub-id-type="pmid">1361171</pub-id></element-citation></ref><ref id="bib86"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yemini</surname> <given-names>E</given-names></name><name><surname>Jucikas</surname> <given-names>T</given-names></name><name><surname>Grundy</surname> <given-names>LJ</given-names></name><name><surname>Brown</surname> <given-names>AE</given-names></name><name><surname>Schafer</surname> <given-names>WR</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>A database of <italic>Caenorhabditis elegans</italic> behavioral phenotypes</article-title><source>Nature Methods</source><volume>10</volume><fpage>877</fpage><lpage>879</lpage><pub-id pub-id-type="doi">10.1038/nmeth.2560</pub-id><pub-id pub-id-type="pmid">23852451</pub-id></element-citation></ref><ref id="bib87"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yu</surname> <given-names>G</given-names></name><name><surname>Wang</surname> <given-names>LG</given-names></name><name><surname>He</surname> <given-names>QY</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>ChIPseeker: an R/Bioconductor package for ChIP peak annotation, comparison and visualization</article-title><source>Bioinformatics</source><volume>31</volume><fpage>2382</fpage><lpage>2383</lpage><pub-id pub-id-type="doi">10.1093/bioinformatics/btv145</pub-id><pub-id pub-id-type="pmid">25765347</pub-id></element-citation></ref><ref id="bib88"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yu</surname> <given-names>B</given-names></name><name><surname>Wang</surname> <given-names>X</given-names></name><name><surname>Wei</surname> <given-names>S</given-names></name><name><surname>Fu</surname> <given-names>T</given-names></name><name><surname>Dzakah</surname> <given-names>EE</given-names></name><name><surname>Waqas</surname> <given-names>A</given-names></name><name><surname>Walthall</surname> <given-names>WW</given-names></name><name><surname>Shan</surname> <given-names>G</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Convergent transcriptional programs regulate cAMP levels in <italic>C. elegans</italic> GABAergic Motor Neurons</article-title><source>Developmental Cell</source><volume>43</volume><fpage>212</fpage><lpage>226</lpage><pub-id pub-id-type="doi">10.1016/j.devcel.2017.09.013</pub-id><pub-id pub-id-type="pmid">29033363</pub-id></element-citation></ref><ref id="bib89"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname> <given-names>L</given-names></name><name><surname>Ward</surname> <given-names>JD</given-names></name><name><surname>Cheng</surname> <given-names>Z</given-names></name><name><surname>Dernburg</surname> <given-names>AF</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>The auxin-inducible degradation (AID) system enables versatile conditional protein depletion in <italic>C. elegans</italic></article-title><source>Development</source><volume>142</volume><fpage>4374</fpage><lpage>4384</lpage><pub-id pub-id-type="doi">10.1242/dev.129635</pub-id><pub-id pub-id-type="pmid">26552885</pub-id></element-citation></ref><ref id="bib90"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zheng</surname> <given-names>C</given-names></name><name><surname>Jin</surname> <given-names>FQ</given-names></name><name><surname>Chalfie</surname> <given-names>M</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Hox proteins act as transcriptional guarantors to ensure terminal differentiation</article-title><source>Cell Reports</source><volume>13</volume><fpage>1343</fpage><lpage>1352</lpage><pub-id pub-id-type="doi">10.1016/j.celrep.2015.10.044</pub-id><pub-id pub-id-type="pmid">26547238</pub-id></element-citation></ref><ref id="bib91"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhong</surname> <given-names>M</given-names></name><name><surname>Niu</surname> <given-names>W</given-names></name><name><surname>Lu</surname> <given-names>ZJ</given-names></name><name><surname>Sarov</surname> <given-names>M</given-names></name><name><surname>Murray</surname> <given-names>JI</given-names></name><name><surname>Janette</surname> <given-names>J</given-names></name><name><surname>Raha</surname> <given-names>D</given-names></name><name><surname>Sheaffer</surname> <given-names>KL</given-names></name><name><surname>Lam</surname> <given-names>HY</given-names></name><name><surname>Preston</surname> <given-names>E</given-names></name><name><surname>Slightham</surname> <given-names>C</given-names></name><name><surname>Hillier</surname> <given-names>LW</given-names></name><name><surname>Brock</surname> <given-names>T</given-names></name><name><surname>Agarwal</surname> <given-names>A</given-names></name><name><surname>Auerbach</surname> <given-names>R</given-names></name><name><surname>Hyman</surname> <given-names>AA</given-names></name><name><surname>Gerstein</surname> <given-names>M</given-names></name><name><surname>Mango</surname> <given-names>SE</given-names></name><name><surname>Kim</surname> <given-names>SK</given-names></name><name><surname>Waterston</surname> <given-names>RH</given-names></name><name><surname>Reinke</surname> <given-names>V</given-names></name><name><surname>Snyder</surname> <given-names>M</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Genome-wide identification of binding sites defines distinct functions for Caenorhabditis elegans PHA-4/FOXA in development and environmental response</article-title><source>PLOS Genetics</source><volume>6</volume><elocation-id>e1000848</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pgen.1000848</pub-id><pub-id pub-id-type="pmid">20174564</pub-id></element-citation></ref><ref id="bib92"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhou</surname> <given-names>Q</given-names></name><name><surname>Liu</surname> <given-names>M</given-names></name><name><surname>Xia</surname> <given-names>X</given-names></name><name><surname>Gong</surname> <given-names>T</given-names></name><name><surname>Feng</surname> <given-names>J</given-names></name><name><surname>Liu</surname> <given-names>W</given-names></name><name><surname>Liu</surname> <given-names>Y</given-names></name><name><surname>Zhen</surname> <given-names>B</given-names></name><name><surname>Wang</surname> <given-names>Y</given-names></name><name><surname>Ding</surname> <given-names>C</given-names></name><name><surname>Qin</surname> <given-names>J</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>A mouse tissue transcription factor atlas</article-title><source>Nature Communications</source><volume>8</volume><elocation-id>15089</elocation-id><pub-id pub-id-type="doi">10.1038/ncomms15089</pub-id><pub-id pub-id-type="pmid">28429721</pub-id></element-citation></ref></ref-list></back><sub-article article-type="decision-letter" id="sa1"><front-stub><article-id pub-id-type="doi">10.7554/eLife.59464.sa1</article-id><title-group><article-title>Decision letter</article-title></title-group><contrib-group><contrib contrib-type="editor"><name><surname>Desplan</surname><given-names>Claude</given-names></name><role>Reviewing Editor</role><aff><institution>New York University</institution><country>United States</country></aff></contrib></contrib-group><contrib-group><contrib contrib-type="reviewer"><name><surname>Chuang</surname><given-names>Chiou-Fen</given-names> </name><role>Reviewer</role><aff><institution/></aff></contrib></contrib-group></front-stub><body><boxed-text><p>In the interests of transparency, eLife publishes the most substantive revision requests and the accompanying author responses.</p></boxed-text><p><bold>Acceptance summary:</bold></p><p>This paper addresses the important point of how transcription factors maintain the identity of the tissue they specify. In this case, the paper shows how UNC-3 maintains motor neuron identity and addresses whether it retains the same targets through time and how dynamic it is. The use of a ChIP time series allowed the identification of the gene targets in very few neurons, showing that UNC-3 binds to (not all) terminal genes and to other genes, engaging in a broad regulatory networks.</p><p><bold>Decision letter after peer review:</bold></p><p>Thank you for submitting your article &quot;Establishment and maintenance of motor neuron identity via temporal modularity in terminal selector function&quot; for consideration by <italic>eLife</italic>. Your article has been reviewed by three peer reviewers, and the evaluation has been overseen by a Reviewing Editor and Marianne Bronner as the Senior Editor. The following individual involved in review of your submission has agreed to reveal their identity: Chiou-Fen Chuang (Reviewer #2).</p><p>The reviewers have discussed the reviews with one another and the Reviewing Editor has drafted this decision to help you prepare a revised submission.</p><p>Your paper addresses the important point of how transcription factors maintain the identity of the tissue they specify. In this case, how does UNC-3 maintain motor neuron identity: Does it retain the same targets though time or is are they dynamic?</p><p>Your use of a ChIP time series allowed you to identify the gene targets in very few neurons, showing that UNC-3 binds to terminal genes and other genes, engaging in broad regulatory networks. You also showed, however, that some terminal genes might not always require direct UNC-3 input.</p><p>It is important that you clarify the difference between target genes for which UNC-3 works as a terminal selector versus those where it only initiates activation and is not required for maintenance.</p><p>The reviewers would therefore like you to examine whether UNC-3 is dispensable for reporter gene maintenance in some of the reporters. This should be a fairly easy experiment as you have UNC-3-AID worms where UNC-3 can be degraded after induction of gene expression. This point should also be discussed in detail in the paper.</p><p>We would like to draw your attention to changes in our revision policy that we have made in response to COVID-19 (https://elifesciences.org/articles/57162). Specifically, when editors judge that a submitted work as a whole belongs in <italic>eLife</italic> but that some conclusions require a modest amount of additional new data, as they do with your paper, we are asking that the manuscript be revised to either limit claims to those supported by data in hand, or to explicitly state that the relevant conclusions require additional supporting data.</p><p>Our expectation is that the authors will eventually carry out the additional experiments and report on how they affect the relevant conclusions either in a preprint on bioRxiv or medRxiv, or if appropriate, as a Research Advance in <italic>eLife</italic>, either of which would be linked to the original paper.</p><p><italic>Reviewer #1:</italic></p><p>Understating how neurons keep their identity is an important question in developmental biology and neuroscience. Li and co-workers use a previously we-all established <italic>C. elegans</italic> model to investigate how UNC-3 maintains motor neuron identity. Specifically, the authors aim to address if UNC-3 maintains its targets though time or its binding and targets are dynamic.</p><p>The authors use an appropriate method, a ChIP time series. It is technically challenging to obtain a time series for a gene expressed in a few neurons, and thus by itself is an achievement. UNC-3 binds to &quot;classic&quot; terminal genes but also other regulatory genes. This data suggest UNC-3 is, and perhaps all terminal selectors, engage in broader regulatory networks. The UNC-3 binding dynamics also revealed that some terminal genes might not require direct UNC-3 input at some developmental stages. Moreover, the authors find a possible &quot;initiation module&quot; for the motor neuron program that required UNC-3 for maintenance.</p><p>I am less convinced the presented experiments support &quot;Disruption of temporal modularity in UNC-3 function leads to locomotion defects&quot;, as the subtitle claims. The experiments are designed around the <italic>cfi-1</italic>. Moreover, &quot;it is unclear whether the expression of UNC-3 targets from the &quot;maintenance-only&quot; module is critical for locomotion&quot;. Following the authors' logic, it is not clear UNC-3 is a terminal selector because it might not be required to maintain cell fate. I believe it is good to challenge hypotheses, but the experiments must be designed to do so.</p><p>The results are not itself conceptually novel as other temporal TF series have been described, even for motor neurons. However, the work is a significant addition to their previous <italic>eLife</italic> publication. Thus, this reviewer believes it is appropriate as a Research Advance.</p><p><italic>Reviewer #2:</italic></p><p>Establishment and maintenance of motor neuron identity via temporal modularity in terminal selector function.</p><p>In this paper, the authors identified direct targets of UNC-3/Ebf, the terminal selector of <italic>C. elegans</italic> cholinergic motor neurons, using ChIP-seq. They found that UNC-3 is required for the initiation and maintenance of expression of one group of target genes, but UNC-3 is only required to maintain expression of motor neuron-specific transcription factors such as CFI-1. The authors also found that the Hox proteins LIN-39 and MAB-5 act synergistically to control initiation and maintenance of <italic>cfi-1</italic> in cholinergic motor neurons through the same distal enhancer used by UNC-3 to maintain <italic>cfi-1</italic> expression. The authors used the auxin-inducible protein degradation system to show that <italic>cfi-1</italic> is required post-embryonically to maintain motor neuron subtype identity. In addition, a <italic>cfi-1</italic> null mutation and deletion of the <italic>cfi-1</italic> enhancer region cause locomotion defects. Furthermore, UNC-30, the terminal selector of GABAergic motor neurons, is required for the maintenance, but not initiation, of <italic>cfi-1</italic> expression in GABAergic neurons. In summary, this study reveals temporal modularity in terminal selector function for motor neuron identity.</p><p>The paper is well written and figures are clearly organized.</p><p><italic>Reviewer #3:</italic></p><p>The manuscript by Li et al. describes in depth analysis of UNC-3 target genes. The genes can be divided based on the UNC-3 role as initiation and maintenance genes and maintenance only. The authors focus on the regulation of one target transcription factor – <italic>cfi-1</italic>. They identify an enhancer that recapitulates to large extent normal <italic>cfi-1</italic> expression and provide evidence that the expression is initiated by Hox factors LIN-39 and MAB-5, while maintenance of the expression is controlled by UNC-3, possibly in conjunction with the Hox factors. Failure to maintain expression of CFI-1 in adult motor neurons has detrimental effects on motor neuron gene expression and worm motor behavior.</p><p>The findings are supported by extensive experimental evidence and in depth genetic and biochemical analysis of the enhancer. Overall this is an interesting in depth analysis of regulatory elements that sheds new light on dynamic changes in transcriptional complexes controlling target gene expression. Below I list several points that the authors should consider during the revision of the manuscript.</p><p>1) The authors place a lot of emphasis on division of target genes into two groups: initiation/ maintenance and maintenance only. However, the maintenance role in the first category has not been rigorously tested. That would require transient expression of <italic>unc-3</italic> early to turn the reporters on, followed by UNC-3 degradation. This raises the possibility that the first category can be subdivided into another subgroup – initiation only genes. Such possibility should be included in the Discussion.</p><p>2) The complexity of expression patterns observed with the transgenic reporters (some are on at L2 some only at L4, some are on in most neurons some in very few), demonstrates that the studied enhancers are regulated by multiple additional transcription factors besides UNC-3 (e.g. MAB-5/LIN-39 shown later in the manuscript). Thus, the conclusion that &quot;UNC-3 can also act directly to either activate or repress expression of multiple TF-encoding genes&quot; needs to be reconsidered, as a likely scenario is that UNC-3 binding to the regulatory element facilitates recruitment of another transcription factor that functions as a strong repressor.</p><p>3) Describing the results in Figure 4 the authors state: &quot;Instead, it identified a 2.5 kb distal element (reporter #7) demarcated by the UNC-3 binding peak (Figure 4A)&quot;. Isn't this the same fragment as the one already tested in Figure 3? Please clarify.</p><p>4) The authors claim that 769bp sequence is necessary and sufficient for expression of reporter gene, however I do not see data testing the sufficiency of this particular fragment. Sufficiency is tested for construct #8 (552bp) that recapitulates only partially expression of <italic>cfi-1</italic> reporter. Moreover, it seems that even the full 2.5kb fragment is not sufficient to completely recapitulate the kinetics of <italic>cfi-1</italic> expression as the transgenic reporter is expressed in ~12 motor neurons (Figure 3B) in L2 while <italic>cfi-1</italic> endogenous reporter is on in ~25 neurons (Figure 4D).</p><p>5) Does UNC-3 bind to the <italic>cfi-1</italic> enhancer in the absence of MAB-5 and LIN-39 or do these factors have to &quot;pioneer&quot; the enhancer for UNC-3 recruitment? Would replacement of the enhancer with a synthetic element that carries only multimeric UNC-3 binding sites suffice to induce expression of <italic>cfi-1</italic> in cholinergic motor neurons?</p><p>6) What is the status of MAB-5 and LIN-39 expression in <italic>unc-3</italic> mutants? And how about UNC-3 expression in <italic>lin-39</italic>/<italic>mab-5</italic> mutants? The authors should consider the fate switch of motor neurons in <italic>unc-3</italic> mutants that could negatively affect maintenance of many motor neuron genes indirectly and independent of the UNC-3 binding sites identified in their promoters.</p><p>7) The 8 COE motifs mut animals should be examined for derepression of <italic>glr-4</italic> in adult motor neurons.</p></body></sub-article><sub-article article-type="reply" id="sa2"><front-stub><article-id pub-id-type="doi">10.7554/eLife.59464.sa2</article-id><title-group><article-title>Author response</article-title></title-group></front-stub><body><disp-quote content-type="editor-comment"><p>It is important that you clarify the difference between target genes for which UNC-3 works as a terminal selector versus those where it only initiates activation and is not required for maintenance.</p><p>The reviewers would therefore like you to examine whether UNC-3 is dispensable for reporter gene maintenance in some of the reporters. This should be a fairly easy experiment as you have UNC-3-AID worms where UNC-3 can be degraded after induction of gene expression. This point should also be discussed in detail in the paper.</p></disp-quote><p>We thank the reviewers for their constructive comments. Through additional experiments and text modifications, we now clarify in the revised manuscript how UNC-3 controls over time these two distinct sets of target genes (module #1: terminal identity genes require UNC-3 for both initiation and maintenance; module #2: motor neuron-specific TFs require UNC-3 only for maintenance). All new data are included and discussed in detail in the revised manuscript (as described below).</p><disp-quote content-type="editor-comment"><p>Reviewer #1:</p><p>[…]</p><p>I am less convinced the presented experiments support &quot;Disruption of temporal modularity in UNC-3 function leads to locomotion defects&quot;, as the subtitle claims. The experiments are designed around the cfi-1.</p></disp-quote><p>We totally agree with the reviewer and modified the subtitle in the Results to &quot;<italic>Minimal</italic> disruption of temporal modularity in UNC-3 function leads to locomotion defects&quot;. As the reviewer correctly points out for this behavioral experiment, we only interfered with the ability of UNC-3 to maintain a single target gene (<italic>cfi-1</italic>) by using a CRISPR-engineered allele that bears mutations in the UNC-3 binding sites located at the distal enhancer of <italic>cfi-1</italic> (Figure 6). Apart from these specific mutations that selectively affect <italic>cfi-1</italic> maintenance (Figure 4E-F), animals carrying this allele do not bear any other mutations in UNC-3 targets either from module #1 (targets that require UNC-3 for initiation and maintenance) or module #2 (targets that require UNC-3 for maintenance only). Hence, the disruption of temporal modularity in UNC-3 function is minimal because UNC-3 can control all those targets, except one. In the revised manuscript, we modified the text in the Results (subsection “Minimal disruption of temporal modularity in UNC-3 function leads to locomotion defects”) to explain better our findings. Also, the phrase “<italic>minimal</italic> disruption…” appears in Abstract, Introduction, Results, and Discussion.</p><disp-quote content-type="editor-comment"><p>Moreover, &quot;it is unclear whether the expression of UNC-3 targets from the &quot;maintenance-only&quot; module is critical for locomotion&quot;.</p></disp-quote><p>Following the reviewer’s suggestion, we modified this sentence to:</p><p>“However, it is unclear whether, <italic>in cholinergic MNs</italic>, the <italic>maintained</italic> expression of <italic>any of the</italic> UNC-3 targets from the “maintenance-only” module is critical for locomotion”.</p><disp-quote content-type="editor-comment"><p>Following the authors' logic, it is not clear UNC-3 is a terminal selector because it might not be required to maintain cell fate. I believe it is good to challenge hypotheses, but the experiments must be designed to do so.</p></disp-quote><p>We thank the reviewer for this comment, which enabled us to improve the manuscript in two ways. First, we used the auxin-inducible degradation (AID) system to selectively deplete UNC-3 in MNs at late larval/early adult stages. We found that UNC-3 is required to maintain the expression of 3 terminal identity genes (<italic>unc-17/ VAChT, acr-2/AChR, glr-4/GluR</italic>) (new Figure 3—figure supplement 2). In previous work (Kerk et al., 2017), we showed that UNC-3 is also required to maintain expression of another terminal identity gene (<italic>unc-129/ TGFb</italic>) in cholinergic MNs. In the current manuscript, we further found – by using a null allele – that UNC-3 is required to establish the early expression of all these 4 terminal identity genes (Figure 3A). Since the terminal selector definition entails that a TF is required to establish and maintain the expression of key effector molecules (e.g., neurotransmitter biosynthesis components, neurotransmitter receptors, ion channels) in a specific neuron type, our findings support the idea that UNC-3 operates as a terminal selector in cholinergic MNs. These new data are discussed in the Results (subsection “Temporal modularity of UNC-3 function in cholinergic motor neurons”) and Discussion (subsection “Temporal modularity offers key insights into how terminal selectors control neuronal identity over time”).</p><p>Second, we improved the Discussion (see the aforementioned subsection) by explaining that our findings do support the traditional view of how terminal selectors work. We find that module #1 targets do require UNC-3 both for initiation and maintenance, in accordance with the terminal selector concept. At the same time, our findings expand our understanding of terminal selectors because we suggest that terminal selector function can be more dynamic than previously thought. This is based on the data on module #2 targets that selectively require UNC-3 for maintenance (not initiation), suggesting terminal selectors can gain additional targets at later life stages.</p><disp-quote content-type="editor-comment"><p>The results are not itself conceptually novel as other temporal TF series have been described, even for motor neurons. However, the work is a significant addition to their previous eLife publication. Thus, this reviewer believes it is appropriate as a Research Advance.</p></disp-quote><p>To help the reader, we clarify in the revised manuscript the potential significance of temporal modularity in terminal selector function and how it expands our understanding of how terminal selectors control neuronal identity (Discussion, subsections “Temporal modularity in terminal selector function may represent a general principle for neuronal subtype diversity” and “Temporal modularity offers key insights into how terminal selectors control neuronal identity over time”).</p><disp-quote content-type="editor-comment"><p>Reviewer #3:</p><p>[…] Below I list several points that the authors should consider during the revision of the manuscript.</p><p>1) The authors place a lot of emphasis on division of target genes into two groups: initiation/ maintenance and maintenance only. However, the maintenance role in the first category has not been rigorously tested. That would require transient expression of unc-3 early to turn the reporters on, followed by UNC-3 degradation. This raises the possibility that the first category can be subdivided into another subgroup – initiation only genes. Such possibility should be included in the Discussion.</p></disp-quote><p>We thank the reviewer for this important point. We performed new experiments using the auxin-inducible degradation (AID) system to selectively deplete UNC-3 in MNs at late larval/early adult stages. We found that UNC-3 is required to maintain the expression of 3 terminal identity genes (<italic>unc-17/ VAChT, acr-2/AChR, glr-4/GluR</italic>) (new Figure 3—figure supplement 2). In previous work (Kerk et al., 2017), we showed that UNC-3 is also required to maintain expression of another terminal identity gene (<italic>unc-129/ TGFb</italic>) in cholinergic MNs. In the current manuscript, we further show – by using a null allele – that UNC-3 is required to establish the early expression of all these 4 genes (Figure 3A). Since the terminal selector definition entails that a TF is required to establish and maintain the expression of key effector molecules (e.g., neurotransmitter biosynthesis components, neurotransmitter receptors, ion channels) in a specific neuron type, our findings support the idea that UNC-3 operates as a terminal selector in cholinergic MNs. These new data are discussed in the Results (subsection “Temporal modularity of UNC-3 function in cholinergic motor neurons”) and Discussion (subsection “Temporal modularity offers key insights into how terminal selectors control neuronal identity over time”).</p><p>Moreover, the identification of UNC-3 targets from module #2 (e.g., UNC-3 is required to maintain, but not initiate, <italic>cfi-1</italic> expression) expand our understanding of how terminal selectors control neuronal identity over time (Discussion, subsection “Temporal modularity offers key insights into how terminal selectors control neuronal identity over time”). As the reviewer correctly points out, UNC-3 could also be controlling additional targets in a different manner, for example, by only inducing but not maintaining their expression. This possibility is now mentioned in the Discussion (subsection “Limitations of this study”).</p><disp-quote content-type="editor-comment"><p>2) The complexity of expression patterns observed with the transgenic reporters (some are on at L2 some only at L4, some are on in most neurons some in very few), demonstrates that the studied enhancers are regulated by multiple additional transcription factors besides UNC-3 (e.g. MAB-5/LIN-39 shown later in the manuscript). Thus, the conclusion that &quot;UNC-3 can also act directly to either activate or repress expression of multiple TF-encoding genes&quot; needs to be reconsidered, as a likely scenario is that UNC-3 binding to the regulatory element facilitates recruitment of another transcription factor that functions as a strong repressor.</p></disp-quote><p>We totally agree and have included this possibility in the Results (subsection “<italic>Cis</italic>-regulatory analysis reveals novel TFs as direct UNC-3 targets in motor neurons”). In addition, the section entitled “Hox proteins collaborate with stage-specific TFs to establish and maintain MN terminal identity” in the Discussion mentions that additional, yet-to-be-identified factors are involved to control expression of UNC-3 targets.</p><disp-quote content-type="editor-comment"><p>3) Describing the results in Figure 4 the authors state: &quot;Instead, it identified a 2.5 kb distal element (reporter #7) demarcated by the UNC-3 binding peak (Figure 4A)&quot;. Isn't this the same fragment as the one already tested in Figure 3? Please clarify.</p></disp-quote><p>Yes, it is the same fragment. We changed this confusing sentence to the following: “Instead, it showed that the same 2.5 kb distal element (reporter #7), that drives RFP expression in subsets of <italic>unc-3</italic>-expressing cholinergic MNs (DA, DB, VA, VB subtypes) at larval and adult stages (Figure 3B), is also sufficient for embryonic (3-fold stage) MN expression (Figure 4A-C).”</p><disp-quote content-type="editor-comment"><p>4) The authors claim that 769bp sequence is necessary and sufficient for expression of reporter gene, however I do not see data testing the sufficiency of this particular fragment. Sufficiency is tested for construct #8 (552bp) that recapitulates only partially expression of cfi-1 reporter. Moreover, it seems that even the full 2.5kb fragment is not sufficient to completely recapitulate the kinetics of cfi-1 expression as the transgenic reporter is expressed in ~12 motor neurons (Figure 3B) in L2 while cfi-1 endogenous reporter is on in ~25 neurons (Figure 4D).</p></disp-quote><p>We apologize for the confusion. The revised manuscript now states: “We conclude that a distal 2.5kb enhancer (located ~12 kb upstream of <italic>cfi-1</italic>) is sufficient for <italic>cfi-1</italic> expression in nerve cord MNs. Genome editing suggests that a 769 bp sequence within this 2.5kb enhancer is required for both initiation and maintenance of <italic>cfi-1</italic> in nerve cord MNs (Figure 4D)”.</p><disp-quote content-type="editor-comment"><p>5) Does UNC-3 bind to the cfi-1 enhancer in the absence of MAB-5 and LIN-39 or do these factors have to &quot;pioneer&quot; the enhancer for UNC-3 recruitment? Would replacement of the enhancer with a synthetic element that carries only multimeric UNC-3 binding sites suffice to induce expression of cfi-1 in cholinergic motor neurons?</p></disp-quote><p>These are both excellent questions. The first one is technically very challenging as it would require us to perform an UNC-3 ChIP experiment on <italic>lin-39 (-); mab-5 (-)</italic> double mutant animals at different developmental stages (embryos and larvae). Getting the required amount of animals for this experiment is extremely difficult, judging from our lab’s experience with ChIP-seq. We also attempted to address this question genetically by increasing the expression levels of UNC-3 in cholinergic motor neurons of <italic>lin-39 (-); mab-5 (-)</italic> double mutants. However, we were unable to generate the required transgenic animals for this experiment, despite repeated attempts.</p><p>To address the second question, we generated transgenic animals carrying 5 copies of the UNC-3 binding site fused to GFP. These animals failed to show GFP expression in cholinergic motor neurons at every life stage examined (larvae, adults), suggesting that other factors are needed to cooperate with UNC-3 and activate its target genes. This scenario is in agreement with our <italic>cfi-1</italic> findings: we propose that the Hox proteins (LIN-39 and MAB-5) cooperate with UNC-3 to control <italic>cfi-1</italic> expression in cholinergic motor neurons (Figure 5G).</p><disp-quote content-type="editor-comment"><p>6) What is the status of MAB-5 and LIN-39 expression in unc-3 mutants? And how about UNC-3 expression in lin-39/mab-5 mutants?</p></disp-quote><p>In a previous study (Kratsios et al., 2017), we showed that the Hox proteins (LIN-39, MAB-5) and UNC-3 do not cross-regulate each other’s expression in cholinergic motor neurons. We added this important information in the Results (subsection “LIN-39 (Scr/Dfd/Hox4-5) and MAB-5 (Antp/Hox6-8) control <italic>cfi-1</italic> expression in cholinergic MNs through the same distal enhancer).</p><disp-quote content-type="editor-comment"><p>The authors should consider the fate switch of motor neurons in unc-3 mutants that could negatively affect maintenance of many motor neuron genes indirectly and independent of the UNC-3 binding sites identified in their promoters.</p></disp-quote><p>We are now mentioning this possibility in the Discussion (subsection “Limitations of this study”).</p><disp-quote content-type="editor-comment"><p>7) The 8 COE motifs mut animals should be examined for derepression of glr-4 in adult motor neurons.</p></disp-quote><p>As mentioned in the Results, CFI-1 represses <italic>glr-4/GluR</italic> expression in a subset of cholinergic MNs (~12 cells) that correspond to DA and DB subtypes. Animals carrying 8 COE motifs (UNC-3 sites) mutated in the context of the endogenous <italic>cfi-1</italic> reporter allele (<italic>mNG::AID::cfi-1<sup>8 COE motifs mut</sup></italic>) show a reduction (from ~30 to ~15 <italic>cfi-1+</italic> cells), but not complete elimination, of <italic>cfi-1</italic> expression in adult (Day 1) cholinergic MNs (Figure 4E-F). This partial elimination is likely due to the presence of cryptic UNC-3 sites that we did not identify and therefore did not mutate in the <italic>mNG::AID::cfi-1<sup>8 COE motifs mut</sup></italic> allele. Supporting this possibility, <italic>cfi-1</italic> expression at Day 1 in <italic>unc-3 (-)</italic> null animals is more severely affected compared to <italic>mNG::AID::cfi-1<sup>8 COE motifs mut</sup></italic> animals (Figure 4E-F). Hence, the remaining expression of <italic>cfi-1</italic> in ~ 15 MNs of <italic>mNG::AID::cfi-1<sup>8 COE motifs mut</sup></italic> animals is likely the reason that we did not observe <italic>glr-4/GluR</italic> ectopic expression in MNs of these animals (new data in Figure 5—figure supplement 2B). We mention this reason in the figure legend.</p><p>However, animals that carry the <italic>mNG::AID::cfi-1<sup>Δ enhancer (769 bp)</sup></italic> allele and completely lack c<italic>fi-1</italic> expression in cholinergic motor neurons at all stages (Figure 4D) do show <italic>glr-4/GluR</italic> expression in MNs to similar levels observed in <italic>cfi-1 (ot786)</italic> putative null animals (new data in Figure 5—figure supplement 2B). We mention this data in the Results (subsection “<italic>cfi-1</italic>/Arid3a is required post-embryonically to maintain MN subtype identity”).</p></body></sub-article></article>